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Prohibitins (PHBs) are a class of conserved mitochondrial proteins that 
profoundly influence ageing. PHB depletion shortens the lifespan of wild type 
animals, while it causes a dramatic extension in metabolically compromised 
daf-2(e1370) mutants. This opposing lifespan phenotype is attributed to 
alterations in mitochondrial function and metabolism, but the exact function of 
PHBs is yet to be deciphered.  This project was developed to better understand 
the function of the essential mitochondrial prohibitins in the regulation of 
ageing. To elucidate novel signalling mechanisms mediating the metabolic 
adjustments that lead to opposite ageing outcomes in response to PHB 
depletion, we performed a kinase RNAi screen using prohibitin deletion 
mutants. First, we characterized prohibitin deletion mutants. As these mutants 
are sterile, they are maintained balanced heterozygous. We accomplished a 
sorting protocol for selection of homozygous PHB mutants. We used vital Nile 
Red (NR) staining as a read-out as PHB depletion reduces NR staining. In order 
to quantify the intensity of NR staining, we developed an image analysis 
protocol. From the screen, we identified the conserved Glycogen Synthase 
Kinase-3 (GSK-3), as a strong suppressor of the reduced NR staining phenotype 
caused by prohibitin deletion mutants.  
Beyond its role as a regulator of insulin-dependent glycogen synthesis, GSK-3 
also controls critical cellular functions. We investigated how GSK-3 influences 
longevity in conditions of compromised insulin signalling and mitochondrial 
impairment. We demonstrate that GSK-3 depletion decreases wild type 
lifespan but does not affect phb-2 mutants. However, the long lived daf-2 and 
phb-2;daf-2 mutants show strong suppression in lifespan upon loss of GSK-3. 
We show that GSK-3 is ubiquitously expressed via CRISPR-Cas9 endogenous 
gene tagging. We examined several parameters, including alterations in energy 
stores - glycogen/triglycerides, mitochondrial respiration and lipid composition 
to deduce how metabolic alterations upon GSK-3 depletion influence lifespan 
and found that these varied in a genetic background specific manner. 
Additionally, we also prove that the activity of GSK-3 is essential in the 
intestine for normal ageing and especially for the long lived daf-2 mutants. Our 
data thus, delineates a novel role for GSK-3 in metabolism and its interplay 





°C - Degree Celsius 
age-1  - AGEing alteration 
AMPK - AMP-activated protein kinase 
Amp - Ampicillin 
ATGL - Adipose triglyceride lipase 
ATP - Adenosine triphosphate 
bp  - Base pair 
cDNA - Complementary DNA 
CGC - Caenorhabditis Genetics Centre 
CK1 - Casein kinase I 
CRISPR - Clustered regularly interspaced                                                                                                         
short palindromic repeats  
daf - Dauer formation  
dInR - Drosophila insulin like receptor 
DNA - Deoxyribonucleic acid 
DNC - Dorsal Nerve Cord 
dsRNA - Double stranded ribonucleic acid 
E. coli - Escherichia coli 
EMS - Ethyl methanesulfonate  
ETC - Electron transport chain 
EtOH - Ethanol 
FOXO - Forkhead box O 
FUdR - Fluorodeoxyuridine 
GFP - Green Fluorescent Protein  
GSK-3       - Glycogen Synthase Kinase-3 
GST - Glutathione-S-transferase 
HSF-1 - Heat shock transcription factor-1 
IGF-1R - Insulin-like growth factor-1  
 receptor 
IIS  - Insulin/ insulin-like growth factor-1  
  signalling 
IPTG - Isopropyl- β-D- 
  thiogalactopyranoside 
IR-A - Insulin receptor-A 
IR-B - Insulin receptor-B 
 
kDa - KiloDalton 
KH2PO4  - Potassium dihydrogen phosphate 
KOH - Potassium hydroxide 
LB - Luria–Bertani 
MgSO4  - Magnesium sulphate 
MQ - MilliQ 
mRNA - Messenger Ribonucleic acid 
Na2HPO4 - Disodium hydrogen phosphate 
NaCl - Sodium chloride 
NAD
+
 - Nicotinamide adenine dinucleotide 
NaOH - Sodium hydroxide
NBRP - National BioResource Project 
NGM - Nematode growth medium 
NR            - Nile Red 
ORO  - Oil -Red-O 
PBS - Phosphate buffered saline 
PCR - Polymerase chain reaction 
PDK - Phosphatidylinositol-dependent  
  kinase 
PHA-4 - Defective pharyngeal development  
  protein 4 
PHB - Prohibitin 
PI3K - Phosphatidylinositol-3-kinase 
PTGS - Posttranscriptional gene silencing 
RISC - RNA-induced silencing complex 
RNAi - Ribonucleic acid interference 
ROS - Reactive oxygen species 
rpm - Revolution per minute 
siRNA - Small interfering RNAs 
SKN-1 - SKiNhead 
Tet - Tetracycline 
TOR - Target of rapamycin 
Tyr - Tyrosine 
UTR - Untranslated region 
VNC - Ventral Nerve Cord 































1. Caenorhabditis elegans as a model organism  
Caenorhabditis elegans (Caeno meaning recent; rhabditis meaning rod; elegans 
meaning nice) is a tiny, free-living, transparent nematode. It feeds on bacteria 
and can be easily isolated from rotting vegetable matter (Barriere and Felix 
2014). They are up to 1mm long in length and are usually observed under a 
dissecting or a compound microscope (Brenner 1974). It is easy and cheap to 
propagate large quantities of worms in the lab, either on a nutritive agar with a 
layer of E. coli cells or in liquid medium. Cholesterol is added because C. 
elegans is unable to synthesize sterol de novo. This method has been 
standardized amongst laboratories to enhance reproducibility of experiments 
(Houthoofd et al. 2003). Worms are usually grown at 15°C or 20°C. Worms 
develop much slower at lower temperatures, whereas at higher temperatures 
the rate of development is faster but reproductive health is often 
compromised. 
Originally derived from mushroom compost isolate, Dr. Sydney Brenner 
introduced the N2 strain that is being used as wild type, in the late 1950s. 
Though he had initially developed the nematode as a model organism to help 
answer questions in development and neurobiology (Brenner 1974),  over 
time, C. elegans has been developed and studied in laboratories worldwide in 
all research areas including metabolism, gene regulation, protein biology, 
ageing, evolution, etc. The Caenorhabditis Genetics Center (CGC), University of 
Minnesota (Gershon and Gershon 2002; Stiernagle 2006) provides nematode 
strains to the C. elegans community and it is recommended that experiments 
should be performed with stocks provided by the CGC. C. elegans has three 
Nobel prizes to its credit - awarded to Dr. Brenner, Dr. Horvitz, and Dr. Sulston 
in 2002 for their discoveries concerning genetic regulation of organ 
development and programmed cell death (apoptosis), awarded to Dr. Fire and 
Dr. Mello for their work on RNA interference (RNAi) in 2006 and awarded to 
Dr. Chalfie in 2008 for development of green fluorescent protein (GFP) as a 
biological marker (Corsi et al. 2015). 
1.1 Life cycle of C. elegans   
The lifecycle of C. elegans at 25°C is 3 days. During its normal development, the 





through four larval (L1 to L4) stages to an egg-laying adult (Figure 1). Worms 
increase in size as they progress through the larval stages. The end of each 
stage is marked by a period of inactivity - lethargus. During this period, the 
worms cease pharyngeal pumping. Lethargus ends with the molting (ecdysis) 
of the old cuticle. Reproductive adult hermaphrodites produce progeny for a 
period of 2-3 days, ~ 12 hrs after the L4 molt. Without food, animals arrest at 
the L1 stage. When they resume feeding, they grow normally to adulthood. 
Under conditions of environmental stress, namely, alterations in population 
density, food availability and ambient temperature, an arrested developmental 
variant of the worm is formed called the dauer larva (from the German dauern, 
to last or to endure). The decision to form dauer is taken at the late L1 larval 
stage. Dauers were first described by Cassada and Russell (Cassada and Russell 
1975) and exhibit different morphological and behavioural features. Dauer 
larvae are thinner in comparison to all the other larval stages (Corsi et al. 2015) 
(Figure 1) and have a specialized cuticle. Dauer larvae do not pump, their oral 
orifices are closed by an internal plug and their pharynxes are constricted. They 
can be easily differentiated from L3 larvae under a dissecting microscope (Hu 
2007). Dauer larvae can survive for up to a year if prevented from desiccation 
(Wood and Johnson 1994). Once favourable conditions are sensed, dauers 
resume development maintaining their normal lifespan. Therefore, the dauer 
stage is considered a non-ageing developmental stage.   
 
Figure 1: Life Cycle of C. 
elegans. Bar 0.1 mm 






The worm exists mostly as a self-fertilizing hermaphrodite, though males arise 
at a frequency of <0.2%. It is hard to distinguish between hermaphrodites 
(females) or males until the L4 stage (Figure 1). In adults, females are 
characterized by a wider girth and tapered tail, whereas, males have a slimmer 
girth and a fan-shaped tail (Figure 1, Adult, black arrowhead). 
1.2 C. elegans tissue system 
C. elegans has a defined tissue system. During hermaphrodite development, 
1090 somatic cells are generated; of which 131 undergo apoptosis at 
distinctive times. There are 959 somatic nuclei in an adult hermaphrodite of 
which 302 are neurons and 95 are body wall muscle cells. On the other hand, 
the adult male has 1031 somatic nuclei, of which 381 are neurons (extra 
neurons are mostly for male mating behavior). The adult male despite having 
more cells, is slightly slender and shorter (approx. 0.8 mm) as compared to the 
hermaphrodite. The animal is composed of a series of concentric tubes (Figure 
2C). The epidermis encloses a pseudocoelomic fluid-filled cavity that houses 
the main organ systems. 
 
Figure 2: Anatomical features 
of C. elegans. A. 
Hermaphrodite worm. B. 
Male worm. C. Cross-section 
of the hermaphrodite in (A) 
shows the four body wall 
muscle quadrants 
surrounded by the epidermis 
and cuticle with the intestine 
and gonad housed within the 
pseudocoelomic cavity 
(Images modified from 
www.wormatlas.org). 
Epidermis - The epidermis of the embryo through a series of cell fusions makes 
large multinucleate epidermal cells that secrete the cuticle. The cuticle is a 
protective layer of specialized extracellular matrix (ECM), composed of 
collagen, lipids and glycoproteins and establishes body shape and provides 
anchoring points for muscle contraction (Figure 3A). Mutations in genes 





(Rol) phenotype (a result of mutations in collagen genes wherein animals move 
in a corkscrew fashion) or the Dumpy (Dpy) phenotype (wherein worm has 
normal width but reduced length). At the end of each larval stage, C. elegans 
sheds its cuticle and secretes a new one to house the growing organism.  
 
Figure 3: Tissue morphology of C. elegans. A. Cross section of the outer layers of the worm show 
muscle cells below the epidermis and cuticle. Transmission electron microscopy (TEM) image B. 
Developing oocytes in the gonad (rectangular cells - clear, circular nucleus inside) followed by 
the spermatheca (where oocytes are fertilized), and multiple embryos in the uterus C. Anterior 
view of the worm showing the mouth, the pharynx, and the start of the intestine  D. Single body 
wall muscle cell with 6 muscle arms extending to the ventral nerve cord (lateral view) (Images 
from www.wormatlas.org). 
Muscles - Body wall muscles that run along the length of the body (Figure 2A 
and 3D) are four quadrants that are connected to the epidermis. The regular 
contraction and relaxation of these muscles leads to the sinusoidal movement 
of the animal.  Apart from body wall muscles, C. elegans has muscles that 
control eating - pharyngeal muscles; egg laying - vulval and uterine muscles 
and the contractile gonad sheath, mating - male specific tail muscles and 
defecation - enteric muscles. 
Digestive System - Bacteria enters through the mouth (anterior region of the 
animal) and passes through the pharynx, a two-lobed neuromuscular pump 
that grinds the food before it is passed on to the intestine for digestion (Figure 
3C). The C. elegans intestine consists of 20 large, polyploid epithelial cells 
arranged in pairs that form a tube running the length of the animal. The 





The primary function is digestion of food and absorption of nutrients. It also is 
a storage organ involved in synthesis and storage of macromolecules. It 
contains a large number of storage granules that change in size, shape and 
number during development (Figure 4C). The intestine is also involved in 
initiation of innate immune responses to pathogens. In hermaphrodites, the 
intestine is also involved in synthesis and secretion of yolk particles. The 
intestine is also thought to be the major organ in which fatty acid metabolism 
takes place.  
 
Figure 4: The intestine of C. elegans . A. The intestine is positioned on the left side of the body 
anterior to the vulva and on the right side of the body posterior to it (ventral view). B. Adult 
intestine runs parallel to the gonad along the length of the body (ventral view). DIC 
image. C. Autofluorescent birefringent granules fill the intestine throughout its length. This is the 
same animal as in B. Epifluorescent image. Images from Wormatlas.  
Nervous system - The nervous system of the adult hermaphrodite has 302 
neurons whereas an adult male has 383 neurons (Figure 5). This simplicity was 
a key feature when Dr. S. Brenner proposed C. elegans as a choice for a new 
model organism (Brenner 1974). 
 
Figure 5: C. elegans nervous system. Image shows some major nerve bundles,  ventral nerve cord 
(VNC), dorsal nerve cord (DNC), nerve ring and ganglia - ring ganglia, retrovesicular ganglion 
(RVG), pre-anal ganglion (PAG), dorsal-root ganglion (DRG) (Image is from the OpenWorm 





A majority of neuronal cell bodies are arranged in the head, in the ventral cord 
and in the tail. Neurons have a simple structure with one or two neurites (or 
processes) exiting from the cell body with the exception of some, for example - 
mechanosensory neurons, that have branched neuritis. 
Reproductive system - The somatic gonad, located at the centre of the body, 
consists of two mirror-image U-shaped tubes in hermaphrodites (Figure 2A,B), 
whereas in males the gonad consists of a single U-shaped lobe (not shown). 
Both gonads house the germline where the oocytes and sperm develop (Figure 
3B, 6A). The somatic gonad and the germline develop together during larval 
stages until animals reach maturity at the young adult stage. Oocytes can be 
fertilized by sperm from the hermaphrodite or sperm obtained from males 
through mating. In the C. elegans germline, one can observe all stages of 
meiosis at once as the germline is a visible gradient of development (Figure 6). 
This property makes it extremely useful for germline studies (Figure 6B). 
 
Figure 6: C. elegans germline. A. Micrograph of a single early adult gonad arm, with gonad arm 
and proximal-most oocyte outlined. When the first oocyte is ovulated, sperm are pushed into 
the spermatheca (Atwell et al. 2015). B. Single gonad arm dissected from a hermaphrodite 
showing germ cell DNA (DAPI stained). Meiosis begins in the Pachytene region (upper right) and 
continues around the loop of the gonad until oocytes are formed. Stored sperm are located in 
the spermatheca of the gonad (bottom right). PCD - Programmed cell death. Images from 
WormAtlas (www.wormatlas.org). 
Secondary sexual mating structures are the vulva in the females and the fan-
shaped tail in males. The vulva located on the ventral side of the 
hermaphrodite is the means for sperm entry from the male and egg laying 
from the uterus. Both sexes are diploid for the five autosomal chromosomes. 
The hermaphrodites have two X chromosomes and males have a single X 
chromosome. C. elegans has no Y chromosome and the genotype of males is 





hermaphrodites. Only 0.1-0.2% of the progeny are males due to rare meiotic 
non-disjunction of the X chromosome. But upon male fertilization, male sperm 
outcompetes that of the hermaphrodite and 50% of males arise. This feature is 
extremely useful for genetic crosses. 
1.3 Nomenclature  
In C. elegans nomenclature, gene names, allele designations, reporter genes 
are written italicized. Gene names consist of 3-4 letters, a hyphen and an 
Arabic number, followed by the mutation (allele) names, usually 1-3 letters and 
an Arabic number. Non-italicized three-letter abbreviations are used to 
indicate the phenotype, which is synonymous with the gene name; but the first 
letter is capitalized. For example, daf-2(e1370) refers to the mutation e1370 in 
the gene daf-2, in which mutation causes a Daf (defective in dauer formation) 
phenotype. The protein product is written in non-italic capitals (DAF-2). Genes 
that have been identified through bioinformatics approaches get systematic 
gene identification (e.g. ZK154.3) until further studies facilitate a gene name.  
In case of strain names, 2 or more capital letters and a number, for example, 
CB429 and TU38 are used to designate a strain containing one or more genetic 
differences. The letters indicate the laboratory that constructed the strain. 
Strains created in our laboratory are pre-fixed with the letters MRS. A more 
comprehensive guide to worm nomenclature description can be found at 
http://www.wormbase.org/about/userguide/nomenclature.  
1.4 Unique attributes of C. elegans  
A combination of several features apart from the ones discussed earlier, make 
C. elegans attractive as a premiere model organism for research. Animal 
populations can be cryo-preserved for years, thus, a large number of strains 
can be maintained. Males can be induced by short exposures to higher 
temperatures. Animals can be synchronized by hypochlorite (bleach) treatment 
of gravid adults - only eggs survive this treatment as they are protected by an 
egg-shell. As the worm is transparent, developmental biologists have used it to 
examine biological problems at the single-cell level. The same also facilitates 
studies in living animals utilizing fluorescent protein reporters (Chalfie et al. 





The entire C. elegans genome (100Mb) has been sequenced and annotated (C. 
elegans Sequencing Consortium, 1998). It has 20104 predicted protein coding 
genes (WormBase release WS264, year 2018)(Gerstein et al. 2010). The 
dedicated website WormBase (www.wormbase.org) provides an incredible 
bioinformatics resource (Bieri et al. 2007; Lee et al. 2018). Another online  
resource on C. elegans research is the Wormbook (www.wormbook.org) 
(Girard et al. 2007) that also houses C. elegans methods (WormMethods) and 
the C. elegans Newsletter (The Worm Breeder's Gazette).  
1.5 Limitations of C. elegans 
Phylogenetically, worms are evolutionarily distant from humans (Johnson 
2003; Gruber et al. 2015) and have a simple body plan that lacks defined 
organs/tissues (Plowman et al. 1999; Gruber et al. 2015; Tissenbaum 2015). 
The nematode, C. elegans, lacks many genes from the hedgehog signalling 
cascade which are important for organ patterning during development in 
vertebrates (Corsi et al. 2015). Similarly, they lack some protein kinases that 
are present in humans. Manipulating an organism only 1mm in length is 
challenging especially at the individual tissue level and in studies involving 
biochemistry (Johnson 2003). Moreover, there are no C. elegans cell culture 
lines. Electrophysiology studies of C. elegans neurons and muscles, though 
possible, are very demanding and indirect measurements such as calcium 
imaging are used as read out of neuronal activity (Corsi et al. 2015; Tissenbaum 
2015). Regarding ageing studies, there is little information regarding late life 
pathology of worms. Worms are scored as dead when they fail to respond to 
touch, but the rate of deterioration due to age is not the same for all tissues of 
worms - muscle degradation is faster whereas nervous system is more resilient 
(Johnson 2003; Antebi 2007). 
2. Technologies for C. elegans  
The usefulness of the nematode is further enhanced by technological 
developments. In particular, I describe those utilised in this Thesis, including 
alteration of gene expression, genome editing techniques, manipulation of 
large numbers of worms and automated imaging techniques. These advances 
bypass laborious efforts and project the worm as a model for studying a wide 





2.1 RNA interference (RNAi) 
RNAi is an evolutionarily conserved process that leads to posttranscriptional 
gene silencing (PTGS) activated by double-stranded RNA (dsRNA) or small 
interfering dsRNA (siRNA)(Figure 7)(Hannon 2002). RNAi has been 
hypothesized  to function as a naturally occurring cellular antiviral defence 
mechanism against foreign dsRNA invasion (Grishok 2005). In the nematode, it 
has emerged as an important tool for studying in vivo gene function (Fire et al. 
1998) as RNAi has the capacity to cross cellular boundaries. Initially used for 
knocking down functions of individual genes, it has now been utilised in several 
organisms on a global level by the production of large scale RNAi libraries that 
target the whole genome. Sequences of identified genes can be known 
immediately and lethal mutations are easier to identify. The inclusion of RNAi 
into research has hastened the pace at which new gene functions are being 
discovered (Kamath and Ahringer 2003; Boutros and Ahringer 2008). 
 
Figure 7: Molecular mechanism of RNAi. A. RNAi 
is initiated by the Dicer enzyme, which processes 
dsRNA into ~22-nucleotide siRNAs which are 
incorporated into a multicomponent nuclease, 
RISC (coded in green). RISC must be activated 
from its dormant form, containing a double-
stranded siRNA to an active form, RISC*, by 
unwinding of siRNAs. RISC* then uses the 
unwound siRNA as a guide to substrate selection. 
B. Representation of Dicer binding and cleaving 
dsRNA (Hannon 2002). 
 
There are four methods for dsRNA delivery in C. elegans - feeding the worm 
with bacteria producing dsRNA (Timmons et al. 2001), injection of dsRNA into 
any region of the worm (Fire et al. 1998), soaking the worms in dsRNA (Tabara 
et al. 1998) or in vivo production of dsRNA from transgenic promoters 
(Tavernarakis et al. 2000). The RNAi in C. elegans is systemic, a distinctive trait 
not seen in Drosophila or mammalian cells, meaning that when dsRNA 
corresponding to the transcript of a gene of interest is introduced into one 





introduced into C. elegans via ingestion of expressing E.coli and are 
intracellularly diced into small-interfering RNAs (siRNAs) leading to an efficient 
knockdown because many different siRNAs are generated from each dsRNA. 
RNAi by feeding is a less labor-intensive procedure than injection, thus, making 
it convenient for performing RNAi on a large number of worms or for testing a 
large number of different genes and also, is considerably less expensive than 
injection or soaking that requires the in vitro synthesis of dsRNA. 
The systemic effects of RNAi are a huge advantage for large-scale genome wide 
RNAi screens. For large-scale RNAi studies, two RNAi feeding libraries covering 
the whole genome have been made and are currently available.  Both libraries 
use bacterial feeding for dsRNA delivery - the method of choice for large-scale 
screens and routinely used for experiments that target individual genes as well. 
The two libraries differ in the type of template that is used to produce dsRNA 
and the number of targeted genes. The first library, from the Ahringer group 
has 16,757 clones. It was made by cloning gene-specific genomic fragments 
between two inverted T7 promoters (Kamath and Ahringer 2003). The second 
library, from the Vidal group has 11,511 clones and was made by the Gateway 
cloning of full-length open reading frame (ORF) cDNAs into a double T7 vector. 
There is some overlap between the two libraries and together they target 
about 94% of C. elegans genes and efforts are underway to create feeding 
strains for the remaining ones. Individual clones and whole libraries are 
available from Geneservice. The Vidal library is also available from Open 
Biosystems (Ahringer 2006; Antoshechkin and Sternberg 2007; Boutros and 
Ahringer 2008). Using genome-wide RNAi feeding libraries (Kamath and 
Ahringer 2003), genes have been identified that are required for longevity 
(Dillin et al. 2002), signal transduction (Keating et al. 2003), development 
(Fraser et al. 2000) and metabolism (Ashrafi et al. 2003), amongst others. 
Large scale RNAi screens are usually carried out either in 96-well liquid culture 
(rapid and employs liquid-handling devices) or solid media (on agar plates, 
more time consuming but allows detailed phenotypic scoring) (Figure 8). 
Worms can be subjected to RNAi at any stage and assayed later, or mothers 






Figure 8: Phenotype based high-throughput RNAi screen strategy. Age-synchronized worms are 
moved to microtiter plates housing the desired RNAi libraries. Each well contains a different 
clone of HT115 E. coli bacteria and produces a specific dsRNA which is taken up by the 
nematodes and induces a knockdown of the corresponding gene. Positive hits from the screen 
are confirmed by sequencing. RNAi feeding can be started at any developmental stage and the 
scoring of the screen depending on the experiment design can be any developmental stage (Sin 
et al. 2014). 
RNAi by feeding method involves cloning of a DNA fragment corresponding to 
the gene of interest into a vector for the expression of dsRNA. L4440 feeding 
vector is used for this purpose which has T7 promoter sites next to both sides 
of the multiple cloning sites (MCS). After a specific DNA fragment is cloned into 
the vector, dsRNA is produced in the bacteria by transcription with T7 
polymerase. The plasmids are then transformed into the bacterial strain HT115 
(DE3), an RNase III-deficient strain of E. coli in which expression of T7 RNA 
polymerase can be induced by addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG). The efficiency of RNAi by feeding is improved by RNase III deficiency 
because the dsRNA produced is more stable in the bacteria. The worm eats the 
bacteria and the dsRNA produced is absorbed by the worms through the 
intestine and distributed throughout the animal (Timmons and Fire 1998; 
Timmons et al. 2001). RNAi efficiency varies spatially and temporally. Late-
stage embryos (whose eggshell may be impermeable to dsRNA), neurons, 
males, and early larval stages have been observed to exhibit resistance to RNAi 
by feeding (Kamath et al. 2001; Timmons et al. 2001). RNAi phenotypes might 
also vary in a gene- and method-dependent manner. Soaking, dsRNA feeding 
or injecting methods are not effective in neurons. In some neurons, only 
injected plasmids producing dsRNA knockdown gene function reproducibly for 





2.1.1 Tissue specific RNAi 
Tissue-specific RNAi is done by generating worms that are proficient for RNAi 
only in a tissue of interest, using a transgenic mutant strain that carries an rde-
1 mutation (RNAi resistant). The wild-type rde-1 is then expressed under the 
control of a tissue-specific promoter (in non-neuronal tissues) (Qadota et al. 
2007). Worms are then fed bacteria expressing dsRNA for a gene of interest, 
which reduces activity of that gene only in the specific tissue in which rde-1 is 
expressed (Figure 9). This technique aids researchers to determine spatial 
requirements for gene function or to study genes with pleiotropic effects in 
different tissues. 
    
Figure 9: Tissue specific RNAi. rde-1 mutants are RNAi-deficient. When wild type rde-1 (+) is 
expressed under the control of a tissue-specific promoter (intestinal, muscle or hypodermal), 
worms become RNAi-proficient in the tissue where rde-1 (+) is expressed (Xu and Kim 2011). 
2.2 Genome editing in C. elegans  
Gene expression pattern is routinely monitored in the worm using the reporter 
genes fluorescent protein to study gene function. This requires injection of 
corresponding transgenes into animals - transgenesis (Chalfie et al. 1994). 
Here, exogenous DNA is introduced into the developing oocytes of adult 
hermaphrodite animals via DNA microinjection or DNA-coated microparticle 
bombardment, which then generate transgenic worms among their progeny 
(Rieckher et al. 2009). In microinjection, transgenic worms are obtained by 
injecting the appropriate DNA fragments or plasmids and their progeny will 
carry and inherit the exogenous DNA as an extrachromosomal array that 
contain many copies of the co-injected DNA. However, extrachromosomal 
arrays can be lost during cell divisions, leading to a variable transmission rate 
(Mello et al. 1991). Microinjection is widely used and enables transgenic 
expression of genes, genome editing by the clustered regularly interspersed 





RNAi. DNA bombardment involves DNA coated gold microparticles that are 
‘shot’ into the worms at high speeds, using a specialized biolistic bombardment 
instrument or ‘gene gun’.  A bulk of transformed worms  generated are 
integrants containing low number of transgene copies, resulting in stable 
transmission of transgenic DNA over future generations (Praitis et al. 2001). 
However, these methods have limitations such as the high copy number 
associated with extrachromosomal arrays and the random site of integration 
associated with bombardment. Newer and more accurate techniques include 
the Mos1-mediated Single Copy Insertion (MosSCI)  method (Frokjaer-Jensen 
et al. 2008) and the CRISPR-Cas9 system (Friedland et al. 2013; Waaijers and 
Boxem 2014) that have rapidly progressed in C. elegans and now facilitate 
targeted mutations in any location in the genome in any genetic background.                                                                                                                                               
2.2.1 CRISPR-Cas9 
CRISPR-Cas9 system for genome engineering has advanced the study of gene 
function, as it allows precise targeted mutations in endogenous genes, 
allowing one to examine the relationship between gene function and 
phenotype. It also facilitates insertion of coding sequence for a fluorescent 
protein and allows monitoring the expression and localization of endogenous 
proteins (Hsu et al. 2014).The CRISPR–Cas9 system compared to other 
approaches is theoretically simpler and has high target specificity.  In brief, a 
single protein (Cas9) is used to generate a DNA break, which is then targeted to 
a DNA sequence using a single short RNA (Figure 10) (Frokjaer-Jensen 2013)  
 
Figure 10: Overview of CRISPR–Cas9 system. The CRISPR–Cas9 enzyme is guided to the target 
site by a single guide RNA. The target sequence is determined by the 20 nucleotides in red 
followed by the PAM sequence (NGG). The double stranded break (DSB) is generated 3 bp 
upstream of the PAM(Frokjaer-Jensen 2013). 
In bacteria, Cas9, an endonuclease is guided to specific DNA sequences by two 





The crRNAs and tracrRNAs can be engineered to form a chimeric single guide 
RNA (sgRNA). The Cas9 nuclease has two independent nuclease domains that 
each cut one DNA strand, leading to a double stranded break (DSB) (Jinek et al. 
2012). Once the sgRNA is loaded into the Cas9 protein, this complex cleaves 
DNA that is complementary to a 20-bp stretch (the “protospacer”) of the 
sgRNA. To cleave DNA, the 20-bp guide sequence must be followed by another 
nucleotide and then the GG – the protospacer-adjacent motif (PAM) motif.  
Three CRISPR-Cas system types (I, II, and III) exist that use unique mechanisms 
for nucleic acid recognition and cleavage. The CRISPR-Cas9 technology 
originates from type II CRISPR-Cas systems, which provide bacteria with 
adaptive immunity to viruses and plasmids. It has a distinctive property very 
useful for genome engineering applications - these require only a single protein 
for RNA-guided DNA recognition and cleavage - making it the backbone of 
CRISPR-Cas9 technology (Doudna and Charpentier 2014). 
The CRISPR-Cas 9 system has been adapted to several model organisms 
including C. elegans. In order to achieve heritable changes in the worm 
genome, Cas9 protein and sgRNA have to be expressed in the germ line. John 
Calarco was amongst the first to demonstrate Cas9 activity in C. elegans, and 
used this to generate mutations by non-homologous end joining (NHEJ) 
(Friedland et al. 2013), followed by the demonstration of  homologous 
recombination-mediated gene conversion (Tzur et al. 2013).  
DSB repair through NHEJ often leads to generation of small insertions or 
deletions - indels, which might disrupt gene function (Figure 11A,B). On the 
other hand, homologous recombination repair allows gene modification and 
addition of specific tags in the genome. This involves supply of a repair 
template that contains sequences identical to the DNA flanking the target cut 
site. Hence, a sequence of choice can be inserted (Figure 11E-G). In case, 
homologous regions are far apart in the genome, endogenous sequences can 
also be replaced with a desired sequence, for example to create a deletion 
mutant (Figure 11C,D) or to replace a gene with a specific mutant variant 









Figure 11:  Genome engineering strategies using CRISPR-Cas9. Target sites are indicated by 
sgRNA. (A- B) Non-homologous end joining can be used to generate mutations and deletions. (C–
J) Homologous recombination being used to generate deletions, insert gene tags, or engineer 
point mutations. Homologous regions are indicated by the red lines in the repair constructs. Re-
cleavage after repair is prevented by having the target sequence in the repair template or the 





Despite the ease of using CRISPR-Cas9 to insert exogenous sequences into a 
genome, several limitations exist. It is time consuming and expensive to 
generate the repair template and guide RNA constructs for each desired 
insertion. Also, one has to exhaustively screen through candidates to identify 
the modified organisms. To identify CRISPR modified animals, commonly used 
strategies such as selectable marker-based strategies and co-CRISPR have been 
optimized and used successfully for insertion of relatively simple sequences, 
such as translational GFP fusions.  
This thesis has used, a PCR-free high-efficiency modular plasmid assembly 
called SapTrap method developed by the Jorgensen Lab. This simplifies the 
production of targeting vectors for tag insertion, as well as the selection of 
successfully modified strains, thus, improving genomic tagging in worms using 
CRISPR (Schwartz and Jorgensen 2016). SapTrap method produces single 
plasmid targeting vectors that, when co-injected with a Cas9 expression 
plasmid, insert genetic tags with high frequency. 
To simplify the repair template production for CRISPR-Cas9 mediated insertion, 
this technique uses a selectable marker for direct identification of modified 
worms. Here, a LoxP-flanked C. briggsae unc-119 selectable marker is 
positioned within a synthetic intron of the tag, such as GFP. The LoxP sites 
allow excision of the unc-119 cassette by CRE recombinase (a recombinase that 
mediates site specific recombination, leaving behind one LoxP site) expression. 
To allow concurrent expression of both gfp and unc-119, the unc-119 gene is 
inserted in the opposite orientation relative to gfp. Using this cassette, a 
complete repair template can be generated simply by adding homology arms 
to each side of the gfp tag. We utilized a SapTrap compatible GFP knockout 
(KO) cassette as tag plus marker donor plasmid that can be utilized to study 
gene function in specific tissues (Munoz-Jimenez et al. 2017).  It is based on 
FLP-mediated gene knockout. FLP is a site-specific recombinase from yeast that 
acts at FLP-recombinase targets (FRTs); if two FRTs are in the same orientation, 
FLP will excise the sequence between the FRTs (Hubbard 2014). This GFP KO 
cassette has Frt sites in introns 1 and 2. If crossed to a transgenic strain 
expressing FLP, the second GFP exon will be excised by recombination between 





generation of a premature termination codon and degradation of any atypical 
GFP::gene of interest transcript by nonsense-mediated mRNA decay.  
Next, to reduce the plasmid assembly workload, a single plasmid was designed 
using Golden Gate strategy, using the restriction enzyme SapI, to encode both 
the sgRNA transcript and the repair template for an individual insertion event.  
The repair template is split into five sections and supplied independently to the 
reaction - 5’ and 3’ homology arms, combined tag and selectable marker, and 
the N- and C- terminal connectors. As the sgRNA targeting sequence and 
homology arms are supplied in the Sap Trap assembly as synthetic, annealed 
oligonucleotides, PCR is not required.  A donor plasmid library supplies the rest 
- fluorescent and non-fluorescent tags, a selectable marker and optional 
regulatory sequences that allow tagging at either termini - N or C (Schwartz 
and Jorgensen 2016). This reduces the expense and time taken to produce 
vectors for genome editing and can provide repair templates that can tag a 
protein in a tissue-specific manner. Eventually, Sap Trap could be used for 
genome-wide projects to verify the expression pattern or to generate 
knockouts of all genes in the C. elegans genome.  
2.3 High-throughput whole animal screening strategies  
The transparency and small size of the worm coupled with the systemic RNAi 
methodology has assisted the design of high-throughput and high-content 
whole worm screens utilising fluorescent protein reporters/dyes (Hamilton et 
al. 2005; Artal-Sanz et al. 2006; O'Rourke et al. 2009a; Lejeune et al. 2012; 
Wahlby et al. 2012). The small size is also compatible with flow cytometric 
systems such as the COPAS (complex object parametric analysis and sorting) 
Biosort System ‘Worm Sorter’ (Pulak 2006) , laFACS (live animal FACS) 
(Fernandez et al. 2012) and automated pipetting devices like MultiFlo (BioTek) 
(Leung et al. 2011), which in turn, have made screenings in multiwell plates 
more convenient. Most high-content RNAi approaches using worms were first 
employed for drug discovery screenings (Kwok et al. 2006) using solid media 
and were laborious. Hence, a liquid based workflow (Lehner et al. 2006; 
O'Rourke et al. 2009a) was adopted using automated robotic liquid handlers 
and imaging platforms. These have been used to search for antimicrobial 
compounds (Moy et al. 2009), to identify pharmaceutical interventions against 





Maglioni et al. 2015), and to look for disease modifiers (Gosai et al. 2010) and 
have further advanced existing genome-wide screening strategies (Gill et al. 
2003; Moy et al. 2009; O'Rourke et al. 2009a; Gosai et al. 2010).  
2.3.1 Worm sorting  
The COPAS (Worm sorter) facilitates the analysis, sorting, and dispensing of C. 
elegans. Sorting parameters are based on the physical parameters of axial 
length of the object (worm length), optical density of the object (optical 
extinction), and the intensity of fluorescent markers (green/yellow/red). Once 
analyzed, worms are selected and dispensed according to user criteria into 
multi-well plates for high throughput screening (User Manual ; Pulak 2006). 
While the earlier mentioned laFACS and MultiFlo are cheaper options - laFACS 
is limited to sorting only L1 larvae due to the nozzle size limitation, whereas, 
the MultiFlo requires a tightly synchronized population, not suitable for sorting 
herterogenous populations. The COPAS on the other hand is apt for isolation of 
sub-populations of worms from a heterogeneous population on the basis of 
fluorescence, optical densities and for stage/size specific sorting (Pulak 2006). 
Previously, the COPAS has been used to carry out large scale fluorescence 
based stage-specific (L1 to adult) sorting of integrated or extrachromosomal 
strains  based on absence or presence of fluorescence such as GFP+/GFP- (Rea 
et al. 2005; Gosai et al. 2010; Twumasi-Boateng et al. 2014), mCherry+/ 
mCherry- (Miedel et al. 2012; Gamerdinger et al. 2015). Further, to sort worms 
using dual fluorescence (reduced green to red ratio) after EMS to screen for 
mutants defective in dopaminergic cell fate (Doitsidou et al. 2008; Nagarajan et 
al. 2014) and to screen for mutants with increased GFP expression profiles 
following EMS (Kuroyanagi et al. 2006).  
The worm sorter comes equipped with the Profiler feature that gives a list of 
successive point measurements along the object passing through the flow cell 
and builds a fluorescence profile. Based on these measurements, it can detect 
fluorescence intensity peaks along the length of the object. This feature has 
been used for accurate acquisition of GFP strains to make post-embryonic 
developmental chronograms (Dupuy et al. 2007) and sorting L4 worms with 
different transgenic arrays (GFP expression in pharynx from worms that had 





COPAS has also been used for sorting balanced mutants for molecular biology 
purposes at the L3 and L4 larval stages where selection of homozygous worms 
that lacked pharyngeal GFP was done from a mixed population that expressed 
pharyngeal GFP (Latorre et al. 2015; Ruegger et al. 2015). An image based high-
content assay to measure germ cell fate reprogramming has sorted balanced 
strains at the young adult stage. Here, worms that lacked GFP and expressed 
mCherry in the pharynx were sorted from a mixed population that carried both 
GFP and mCherry in the pharynx (Benson et al. 2014). The COPAS, thus, 
provided a solution to a major bottleneck that prevented use of balanced 
strains on a large scale basis. It also reduces time and human errors and 
facilitates new experiments previously considered difficult. 
In this thesis, we have utilized the worm sorter, for sorting a balanced strain. 
This involved sorting and selecting homozygous worms at the L1 larval stage 
that lack GFP expression in the pharynx from a heterozygous balanced 
population expressing pharyngeal GFP.  
2.3.2 Imaging strategies 
A complicated aspect in screening strategies is the integration of effective and 
automated analysis of the acquired data, which is often, in the form of images. 
Automated image based high content platforms allow measurement of 
different properties at the same time unlike high throughput where there is 
only a single readout (Buchser et al. 2004). Acquired images can be stored, 
making it accessible for re-analysis or for screening of other phenotypes. 
Fluorescence microplate readers have been used previously for automated 
real-time fluorescence detection in worms (Gill et al. 2003; Leung et al. 2011). 
For quantitation of complex phenotypes in worms, several software programs 
have been designed and implemented. The  open-source cell image analysis 
program CellProfiler has been used for automated quantification of  worm 
survival (Moy et al. 2009), the Cellomics ArrayScan VTI and its BioApplication, 
the SpotDetector program has been utilized to develop a high-quality drug 
discovery platform (Gosai et al. 2010) and also to screen for pro-longevity 
interventions targeting the mitochondria (Maglioni et al. 2015) . The image-
analysis toolbox “WormToolbox” from the CellProfiler project caters to a 
variety of assays irrespective of the imaging system used (Wahlby et al. 2012; 





specifically for C. elegans . A challenging aspect of measurement of single 
worms is that they might overlap during imaging. WormToolbox has got past 
this block, as it is able to computationally untangle worms from within a cluster 
of worms so that data for these worms can be obtained. Apart from size, shape 
and fluorescence measures, the machine-learning algorithm in CellProfiler 
Analyst can be used to spot slight and complex differences in various 
measurable phenotypes (Wahlby et al. 2012). 
In this thesis, an automated image acquisition protocol has been designed 
using the INCA Analyzer 2000 (GE Healhcare), a microscope that facilitates 
high-content screening. Also, worm segmentation protocols were developed 
using the Developer Toolbox software (version 1.9.2) (GE Healthcare), 
accompanying the INCA Analyzer 2000. 
For complex phenotypes lacking robust methods of quantification, such as in 
ageing worms (paralysis, uncoordinated locomotion, less/loss movement) 
‘worm tracking systems’ exist. These include high-throughput softwares like 
the Multi-Worm Tracker (MWT) and the Parallel Worm Tracker (Ramot et al. 
2008; Swierczek et al. 2011) for automated movement behavior analysis and 
tracking, for measurement of thrashing (Buckingham and Sattelle 2009), 
DevStaR (Developmental Stage Recognition) for quantification of 
developmental stages  (White et al. 2013), WormScan  for measuring mortality, 
movement, fecundity and size (Mathew et al. 2012) etc. An upgrade of this is 
the Lifespan Machine that allows automated collection of  lifespan data 
(Stroustrup et al. 2013). As these strategies are further refined, they will open 
the doors for novel and more complex C. elegans based high-throughput 
screenings. 
3. Ageing 
The Oxford Dictionary defines ‘Age’ as the length of time that a person has 
lived or a thing has existed and ‘Ageing’ as the process of growing old. Ageing is 
a fundamental, time-dependent degenerative process transcending species 
and evolutionary boundaries and is inevitable. Understanding the cause of 
ageing is one of the major challenges for this century, as age related 
deterioration is the primary cause factor for afflictions like cancer, Alzheimer’s 





Tentative hallmarks of the ageing process with an emphasis on mammalian 
ageing are - genomic instability, shortened telomeres, epigenetic alterations, 
loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, 
cellular senescence, stem cell exhaustion and altered intercellular 
communication (Lopez-Otin et al. 2013). Ageing is also accompanied with 
significant alterations in metabolic and physical activity. Though ageing was not 
thought to be a regulated process, genetic and genomic studies have helped 
accelerate ageing research by revealing that ageing is subject to regulation 
from signalling pathways and transcription factors.  Mechanistic insights into 
the genetic regulation of ageing arise from studies done in model organisms 
like yeast, worms and flies. An important goal of ageing studies is to achieve 
life span extension along with an increased quality of life, with minimal side 
effects (Collins et al. 2008; Kaletsky and Murphy 2010; Kenyon 2010b; Lopez-
Otin et al. 2013; Gruber et al. 2015)  
3.1 C elegans in ageing research 
C. elegans is a leading model organism to understand the genetic control of 
longevity owing to its ease of handling and a short and invariant lifespan ( ~ 17 
days at 20 °C). This invariance and the ease of genetic manipulation allows for 
identification of mutants that shorten or lengthen lifespan (Collins et al. 2008; 
Tissenbaum 2015). In worms,  lifespan (synonymous to the total rate of ageing) 
is defined as the number of days, the worm remains responsive to external 
stimuli (Sutphin and Kaeberlein 2009).  
Ageing in the worm (Figure 12) is accompanied with several phenotypic 
features - torpor, cessation of mobility and reproductive capacity, reduction in 
the ability to sense/respond to environmental stimuli and accumulation of 
auto-fluorescent deposits (lipofuscin) in cells - that are also seen in other 
animals (Kaletsky and Murphy 2010). Decline in pharyngeal pumping rate and 
defecation rates are also observed (Houthoofd et al. 2003).  
Hence, aged worms look and behave old, just as people do.  The first evidence 
for a gene that influenced ageing in the worm,  came with the discovery of 
age-1 (Friedman and Johnson 1988) and since then over several 100 genes 
including the insulin receptor daf-2 (Kenyon et al. 1993) have been discovered 






Figure 12: Ageing in C. elegans. A. The morphology 
of a young day 5 adult worm is different when 
compared to B. an aged day 16 worm. C. Lipofuscin 
accumulation in a day 16 adult worm. Lipofuscin 
serves as an auto fluorescent ageing biomarker in 
both worms and humans. (Kaletsky and Murphy 
2010) 
 
3.2 Pathways that regulate ageing 
Ageing is subject to regulations by several signalling pathways and 
transcription factors. Though these were first described in organisms like yeast, 
worms and flies, a huge number extend lifespan in mammals as well. These 
include the well described insulin/insulin-like growth factor- 1 (IGF-1) signalling 
pathway, nutrient sensing pathways such as TOR, AMPK and sirtuin regulated 
signalling, germline signalling and epigenetic mechanisms. Apart from ageing, 
these pathways also control biological processes, such as development, 
reproduction, metabolism, etc. Though these pathways have different 
transcription factors, they influence nematode longevity in a conserved 
manner through overlapping processes, for example through modulations in 
lipid metabolism. Here, the insulin/IGF-1 signalling pathway has been 
discussed in more detail, for other pathways influencing ageing, refer Table 1. 
3.2.1 Insulin/IGF-1 signalling pathway 
Around two decades ago, it was discovered that mutations in age-1 (Friedman 
and Johnson 1988) and daf-2 (Kenyon et al. 1993) are capable of doubling the 
lifespan of worms. Further studies revealed the significance of the 
insulin/insulin-like growth factor- 1 (IGF-1) signalling (IIS) pathway in regulation 
of ageing. The IIS was one of the first pathways identified in this regard 
(Kenyon 2005). The lone insulin/IGF-1 receptor in worms is encoded by daf-2, 
and age-1 is the catalytic subunit of the downstream phosphoinositide 3-
kinase (PI3K) (Kimura et al. 1997). Apart from lifespan extension, age-1 and 
daf-2 mutants also exhibit resistant to oxidative stress, hypoxia, heat stress, 
heavy metals and bacterial pathogens (Lithgow et al. 1995; Barsyte et al. 2001). 





genetic control (Kenyon 2010b). The IIS pathway also acts as a food and stress 
sensing pathway all through development. When food is in abundance, worms 
progress through the larval stages and into adulthood. But on encountering 
conditions of stress - food limitations or overcrowding, they enter the dauer 
state, marked by delayed reproductive maturity and increased stress 
tolerance. When favourable conditions return, the dauers develop into 
reproductive adults (Cassada and Russell 1975). daf-2 mutants have a 
prominent dauer- constitutive phenotype (Riddle et al. 1981). 
Both the long lived and the dauer phenotypes of daf-2 worms are dependent 
on DAF -16, the downstream FOXO forkhead transcription factor (Riddle et al. 
1981; Kenyon et al. 1993). Ligand binding to the insulin receptor DAF-2 leads to 
activation of its tyrosine kinase activity. This in turn initiates a cascade of 
phosphorylation events that activate several downstream kinases such as AGE-
1/PI3K, PDK-1, AKT-1/2, and SGK-1 which phosphorylate DAF16 leading to its 
inactivation and retention in the cytoplasm, thus, blocking transcription of 
target genes. When IIS pathway is absent or there is a mutation in daf-1 or 
age-1, DAF - 16 enters into the nucleus where it turns on survival genes that 
double lifespan of the worms (Lin et al. 1997; Lee et al. 2001). Loss of the daf-2 
or age-1 also slows down the age-related downfalls. Hence, the IIS pathway 
regulates longevity.  Inhibiting IIS modulates lifespan also through changes in 
gene expression of the heat-shock transcription factor HSF-1 (Hsu et al. 2003); 
SKN-1, a Nrf-like xenobiotic-response factor (Tullet et al. 2008); and PQM-1 (a 
gene encoding the C2H2-type zinc finger and leucine zipper-containing protein) 
(Tepper et al. 2013).  These transcription factors, up regulate or down regulate 
various genes that mediate effects on lifespan (Kenyon 2010b). 
The IIS pathway is an evolutionarily conserved pathway that regulates lifespan 
across many species (Kenyon 2005)(Figure 13). Drosophila melanogaster has a 
single insulin-like receptor (dInR) and reducing IIS signalling or increasing the 
activity of FOXO (the Drosophila orthologue of DAF-16) specifically in adipose 
tissue extends lifespan (Clancy et al. 2001; Tatar et al. 2001; Hwangbo et al. 
2004). Mammals have several daf-2 homologs [IGF-1 receptor (IGF-1R), insulin 
receptor (IR)-A and IR-B] that are able to form multiple homodimer and 
heterodimer pairs (Benyoucef et al. 2007). Despite these differences in insulin 





also extends life span in multiple mammalian species. In mice, a striking inverse 
correlation between IGF-1 levels and lifespan has been observed amongst 
inbred strains (Yuan et al. 2009). Likewise, longevity in dogs is also inversely 
proportional to body size (Greer et al. 2007b).  Perturbation of insulin/IGF-1 
activity can also increase lifespan in humans. Mutations known to impair IGF-1 
receptor function are overrepresented in certain cohorts of centenarians 
(Kojima et al. 2004; Suh et al. 2008). 
 
Figure 13: Evolutionary conservation 
of the IIS pathway. IIS pathway in C. 
elegans, Drosophila melanogaster and 
mammals. Orthologous signalling 
components are depicted at level with 
each other across the three pathways 
(O'Neill et al. 2012)       
 
Studies on the tissue-specificity of the IIS pathway with respect to longevity 
have established differing results. While restoring DAF-2 and AGE-1 
expression specifically in neurons seems sufficient to decrease the lifespan 
of the long-lived daf-2 and age-1 mutants, the same is not true in the 
intestine (Wolkow et al. 2000).  However, another study established that 
AGE-1 expression in the intestine can decrease the long lifespan of the age-
1 mutant (Iser and Wolkow 2007). Also, in a daf-2;daf-16 mutant, tissue-
specific restoration experiments demonstrated that reestablishment of DAF-
16 expression in the intestine extends the lifespan, whereas in neurons, the 
same exhibited only modest effects on lifespan (Libina et al. 2003). The IIS 
pathway acts both in a cell-autonomous and non-autonomous manner, 





the IIS pathway (Apfeld and Kenyon 1998; Wolkow et al. 2000; Libina et al. 
2003; Iser and Wolkow 2007; Zhang et al. 2013).  
3.3 Mitochondria in ageing 
Mitochondria are ubiquitous intracellular organelles, primarily involved in 
adenosine triphosphate (ATP) production through oxidative phosphorylation (a 
series of electron transferring reactions via the electron transport chain (ETC) 
located in the mitochondrial inner membrane), which is the main source of 
intracellular energy. These organelles also serve as sites for key processes - 
beta oxidation, the tricarboxylic acid cycle, and apoptosis regulation. Hence, 
mitochondrial function is central to cell homeostasis and survival and has long 
been linked to ageing. Mitochondrial oxidative phosphorylation declines with 
age in diverse organisms (Pulliam et al. 2013).  
The first evidences that disrupting mitochondrial function could directly control 
lifespan came from studies in C. elegans. Loss-of-function mutations in clk- 1 
(clk-1 encodes a protein required for the biosynthesis of ubiquinone - an 
essential cofactor in the ETC), and also mutation of the iron sulfur protein (ISP-
1) of the mitochondrial complex III were found to extend worm lifespan 
(Lakowski and Hekimi 1996; Feng et al. 2001). Eventually, genetic screens in C. 
elegans identified that knockdown of more components of the ETC extended 
lifespan (Dillin et al. 2002; Lee et al. 2003) . A bulk of these results that altered 
expression of ETC components and impaired mitochondrial function, still, led 
to an increase in lifespan. A scenario opposite to human ageing that is 
generally associated with a decline in mitochondrial function (Short et al. 
2005). Likewise, mouse models with increased mitochondrial mutations, 
exhibit accelerated ageing (Trifunovic et al. 2004; Kujoth et al. 2005). A reason 
for these opposing observations could be the scale  of mitochondrial 
dysfunction achieved, as a mild knockdown of various mitochondrial ETC 
components leads to increased lifespan in C. elegans, a higher-efficiency 
knockdown, that  increases mitochondrial impairment, shortens lifespan (Rea 
et al. 2007). There is also genetic evidence in mammalian models that mild 
impairment of mitochondrial function might extend lifespan (Liu et al. 2005).  
Based on work in C. elegans, it has been described that several pathways are 





mediator is the mammalian hypoxia inducible factor 1 (HIF-1α, encoded in 
worms by hif-1). Activation of hif-1 is required for the extended lifespan of 
several long-lived mitochondrial mutants. Other mediators include the p53 
ortholog CEP-1, the homeobox protein CEH-23, the apoptotic factor CED-3 and 
skinhead-1 SKN-1, the C. elegans ortholog of the mammalian transcription 
factor NF-E2 (Nrf2) (Chang et al. 2015; Finkel 2015). 
Additionally, it has been shown that the lifespan of several ETC mutants are 
also mediated by the transcription factors UBL-5, DVE-1, and ATFS-1, which 
regulate the mitochondrial unfolded protein response (UPRmt). UPRmt is a 
mechanism that monitors protein homeostasis and maintains proper protein 
function within the mitochondria (Yoneda et al. 2004; Durieux et al. 2011). 
Briefly, UPRmt signalling is initiated when the amount of unfolded proteins in 
the matrix exceed the capacity of the mitochondrial chaperones. The ClpXP 
protease degrades unfolded proteins to peptides, which are then exported by 
the putative mitochondrial inner membrane ATP-binding cassette (ABC) 
transporter protein HAF-1 to the cytosol. The presence of these peptides in the 
cytosol leads to the activation and nuclear translocation of the the bZIP 
transcription factor ATFS-1 (via unknown mechanisms). Additionally, UBL-5, a 
ubiquitin-like protein, and the transcription factor DVE-1 are translocated from 
the cytoplasm into intestinal nuclei and form a complex (Benedetti et al. 2006; 
Haynes et al. 2007). These promote ATFS-1 binding and transcriptional up 
regulation of mitochondrial chaperone genes that lead to their import into 
mitochondria, hence, restoring homeostasis.  The UPRmt in C. elegans can be 
visualized by the induction of the mitochondrial chaperones, hsp-6::GFP and 
hsp-60::GFP (Yoneda et al. 2004). 
3.3.1 Mitochondrial Prohibitins  
A class of mitochondrial proteins that influence longevity differentially by 
modulating energy metabolism are prohibitins (Artal-Sanz and Tavernarakis 
2009b), and named as prohibitin because the first prohibitin (PHB1) was 
identified in mammals as a potential tumour suppressor that inhibited 
proliferative activity (McClung et al. 1989). Later, it was shown to be an 
artefact of the 3’UTR (Jupe et al. 1996b; Jupe et al. 1996a). The second 
prohibitin (PHB2) was identified via its binding, to the IgM antigen 





receptor and hence, Terashima et al., named these proteins as B-cell receptor 
complex associated proteins (BAP) - BAP32/PHB1 and BAP37/PHB2.  
Prohibitins are ubiquitously expressed, evolutionarily conserved proteins that 
localize to the mitochondria. PHB1 and PHB2 having the molecular weights of 
32kDa and 34kDa respectively, together form the mitochondrial prohibitin 
complex (PHB). They associate with each other to form a high molecular 
weight ring like structure of 1MDa (Back et al. 2002) with a diameter of 20-25 
nm in the inner mitochondrial membrane. About 12 to 16 PHB heterodimers 
contribute to this ring like structure(Figure 14) (Back et al. 2002). Loss of either 
PHB1 or PHB2 leads to absence of the entire prohibitin complex (Nijtmans et 
al. 2000). PHB1 and PHB 2 have around 50% amino acid sequence identity and 
60% similarity. The mitochondrial prohibitin complex has been identified in 
yeast (Steglich et al. 1999; Nijtmans et al. 2000), C. elegans  (Artal-Sanz et al. 
2003) and in human fibroblasts (Nijtmans et al. 2000).  
 
Figure 14: The prohibitin complex. PHB1 and PHB2 compose the mitochondrial prohibitin 
complex. These heterodimers assemble into a ring-like prohibitin complex with alternating 
subunit composition.  The prohibitin complex is located in the mitochondrial inner membrane. 
Intermembrane space- IMS, inner membrane – IM (Merkwirth and Langer 2009) 
Despite extensive research, the exact molecular mechanism of the prohibitin 
complex is yet to be deciphered. Nevertheless, they have been implicated in 
several cellular processes: cell-cycle regulation, cell signalling, senescence, 
nuclear transcriptional activation, apoptosis, mitochondrial biogenesis and may 
also regulate inflammation, obesity, neurodegenerative disorders in mammals 
(Artal-Sanz and Tavernarakis 2009a; Merkwirth and Langer 2009; Theiss and 
Sitaraman 2011). Apart from the initial role proposed for prohibitins in cell 
cycle progression (McClung et al. 1989; Nuell et al. 1991), a variety of roles 
have been proposed for PHBs in the mitochondria. They maintain 
mitochondrial morphology (Artal-Sanz et al. 2003; Kasashima et al. 2006; 





2006; Merkwirth et al. 2008) and additionally function as a scaffold that 
recruits membrane proteins to a specific lipid environment (Osman et al. 
2009).  The PHB complex  regulates membrane protein degradation by the 
mitochondrial m-AAA protease (Steglich et al. 1999). It also functions as a 
chaperone that stabilizes unassembled membrane proteins (Nijtmans et al. 
2000; Nijtmans et al. 2002) and also has a role in mitochondrial genome 
stabilization (Wang and Bogenhagen 2006; Bogenhagen et al. 2008; Kasashima 
et al. 2008). Recently, PHB-2 has been established to be a mitophagy receptor 
that is essential for Parkin mediated mitophagy in mammalian cells and C. 
elegans (Wei et al. 2017). 
Prohibitins have been found in circulation (Mengwasser et al. 2004) and on the 
plasma membrane (Terashima et al. 1994). Several experiments have shown 
that PHBs localise predominantly to the mitochondria (McClung et al. 1995; 
Nijtmans et al. 2000), but nuclear localisation of PHB1 (Wang et al. 2002; 
Fusaro et al. 2003) and PHB2 (Sun et al. 2004) has also been shown by several 
investigators.   
In the yeast, Saccharomyces cerevisiae, depletion of PHB decreases replicative 
lifespan of the cells, accompanied with defects in mitochondrial membrane 
potential and extended cell division time (Coates et al. 1997; Berger and Yaffe 
1998). In contrast, in multicellular organisms like C. elegans  (Artal-Sanz et al. 
2003), depleting PHB proteins leads to developmental arrest and germline 
(sterility and small brood size) and somatic defects (reduced body size and 
abnormal somatic gonad) (Artal-Sanz et al. 2003). Also, in C. elegans embryos, 
PHB-2 is required for paternal mitochondrial clearance (Wei et al. 2017).  In 
mice, PHBs are essential for development and neuron-specific PHB2-deficient 
mice exhibit premature death (Park et al. 2005; Merkwirth et al. 2008; 
Merkwirth et al. 2012). PHB depletion also shortens lifespan of petunia flowers 
whether on the plant or detached (Chen et al. 2005). 
A striking feature of PHB depletion in the nematode is with respect to ageing. 
Depletion of PHBs decreases the lifespan of wild type animals, whereas, the 
same in metabolically compromised long lived daf-2 (e1370) IIS mutants leads 
to a dramatic extension in lifespan (Figure 15A,B). Additionally, loss of PHB also 
increases the lifespan of TGF-β pathway mutants (daf-4, daf-7) that controls 





lifespan of several mitochondrial (gas-1, mev-1, clk-1, isp-1) and dietary-
restricted (eat-2) mutants (Artal-Sanz and Tavernarakis 2009b). Thus, PHB 
deficiency leads to an opposing ageing phenotype depending on the 
compromised metabolic background. This is seen to be conserved in both mice 
(Ising et al. 2015) and yeast (Schleit et al. 2013). 
 
Figure 15: Prohibitin depletion 
phenotypes in C. elegans. PHB 
deficiency leads to opposing 
lifespan phenotypes.  Survival 
curves depicting A. wild type 
and B. IIS defective daf-
2(e1370) mutants when 
subjected to phb-1/-2(RNAi). 
Reduced Nile Red staining 
upon PHB knockdown, C. Wild 
type animals (left panel) and 
daf-2 mutants (right panel) 
subjected to RNAi with either 
phb-1 or phb-2 (Anterior side 
of the animals is shown) (Artal-
Sanz and Tavernarakis 2009b). 
The ageing process is accompanied by marked alterations in fat metabolism 
and fat utilization is strongly linked to mitochondrial energy metabolism. 
Alterations in the levels of fat content, as measured by vital Nile Red staining, 
also varies differentially upon PHB depletion. Early in adulthood, PHB 
deficiency reduces Nile Red accumulation in both wild type and daf-2 (e1370) 
mutants. However, this reduction is only maintained in the PHB depleted daf-2 
(e1370) mutants through ageing (Artal-Sanz and Tavernarakis 2009b).  Hence, 
prohibitin depletion affects vital NR staining in a genetic background and age-
specific manner (Figure 15C). Despite the lipid staining NR dye establishing 
functions for several metabolic genes (Ashrafi et al. 2003; Mak et al. 2006), its 
usage in vivo has come under controversy as it fails to correlate to triglyceride 
levels (O'Rourke et al. 2009b). This has been addressed in further detail in 
section 4.1.2.1 of the thesis. Inspite of this, we have evidences that PHB 
deficiency broadly influences metabolism. Utilising advanced metabolomics, 





(1370) mutants leads to pronounced alterations in fatty acid composition, 
carbohydrate and amino acid metabolism (Lourenco et al. 2015).  
 4. Lipid and carbohydrate metabolism in C elegans  
Lipid and carbohydrate synthesis and breakdown (Figure 16) are highly 
conserved processes and the worm has orthologs for most of the key 
metabolic enzymes, thus major metabolic pathways are present in C. elegans. 
Conserved metabolic pathways include lipid uptake and transport, fat synthesis 
pathways, pathways of β-oxidation in the mitochondria and peroxisomes, 
glycolysis, gluconeogenesis and amino acid metabolism.  
 
Figure 16: Overview of fat 
and sugar synthesis and 
breakdown pathways. 
Carbohydrate and fat 
stores, glycogen and 
triglycerides respectively 
are broken down by cells to 
generate acetylCoA and 
NADH and FADH2 through 
the tricarboxylic acid cycle 
(TCA) cycle. NADH and 
FADH2 are further used to 
generate ATP through 
oxidative phosphorylation. 
Image from Wormbook 
Research in worms has been ongoing to illustrate genes involved in and 
affecting lipid synthesis, storage and breakdown. Also, there have been 
investigations regarding the developmental consequences that occur when 
specific lipids are incorrectly synthesized or when lipid homeostasis is 
deregulated (Ashrafi et al. 2003; McKay et al. 2003; Van Gilst et al. 2005a; Van 
Gilst et al. 2005b; Taubert et al. 2006; Ashrafi 2007; Brock et al. 2007; 
Braeckman et al. 2009; Lemieux and Ashrafi 2015; Watts and Ristow 2017).  
4.1 C. elegans fat 
Just like mammals have adipocytes for storage of fat, C. elegans stores fat in 
lipid droplets, mostly in their intestinal and hypodermal cells. Lipid droplets are 
subcellular organelles that store neutral lipids (Walther and Farese 2012). They 





and cholesterol esters and are surrounded by a monolayer of phospholipids 
(Zhang et al. 2010b). Apart from this, substantial fat deposits are also found in 
maturing oocytes of the germline as well as fertilized embryos (Figure 
17)(Ashrafi 2007; Lemieux and Ashrafi 2015).      
 
Figure 17: Visualization of lipid droplets using Oil- Red-O staining. Oil-Red-O stain in the 
transparent body of a wild type animal (Head of the animals are towards bottom right). 
TAGs are also a component of yolk (similar to mammalian lipoproteins), which 
is synthesized in the intestine and transferred to developing oocytes during 
reproduction. This manner of triglyceride mobilisation during reproduction in 
the nematode is called vitellogenesis. Members of the vitellogenin (vit) family 
function to transport stored lipids in the form of yolk to the oocytes from the 
intestine (Kimble and Sharrock 1983; Schneider 1996). The C. elegans has 6 vit 
genes, vit-1 to vit-6. The vit-1, -2, -3, -4 and -5 genes, contribute to the pool of 
YP170 - the major yolk protein , whereas, the vit-6 encodes a protein that is 
processed into YP115 and YP88 (Blumenthal et al. 1984; Spieth and Blumenthal 
1985). 
4.1.1 Composition of C. elegans fat 
40-55% (approximately) of total lipids are composed of triacylglyceride fat 
stores. This is dependent on diet and growth stage. Also, approximately 35% of 
the dry body mass of the worms is lipid (Braeckman et al. 2009). While the 





(Brooks et al. 2009). Phospholipid pools are composed of 55% ethanolamine 
glycerophospholipid, 32% choline glycerophospholipid, 8% sphingomyelin 
(approximately). The remaining 5% are lyso-choline glycerophospholipids, 
cardiolipin, inositol glycerophospholipids. Relative abundance of these might 
change with changes in growth temperature (Ashrafi 2007). The nematode also 
has a wide range of saturated, monounsaturated and polyunsaturated fatty 
acids (PUFAs) including arachidonic (20:4n-6) and eicosapentaenoic acid 
(20:5n-3) as well as monomethyl branched chain fatty acids (mmBCFAs) (Watts 
and Browse 2002). 
4.1.2 Visualization and quantification of C. elegans fat  
As C. elegans is transparent, fat stores can be directly visualized with ease in 
intact animals. Diverse methods ranging from staining techniques, advanced 
non invasive microscopy methods, biochemical extractions and quantifications 
have been employed for this purpose. Only the techniques utilized in this 
thesis have been described here, however, a summary of all methods with 
their respective pros and cons can be found in Table 2.  
4.1.2.1 Vital dye methods 
An easy manner of visualizing fat depots in the worm is supplementing their E. 
coli bacterial diet with vital dyes, like Nile Red or BODIPY-labelled fatty acids 
(BODIPY-FA). This method leads to accumulation of these fluorescent dyes in 
various sub cellular compartments, some of which are lipid droplets while 
others are lysosome related organelles (Schroeder et al. 2007; O'Rourke et al. 
2009b; Mullaney et al. 2010; Zhang et al. 2010a). However, staining methods 
using Nile Red and BODIPY-labelled fatty acid do not distinguish between 
animals with low fat levels and animals that fail to uptake these dyes (Ashrafi 
2007). A major advantage of vital dye labelling is that sample preparation time 
is minimal, lower variability between samples and in vivo studies are 
facilitated. Also, vital dyes are not known to produce any adverse effects on 
the growth rate, brood-size, pharyngeal pumping, dauer formation and 
recovery or lifespan of the worms.  These qualities make it profitable for 








Nile Red is a lipophilic dye that fluoresces in hydrophobic environments making 
it a useful indicator of lipid droplets in cells, tissues, or, in the case of C. 
elegans, in living animals. Nile Red produces a peak emission of 560–580 nm 
when in environments that have a high concentration of triacylglycerides or 
very low-density lipoproteins. When in environments that have more of mono- 
or diglycerides, phospholipids, free fatty acids, Nile Red produces a red shifted 
peak emission of  620–640 nm (Greenspan and Fowler 1985). 
As mentioned earlier, C. elegans stores its fat mainly in the gut or intestinal 
epithelial cells apart from the hypodermis and in the embryos. The intestinal 
cells of the worm contain gut granules - cell type specific compartments that 
have been proposed to be lysosome-related organelles (LRO) (Hermann et al. 
2005) that are birefringent and auto fluorescent (Schroeder et al. 2007). These 
granules are different from lysosomes since they lack the key molecular marker 
LMP-1, the C. elegans LAMP homolog of true lysosomes (Schroeder et al. 2007; 
O'Rourke et al. 2009b). But the understanding of these organelle structures or 
the properties of these fat storage structures is very poor. 
In the worm, LROs are sites of accumulation of age-related auto-fluorescence 
(Gerstbrein et al. 2005), sites for cellular reservoir for zinc (Roh et al. 2012) and 
have also been reported to be sites for storage of cholesterol (Wang et al. 
2014). It was also observed that these gut granules are the site of 
accumulation of vital dyes such as Nile Red and BODIPY-FA when these dyes 
are fed to worms mixed within the bacteria. The C. elegans metabolism field 
has extensively used this fluorescent lipophilic dye, Nile Red to indicate fat 
stores, based on the staining of granules in the worm’s main fat storage organ, 
the intestine and the lipophilic properties of the above mentioned dyes. 
Hence, it was concluded that Nile Red stores were the main sites of fat stores.  
It was observed that Nile Red stains eggs, hypodermis, germ line etc. poorly – 
tissues that were known to have a higher content of triglycerides as measured 
by other techniques. Additionally, the IIS defective daf-2(e1370) mutant was 
shown to have a decreased fat phenotype when stained using the vital Nile 
Red and BODIPY-FA staining, the opposite of what was observed with 
biochemical analysis which indicated increased fat levels in the daf-2(e1370) 





levels fell with fasting, but Nile Red signal intensity increased in wild type 
animals. Some other metabolic mutants also showed similar discrepancies 
(O'Rourke et al. 2009b; Soukas et al. 2009). Moreover, mutants defective for 
gut granule formation show almost nil staining using Nile Red with normal 
levels of fat stores (Schroeder et al. 2007). This means that fat stored outside 
of gut granules might not be correctly quantified using vital Nile Red. This 
would make it necessary to confirm the observed phenotype with additional 
measures of quantification of lipids.   
Irrespective of this controversy, over 45 papers have used vital Nile Red as a 
proxy stain for fat stores and have implicated over 400 genes in lipid 
regulation. This includes usage in  high-throughput screens (Ashrafi et al. 2003) 
designed to identify gene inactivations that cause fat reduction or 
accumulation. This thesis has utilised the vital Nile Red staining to identify 
signalling pathways required for the reduced NR staining phenotype observed 
upon PHB depletion.   
4.1.2.2 Fixed staining methods 
The very first method employed for histochemical assessment of fat in C. 
elegans was done by fixation using the dye- Sudan Black B (Kimura et al. 1997). 
Since then several other dyes such as Oil- Red-O (ORO)(Soukas et al. 2009) and 
fluorescent dyes such as LipidTox (O'Rourke et al. 2009b), BODIPY (Klapper et 
al. 2011) and Nile Red (Brooks et al. 2009) have been utilized as a proxy for fat 
content. This thesis has utilised the dye, ORO to determine triglyceride levels in 
worms. Fixative staining technique involves fixation of the worms using 
isopropanol or paraformaldehyde and staining with ORO (or any of the above 
listed dyes). The fixative based treatment is followed by image-based 
quantification of the amount of bound dye. ORO dye produces results 
representative of biochemical determination of fat stores (O'Rourke et al. 
2009b; Wahlby et al. 2014). Lipid droplets in the intestine, hypodermis and 
germline can be visualised using this dye (Figure 17). As the worm has a thick 
cuticle, even after fixation, worms are not uniformly permeable to staining. 
Therefore, they are subjected to rapid free/thaw cycles to disrupt the cuticle 
for permeabilisation and penetration of the dye. This technique often disturbs 





result in broken/destroyed worm bodies, making this method difficult for 
forward genetic approaches.  
The methods discussed above are not without their liabilities regarding both 
execution and analysis. It is always better to use more than one method in 
order to correctly analyse a metabolic phenotype in an organism. 
4.1.3 Fat synthesis and storage  
Fatty acids are known to have roles in selective permeability, membrane 
fluidity and signalling (Watts 2009) and are mostly obtained from the bacterial 
diet. But, C. elegans can also synthesize them de novo from acetyl CoA. In de 
novo synthesis of fatty acids - Acetyl-CoA is carboxylated by acetyl-CoA 
carboxylase (ACC, encoded by pod-2 gene in C. elegans ) to form malonyl-CoA. 
Malonyl- CoA provides 2 carbon units to fatty acid synthase (FAS) to generate 
fatty acids of different lengths, mainly chains of sixteen carbons (C16:0) 
(Rappleye et al. 2003; Ashrafi 2007). Palmitic acid (C16:0) can be integrated 
into TAGs or phospholipids or can be modified by fatty acid elongases and 
desaturases to form a variety of saturated, monounsaturated (MUFAs) and 
polyunsaturated fatty acids (PUFAs) of different lengths (Watts and Browse 
2002; Watts and Ristow 2017).  For storage of fatty acids, fatty acyl-CoAs 
derived from exogenous or endogenous sources are converted to phosphatidic 
acid, diacylglycerol and eventually to triacylglycerols (TAGs)(Salway 2004) that 
are then stored as lipid droplets and yolk. TAGs are a vital energy source during 
embryogenesis, during low food availability and during the dauer stage 
4.1.4 Fat oxidation/breakdown  
The flux of lipids through β-oxidation pathways determines how stored lipids 
are moved. Homologs of mitochondrial and peroxisomal genes encoding 
proteins involved in β-oxidation of fatty acids are present in the nematodes. 
Though many of these are encoded by many different family members, studies 
do suggest that different family members might function under different 
circumstances. Stored triacylglycerides are mobilized by lipolytic enzymes 
called lipases that breakdown triacylglycerides to liberate fatty acids. 
Nematode lipases have homologues for many mammalian lipases including the 
hormone sensitive lipase (C46C11.1), phospholipase A2 (C07E3.9 and C03H5.4) 





AMP-activated kinase and modulates lipid mobilization during the dauer stage 
(Narbonne and Roy 2009). Another lipase, LIPase Like-4 (lipl-4) is known to act 
downstream of the signals from the germline to regulate fat storage in C. 
elegans (Wang et al. 2008). 
Fatty acids that are liberated are then activated to their respective acyl-CoA 
derivatives by acyl-CoA synthases. There exist short and medium/long chain 
acyl-CoA synthetases for activation of short and medium/long chain fatty acids. 
There are at least 7 members of the long chain acyl-CoA synthetases in C. 
elegans. Activation of free fatty acids is important for efficient uptake of 
nutrients into cells so that it can be utilized by catabolic or anabolic pathways 
(Mashek and Coleman 2006).  Activated fatty acyl-CoA are oxidised depending 
on their size within mitochondria (short/medium/long chain fatty acids) or 
peroxisomes (very long chain fatty acids). Activated short chain fatty acids can 
translocate freely between the cytosol and the mitochondria of cells, however, 
activated medium- or long chain free fatty acids require the aid of CPT-1 (the 
nematode ortholog of the human carnitine palmitoyltransferase I) to proceed 
to β- oxidation. A bulk of these degradation related enzymes have been shown 
to be expressed in the intestine, hypodermis or both (Mullaney and Ashrafi 
2009). Acyl CoA dehydrogenases involved in β-oxidation pathways breakdown 
fatty acyl-CoAs to acetyl-CoA which can enter the TCA. β-oxidation occurs in 
the mitochondrial matrix and yields reduced electron carriers, whereas 
peroxisomal β-oxidation of long-chain fatty acids is not linked directly to 
energy metabolism as the reduced electron carrier is directly oxidized by 
molecular oxygen yielding hydrogen peroxide. 
4.2 C. elegans carbohydrate  
Carbohydrates are hydrated organic molecules consisting of carbon, hydrogen 
and oxygen and are classified based on their structural complexity. The 
simplest being a monosaccharide, which then form polymers referred to as di-, 
tri-, oligo- and polysaccharides consisting of repeated monosaccharide 
moieties with acetal type linkages. Carbohydrates are a major energy source 
and worms store it as glycogen. Although the bulk of the worm’s carbohydrate 
stores is glycogen (3.3% of the dry body mass) (Cooper and Van Gundy 
1970), significant amounts of trehalose and glucose stores are also found 





is broken down by an enzymatic process called glycogenolysis. On the other 
hand, excess glucose is stored as glycogen by activation of glycogen synthase. 
There is evidence for glycogen storage as well as glucose mobilization from 
glycogen in the nematodes. It has been observed that dauers not only 
accumulate significant amounts of lipids but also glycogen. Glycogen is 
preferentially mobilized in the dauer state, while glycogen synthesis is 
downregulated (Holt and Riddle 2003; Depuydt et al. 2014). Since glucose can 
be used to generate ATP in the absence of oxygen by means of anaerobic 
glycolysis (Braeckman et al. 2009),it has been shown that increased 
glycogenolysis can mediate survival in states of anoxia  and hypo-osmotic 
stress (Frazier and Roth 2009; LaRue and Padilla 2011; Depuydt et al. 2014; 
LaMacchia and Roth 2015). 
4.2.1 Visualization and quantification of glycogen 
Iodine staining is a simple method, wherein the color of the stain ranges from 
light brown to dark brown indicating presence of glycogen.  But quantitative 
iodine staining is an issue, as the staining is sensitive to the concentration of 
iodine used. Moreover, the color is unstable after staining (Morris 1946; 
Wilson et al. 2002). Effective glycogen staining can be done on whole worms by 
exposing unfixed worms to iodine vapor or a diluted (1:10-1:20) Lugol’s iodine 
solution (2% I2 in 4% KI) (Frazier and Roth 2009). Both methods are easy and 
fast but, the Lugol’s method has lower contrast than the vapor method.  
 
Figure   18: Iodine staining for visualising 
glycogen stores.A wild-type and a daf-2 
(e1370) mutant (top and bottom respectively) 
stained with iodine and photographed 
simultaneously. Glycogen can be seen under 
the pharynx, hypodermis and gut. daf- 2 
(e1370) adults exhibit increased glycogen 
storage as shown (Frazier and Roth 2009). 
Glycogen stores are observed in early embryos. L1 larvae have little glycogen, 
but as larval stages progress, glycogen accumulation is observed in the head, 
tail, hypodermis, or gut in L2/L3 animals. L4 and very young adult animals 
(Figure 18) had maximal glycogen concentration, which shows a decrease as 





stored carbohydrates). In adult males, glycogen is localized in the anterior of 
the worm and absent from the tail hypodermis (Frazier and Roth 2009).   
To validate iodine staining, a histological method - Best’s Carmine was tested 
which gave similar results to the iodine method (Frazier and Roth 2009). A 
means of observing glycogen stores via vital staining is by using Carminic acid. 
But, this method of staining has been observed to stain carbohydrate stores 
only in the intestinal cells or gut of the worms (Hanover et al. 2005; Forsythe et 
al. 2006; LaRue and Padilla 2011).  
4.2.2 Carbohydrate synthesis and storage 
Gluconeogenesis is responsible for synthesizing glucose from noncarbohydrate 
precursors. One of the substrates for gluconeogenesis is glycerol that is derived 
from triacylglyceride breakdown. Excess carbohydrates may be stored as 
glycogen.  While most of the enzymes in gluconeogenesis catalyze reversible 
reactions, few non-reversible reactions of gluconeogenesis are catalyzed by 
phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carboxylase, fructose 1, 
6-bisphosphatase and glucose 6-phosphatase. Worms also possess the 
glyoxylate shunt that allows the synthesis of carbohydrates via 
gluconeogenesis from acetyl-CoA obtained from fatty acid β- oxidation. The 
glyoxylate pathway is also known in bacteria, fungi, protists and plants. The 
main glyoxylate cycle enzymes in C. elegans, isocitrate lyase and malate 
synthase, are contained as two separate structural domains in a single protein, 
ICL-1 (Liu et al. 1995). An active glyoxylate pathway (Kahn and McFadden 1980; 
Vanni et al. 1990) has been shown to be required for the survival of long –lived 
daf-2 and several ETC-defective mutants (Mit mutants) as well as the 
mitochondrial mutant clk-1(qm30) (Murphy et al. 2003; Cristina et al. 2009; 
Gallo et al. 2011) 
4.2.3 Carbohydrate oxidation 
Carbohydrates are broken down by glycolytic enzymes to pyruvate and 
ultimately to acetylCoA. They can then be converted to and stored as fats. 
Most enzymes in glycolysis catalyze reversible reactions. The irreversible steps 







5. Protein kinases 
Kinases are enzymes that by phosphorylation can alter other proteins. These 
control key biochemical pathways by phosphorylation of substrate proteins 
and account for ~2% of genes in several eukaryotic genomes making them one 
of the largest gene families. Kinases are known to modify the activities of up to 
30% of all cellular proteins (Manning 2005). Protein phosphorylation regulates 
basic functions of all eukaryotes such as DNA replication, cell cycle control, 
gene transcription, protein translation, signal transduction, growth, 
differentiation, apoptosis and energy metabolism (Plowman et al. 1999).  
Kinases are also a part of several conserved signalling pathways that are known 
to modulate ageing. Also, several of these signalling pathways have been 
described to cross-talk via their kinase components.  Kinases are evolutionarily 
conserved and C. elegans has homologs for over 80% of the human kinome. 
The fact that 53 kinase families are conserved amongst yeast, invertebrate and 
mammalian kinomes shows the diversity of essential functions mediated by 
kinases (Figure 19A)(Manning 2005). 
A                                               B              
 
Figure 19: C. elegans kinome A. 
Distribution of 212 kinase 
subfamilies throughout four 
kinomes (Manning 2005) B. 
Hyperbolic tree representation of 
C. elegans protein kinases with the 
major protein kinase groups are 
labelled in different colours 
(Plowman et al. 1999). 
Based on the current accepted classification of protein kinases (as per the  
KinBase resource - http://www.kinase.com/kinbase/ (Manning et al. 2002a)), 
the C. elegans  kinome is divided into two groups –the atypical protein kinases 
(aPKs) and the conventional eukaryotic protein kinases (ePKs). aPKs are a small 
set of protein kinases that do not share clear sequence similarity with ePKs, but 
have been shown experimentally to have protein kinase activity (Manning et 
al. 2002b). ePKs are the largest group and share a conserved catalytic domain. 
ePKs have been further classified into eight families (Plowman et al. 1999; 





1. AGC family (including cyclic-nucleotide and calcium-phospholipid dependent 
kinases, ribosomal S6-phosphorylating kinases, G protein-coupled kinases, and 
all close relatives of these groups) 
2. CAMKs (calmodulin-regulated kinases) 
3. CK1 family (casein kinase 1, and close relatives) 
4. CMGC family (including cyclin-dependent kinases, mitogen-activated protein 
kinases, CDK-like kinases, and glycogen synthase kinase) 
5. RGC family (receptor guanylate cyclase kinases, which are similar in domain 
sequence to tyrosine kinases, TKs) 
6. STE family (including many kinases functioning in MAP kinase cascades) 
7. TK family (tyrosine kinases) 
8. TKL family (tyrosine kinase- like kinases (TKLs), a diverse group resembling 
TK but which are in fact serine-threonine kinases) 
9. Other group consisting of a mixed collection of kinases that could not be 
classified easily into the previous families. 
In C. elegans, kinome wide screenings have been employed to enhance the 
current understanding of kinases in different processes. For example, to 
understand the influence of kinases in muscle protein degradation, a kinase 
screening for over 90% of the kinome  was initiated (Lehmann et al. 2013) 
wherein 40% of kinases studied were found to be of importance in establishing 
or maintaining muscle cell health, with most kinases required for both. Also, 
kinases from the Ahringer and the ORFeome library were screened to identify 
kinases involved in germline hyperplasia (Qi et al. 2017). 
5.1 Glycogen Synthase Kinase -3 (GSK-3)  
GSK-3 is an evolutionarily conserved serine-threonine kinase. It was first 
identified as one of the several protein kinases capable of phosphorylating and 
inactivating glycogen synthase, an enzyme that catalyses the last step in 
glycogen synthesis. This was reported in rabbit skeletal muscles and was the 
third such kinase to be discovered, hence named GSK-3 (Embi et al. 1980; 
Woodgett and Cohen 1984). GSK-3 was later on identified as a major tau 
protein kinase (Ishiguro et al. 1993).These findings showed the importance of 
GSK-3 in glucose metabolism and neurodegeneration, which remain major 
areas of GSK-3 research.  Despite its original name, the functions of this kinase 





in a wide range of biological scenarios including signalling pathways and 
processes such as cell fate determination, metabolism, transcriptional control 
across several species (reviewed in (Cohen and Frame 2001; Woodgett 2001). 
Later on, it was shown through studies using L6 myotubes that insulin 
signalling through protein kinase B inhibits GSK-3 (Parker et al. 1983; Cross et 
al. 1995) resulting in the dephosphorylation of substrates of GSK-3, including 
glycogen synthase and eIF2B (eukaryotic initiation factor 2B). This leads to the 
insulin-induced stimulation of glycogen and protein synthesis (Cohen and 
Frame 2001).  
5.1.1 GSK-3 isoforms, orthologues and expression 
GSK-3 is ubiquitously expressed and is composed of 2 highly homologous 
genes, GSK-3α (51 kDa) and GSK-3β (47 kDa) (Woodgett 1990) which have 
similar biological functions and belong to the CMGC group of protein kinases. 
Both isoforms have 11 exons and share 98% similarilty within their kinase 
domains, with substantial differences in their N- and C-terminal domains (Lau 
et al. 1999; Yao et al. 2002). Immunoelectron microscopy and sub fractionation 
studies in rat cerebellum showed that GSK-3β locates in the cytoplasm, with 
small amounts detected in the mitochondria and nucleus; while GSK-3α is not 
detected in the mitochondria (Hoshi et al. 1995). The Drosophila orthologue of 
GSK-3 is Zeste-White3 or Shaggy (Bourouis et al. 1990; Siegfried et al. 1990) 
and is known to regulate segment polarity and wing organization. GSK-3 
homologues are conserved through eukaryotic evolution (Ali et al. 2001). Many 
species like fish, amphibians, lizards have both isoforms, while birds have only 
GSK-3β and appear to have selectively lost GSK-3α (Plyte et al. 1992; Bianchi et 
al. 1993; Alon et al. 2011). GSK-3α KO mice are viable (MacAulay et al. 2007) 
whereas, GSK-3β KO mice are inviable (Hoeflich et al. 2000). This distinct 
phenotype difference between GSK-3α and -β KO mice prompted further study 
of their individual roles. So far, no isoform-selective inhibitors exist. However, 
GSK-3 conditional KO models have been generated that allow for tissue-
specific deletion of isoforms. 
5.1.2 GSK-3 regulation  
In contrast to other kinases, GSK-3 is unusual in that it is typically active under 





Force 2005). GSK-3 mediated phosphorylation of substrates usually leads to 
inhibition of those substrates, hence, the inhibition of GSK-3 leads to functional 
activation of its downstream substrates. Regulation of pathways in which GSK-
3 is involved may occur through inactivating phosphorylation by other protein 
kinases on serine-21 of GSK-3α or serine-9 of GSK-3β. In vitro studies have 
shown that insulin, growth factors, or certain amino acids inactivate GSK-3 
through phosphorylation at serine 21 (GSK-3α) or serine 9 (GSK-3β) through 
the action of kinases such as AKT/PKB, p90rsk, and p70rsk (Cross et al. 1995; 
Eldar-Finkelman et al. 1995). Also through changes in tyrosine phosphorylation 
of GSK-3α at Tyr-279/GSK-3β at Tyr-216 (Cole et al. 2004). More than 50 
targets have been reported to be phosphorylated by GSK-3, including 
metabolic enzymes, signalling molecules, structural proteins, and transcription 
factors. GSK-3 also exerts a strong influence on several signalling pathways that 
regulate various cellular functions (Doble and Woodgett 2003; Force and 
Woodgett 2009; Xu et al. 2009; Cheng et al. 2011; Kaidanovich-Beilin and 
Woodgett 2011) and is downstream of several signalling pathways such as IIS, 
Wnt, Hedgehog and Notch (Doble and Woodgett 2003; Sutherland 2011).  
Here, we will limit the discussion to insulin and Wnt signalling pathway, as they 
are more relevant to this thesis. As mentioned earlier for insulin signalling, 
GSK-3 also plays a key inhibitory role in the Wnt pathway, however, the 
molecular mechanism of this is still unclear. The Wnts are a family of secretory 
glycoproteins functioning in diverse developmental processes (Miller 2002). 
Wnt signalling can be either the canonical or the noncanonical pathway. Here 
we focus on canonical Wnt signalling. A cytoplasmic destruction complex 
consisting of GSK-3, Casein Kinase 1 (CK1), Adenomatous Polyposis Coli (APC) 
and Axin mediate the phosphorylation of β-Catenin, targeting it for 
polyubiquitinylation and degradation in proteasomes. In the presence of Wnt, 
the destruction complex becomes inactivated. Wnt triggers signalling by 
binding to Frizzled and LDL-receptor related protein 6 (LRP6), causing the 
aggregation of Dishevelled (Dvl) and Axin on the plasma membrane (Bilic et al. 
2007; Zeng et al. 2008; Wu and Pan 2010), unphosphorylated β-catenin 
accumulates in the cytoplasm and translocates to the nucleus, where it can 
associate with the TCF/LEFs and become a transcriptional transactivator. A 
model to explain how GSK-3 is inhibited in canonical Wnt signalling suggests 





vesicular endosomes, thus reducing its cytosolic levels. Though β-Catenin also 
translocates into the endosomes with GSK-3, once cytosolic GSK-3 is 
sufficiently degraded, newly translated β-Catenin is not phosphorylated and 
accumulates in the nucleus (Taelman et al. 2010). 
5.1.3Therapeutic perspectives 
Deregulation of GSK-3 function has been implicated in many age related 
pathophysiological processes such as diabetes, Alzheimer’s disease, bipolar 
disorder and cancer, making GSK-3, a tempting therapeutic target. Lithium was 
one of the first inhibitors of GSK-3 to be discovered (Klein and Melton 1996) 
and shown to work in intact cells (Stambolic et al. 1996). Lithium activates 
glycogen synthase and stimulates glucose synthesis in primary rat adipocytes 
(Cheng et al. 1983) and  in muscle. Stronger inhibitors like, SB 216763 and SB 
415286, exhibit high rates of glycogen synthesis in HeLa cells (Coghlan et al. 
2000). Since then many chemical inhibitors of GSK-3 have been developed. 
Lithium has been used for the past several years for treatment of bipolar 
disorder, Alzheimer’s disease, depression and stroke (Chiu and Chuang 2010). 
5.1.4 GSK-3 in nematodes  
The C. elegans orthologue of mammalian gsk-3β is gsk-3 (previously called, 
sgg-1). In C. elegans, the function of Wnt genes, including GSK-3 is required for 
endoderm specification and mitotic spindle orientation (Schlesinger et al. 
1999). GSK-3 also influences C blastomere differentiation during embryonic 
development independently of its well documented role in Wnt signalling. It 
restricts the specification of mesendodermal tissue to a single blastomere 
(Maduro et al. 2001). Wnt signalling regulates diverse biological processes, but, 
how such varied responses are produced is not yet clear (Sawa and Korswagen 
2013). In worms, loss of BAR-1 reduces the activity of the FOXO ortholog DAF-
16 in dauer formation and lifespan (Essers et al. 2005). BAR-1 also has a role in 
vulval precursor cell specification, with bar-1(ga80) mutants exhibiting delayed 
development (van der Bent et al. 2014) along with an incomplete vulva, a 
protruding vulva and egg-laying defects (Eisenmann et al. 1998). Additionally, 
Wnt signalling contributes to spindle orientation, cell corpse clearance, and 
gonadal migration. These depend on a common process of cell cytoskeleton 





two separate branches to regulate modulation of the cytoskeleton in different 
scenarios. Cell corpse clearance and gonadal migration require the MOM-5 /Fz 
receptor, GSK-3, and APC/APR-1, that activates the CED-2/5/12 branch of the 
engulfment machinery. Rearrangement of mitotic spindles requires the MOM-
5/Fz receptor, GSK-3, and β-catenins, but not the downstream factors LIT-
1/NLK or POP-1/Tcf (Cabello et al. 2010). The canonical Wnt pathway also 
mediates anteroposterior axon guidance in motor neurons (Maro et al. 2009). 
GSK-3 dynamics also include regulating oocyte to embryo transition along with 
KIN-19 (Nishi and Lin 2005; Shirayama et al. 2006). gsk-3 also inhibits the 
RAS/ERK pathway function and regulates oocyte growth (Arur et al. 2009). It 
has been proposed that GSK-3 phosphorylates SKN-1 under normal conditions, 
and prevents it from accumulating in intestinal nuclei, whereas in conditions of 
oxidative stress, p38 pathway signalling and PMK-1phosphorylation of SKN-1 
are dramatically increased that counteracts inhibition of SKN-1 by GSK-3 (An et 
al. 2005).A kinome wide screening has also indicated GSK-3 as being essential 
in protein homeostasis, autophagy and in maintaining mitochondrial network 
and sarcomere structure in muscle (Lehmann et al. 2013)  
5.1.5 GSK-3 in ageing and metabolism  
GSK-3α KO mice have a short lifespan (Zhou et al. 2013). In worms, gsk-3 
(nr2047) mutants have been shown to have a 36% reduction in median lifespan 
compared with wild type. Hence, loss of GSK-3 is detrimental to lifespan 
(McColl et al. 2008). Inhibition of GSK-3 via administration of lithium has  been 
observed to extend lifespan, in yeast, flies, humans and C. elegans (McColl et 
al. 2008; Zarse et al. 2011; Sofola-Adesakin et al. 2014; Tam et al. 2014; 
Castillo-Quan et al. 2016). Lithium addition in the diet can also modulate 
resistance to stress and metabolism in Drosophila, via inhibition of GSK-3 
(Castillo-Quan et al. 2016). Recently, there is evidence from studies during late 
oogenesis in Drosophila, that decreased insulin signalling initiates ETC 
remodeling and mitochondrial respiratory quiescence through GSK3 (Sieber et 
al. 2016). GSK-3 was also implicated in inhibition of AMPK activity - a key kinase 

































Depletion of prohibitins (PHBs) reduces lifespan in wild type worms, while, 
under compromised insulin signalling it extends lifespan. PHB depletion also 
alters Nile Red (NR) staining in vivo both, in wild type and IIS mutants early in 
adulthood while the phenotype is retained only in IIS mutants during ageing. 
Thus, loss of PHBs influences ageing and metabolism in a genetic background 
specific manner. The unique phenotype of PHBs can help to better understand 
how mitochondrial function regulates lifespan in reponse to different cues. 
Therefore, the main objective of this thesis is to reveal novel regulators 
involved in the metabolic response to PHB deletion in wild type and IIS 
mutants. The specific objectives towards the achievement of this goal are: 
1. Characterise C. elegans prohibitin deletion mutants. 
2. Establish an automated sorting and imaging strategy to screen for genetic 
interactions of essential genes. 
3. Identify signalling pathways mediating the response to PHB depletion by 
performing a kinase RNAi screen. 





























1. Characterisation of mitochondrial PHB deletion mutants  
Prohibitin proteins are essential for embryonic development and for somatic 
and germline differentiation in the larval gonad of C. elegans (Artal-Sanz et al. 
2003).  In line with that homozygous mutants having a null phb-1 allele develop 
into gametogenesis-defective sterile adults due to maternal effect (Artal-Sanz 
and Tavernarakis 2009b). This makes PHBs part of the approximately 30% of 
the genes in the worm genome, that have been categorized as essential genes 
- based on information from screens for lethal or sterile mutants (Brenner 
1974; Kemphues 2005). A bulk of these was associated with developmental 
processes, and hence, the study of such lethal mutations may disclose new 
information about essential biological processes.Lethal mutations can be 
propagated and stably maintained in heterozygosis, by introduction of 
balancer chromosomes. Briefly, these are chromosomal rearrangements that 
allow lethal or sterile mutations to be maintained in a stable way in 
heterozygosis. They carry chromosomal errors like inversions or translocations 
that suppress recombination and thus, prevent loss of terminal alleles in a 
population. About 85% of the worm genome has been successfully balanced by 
this manner, with ongoing efforts aimed at covering the whole genome. A bulk 
of the balancers carry fluorescent transgenes (commonly, GFP) that enable 
easy identification of heterozygous animals. Homozygous animals are 
identified with ease as they lack fluorescent transgene expression (Edgley et al. 
2006; Chen et al. 2015; Iwata et al. 2016). 
Homozygous PHB deletion mutants resulting from heterozygous mothers 
exhibit sterility and hence, need to be maintained as balanced heterozygous to 
be viable. The phb-2 deletion was balanced using an inversion on chromosome 
II - mIn1[dpy-10(e128) mIs14 (myo-2::GFP)], which carries an integrated 
pharyngeal GFP. Balancer homozygotes are Dumpy and sterile (because of the 
dpy-10(e128) allele) having two copies of GFP (Figure 20, left), heterozygotes  
are phenotypically wild type having a single copy of GFP (Figure 20, middle) 
and homozygous PHB deletion mutants lack GFP (Figure 20, right) and are 
sterile. As we intended to study PHB deletion mutants in an IIS depleted daf-
2(e1370) mutant background, phb-2(tm2998);daf-2(e1370) double mutants 
were generated. Since the same allleles are used all through this thesis, 






Figure 20: Mitochondrial deletion mutant, phb-2(tm2998). Balanced phb-2(tm2998) deletion 
mutants containing the chromosomal inversion mIn1[dpy-10(e128)mIs14(myo-2::GFP)]. 
Homozygous phb-2 mutants are smaller in size and lack GFP (right). All worm images were 
acquired at the Young Adult stage using an Olympus Stereoscope.  
 
On the other hand, phb-1 deletion was balanced by a reciprocal translocation 
between chromosomes I and III - hT2[bli-4(e937)qIs48(myo-2::GFP)](I;III). 
However, the qIs48 element housing the GFP transgene is not very stable 
(Fernandez et al. 2012) and is often lost, making the task of distinguishing the 
homozygous phb-1 worms from the heterozygous wild type difficult and thus, 
not suitable for large scale experiments. In C. elegans, the phenotypes elicited 
by knockdown of either phb-1 or phb-2 via RNAi are the same (Artal-Sanz and 
Tavernarakis 2009b; Lourenco et al. 2015). Also, both subunits of the PHB 
complex have been confirmed as absent in both phb-1 (tm2571) and phb-
2(tm2998) mutants (Hernando-Rodriguez et al. 2018). Therefore, we focused 
on phb-2 deletion mutants. 
1.1 Development is severely delayed in PHB mutants 
As mentioned earlier, C. elegans develops through four larval stages (L1, L2, L3 
and L4) before exiting as a reproductive young adult (YA). All the larval stages 
are separated by periods of molting (M1, M2, M3 and M4). We utilised a 
recently developed technique to precisely measure the duration of each larval 
developmental stage. Briefly, we use C. elegans expressing the firefly luciferase 
(LUC) constitutively and ubiquitously throughout development (Lagido et al. 
2008). The luciferase enzyme catalyses oxidation of luciferin generating light. 
As C. elegans is transparent, the LUC-marked strains emit light when provided 
with exogenous luciferin. The absence of luciferin intake during the molts 





Luminescence signal can be determined in single animals. For this purpose, 
LUC::GFP was introduced in daf-2 and phb-2 mutants, as well as phb-2; daf-2 
double mutants. Development from arrested L1s was measured at 20°C. phb-2 
and phb-2; daf-2  mutants exhibit a strong delay in development in comparison 
with wild-type and daf-2 mutants (Figure 21A).  
A 





Time on food (h)  




























































































































































































































































































Figure 21: Quantification of the duration of larval stages and periods of molting, using the 
LUC::GFP bioluminescent reporter. A. Average duration of development for wild type (n = 17), 
daf-2 (n=19), phb-2 (n = 14) and phb-2; daf-2 (n= 11) at 20 ºC. Red represents the molts as 
inferred by low LUC signal. Error bars represent the SD of the duration of each interval. B. 
Duration of all larval stages (L1-L4). C. Duration of all molting cycles. Scatter plot representative 
of one of two independent experiments (***P ≤ 0.001, **P ≤ 0.01, ns- not significant; 1 way 
ANOVA, Bonferroni’s multiple comparison test). 
 
When comparing each larval stage, we observe that phb-2 deletion extends the 
duration of all larval stages, both in wild type and in daf-2 mutants (Figure 
21B). However, the duration of the molting cycles are not significantly affected 
by phb-2 deletion, with the exception of the M4, which is extended in both 
genetic backgrounds (Figure 21C).Additionally, we also note that the duration 





the wild type, especially the L2 stage, as previously established (Ruaud et al. 
2011; Olmedo et al. 2015).  
1.2 Pharyngeal pumping is reduced in PHB mutants 
Alterations in physiological processes such as delayed development, altered 
defecation, feeding and pharyngeal pumping rates, reduction in mobility, low 
brood size, etc. often accompany scenarios wherein mitochondrial function has 
been compromised (Tsang and Lemire 2003). Pharyngeal pumping was 
observed to be reduced in wild type animals when subjected to phb-1/-2 RNAi 
(Artal-Sanz et al. 2003). PHB deletion in both wild type and daf-2 mutants 
significantly reduced the rate of pharyngeal pumping (Figure 22).  





























                          
Figure 22: Pharyngeal pumping rates in wild type, phb-2, daf-2 and phb-2;daf-2 mutants. Bar 
graph representative of one of two independent experiments (n>10, Mean ± SD, 1 way ANOVA, 
Dunn’s multiple comparison test, ***P ≤ 0.001, **P ≤ 0.01) 
We also observed daf-2 mutants displayed lower rates of pumping in 
comparison to wild type animals on both day 1 and day 5. daf-2 mutants have 
been previously shown to have reduced pharyngeal contractions albeit at a 
lower temperature of 15°C (Bansal et al. 2015; Dillon et al. 2016). Pharyngeal 
pumping decreases during ageing (Huang et al. 2004; Bansal et al. 2015). We 
observed the same from day 1 to day 5 across all genetic backgrounds (Figure 
22). 
1.3 Lifespan of the PHB mutants 
PHB mutants, phb-1(tm2571), phb-2(tm2998) and phb-2(tm2998);daf-2(e1370) 
were subjected to lifespan analysis on E.coli OP50 to verify whether they 
recapitulate the results obtained using RNAi against phb-1 and phb-2 (Artal-





upon RNAi, both phb-1 and phb-2 deletion mutants lived shorter than wild type 
animals. On the other hand, phb-2;daf-2 double mutants exhibited increased 
longevity in comparison to daf-2 mutants (Figure 23, Table 3). 























Figure 23: Lifespan of phb-1, 
phb-2 and phb-2;daf-2 
mutants on E.coli OP50. 
Survival curves are 
representative of two 
independent longevity 
assays. 
1.4 Nile Red staining is reduced in PHB mutants 
It has been previously shown that prohibitin depletion reduces Nile Red 
staining both, in wild type and daf-2 mutants early in adulthood. However, as 
animals age, this phenotype is retained only by daf-2 mutants on phb-1/2 RNAi 
(Artal-Sanz and Tavernarakis 2009b). We assayed the same using PHB mutants 
to evaluate if Nile Red could be used for screening purposes. The phb-2 
mutants show reduced Nile Red staining (Figure 24A) in comparison to wild 
type, but reach wild type levels on day 15.  
However, phb-2 deletion in daf-2 mutants exhibited low staining all throughout 
ageing up to day 25 (Figure 24B,C), thus, recapitulating the Nile Red phenotype 
observed upon phb-1/-2 RNAi. Nile Red staining accumulates through the 





























































































Figure 24: Reduced Nile Red staining in mitochondrial PHB mutants. A-B Comparion of Nile Red 
staining during the course of ageing (day 1 to 15) in A. wild type and phb-2 mutants - images (left 
panel), the quantification of the same (right panel) and in B. phb-2;daf- 2 mutants as compared 
to the daf-2 mutants (left) and bar graph representing average pixel intensity (right). The bar 
graphs are representative of two independent experiments in both A and B (n>70 for day 1 & 5, 
n>50 for day 10 and n>25 for day 15 - all conditions, Mean ± SD, 1 way ANOVA , Dunn’s multiple 
comparison test, ***P ≤0.001, **P ≤ 0.01, ns >0.05; D-Day). C. Nile Red staining of daf-2 and 
phb-2;daf-2 mutants on day 20 and 25. Bar graph representative of two independent 
experiments (n>60, Mean ± SD, 1 way ANOVA, Dunn’s multiple comparison test, ***P ≤ 0.001; D- 
Day). 
1.5 Triglyceride levels are increased in PHB mutants  
Vital dyes have been strongly debated over what exactly they are staining 
within the nematode in the recent past. Hence, we analyzed the lipid status of 
PHB mutants using Oil-Red-O, a fixative based staining method more reliable 





mutants (Figure 25). In accordance with previously published data, daf-2 
mutants showed increased triglycerides (Yen et al. 2010) in comparison to wild 
type animals. Moreover, phb-2;daf-2 mutants displayed more triglyceride 


























      
Figure 25: Oil-Red-O staining of mitochondrial PHB mutants compared to wild type and daf-2 
mutant backgrounds on first day of adulthood (Day1). Worms were stained using the quick Oil-
Red-O method (wild type (n=52), phb-2 (n =38), daf-2 (n =67), phb-2;daf-2 (n =34), Mean ± SD, 



















2. Automated worm-sorting and image analysis for the study of essential 
genes  
2.1 Sorting conditions for homozygous PHB deletion mutants 
The worm sorter, COPAS, was used to facilitate sorting of the mitochondrial 
PHB mutants. Previously, similar sorting conditions have been reported for 
selection of homozygous worms that lack pharyngeal GFP from a mixed 
population at the L3 (Latorre et al. 2015)and L4 (Ruegger et al. 2015)larval 
stages. In this thesis, worms were sorted at the L1 larval stage in order to 
facilitate RNAi from the start of larval development. 
In order to select the population of interest lacking pharyngeal GFP, we initially 
acquired data from over 200-500 worms in order to gate a proper region of 
worms hence, excluding unhatched eggs, dead corpses within the samples, 
curled worms etc. The data of acquired worms can be stored as.txt or in an 
excel format for review, in order to set proper conditions and also for future 
references. Based on that, we drew a gating region within a particular area on 
Extinction PeakHeight (Ext PH) vs Extinction PeakWidth (Ext PW)( see Figure 
26, upper dot plot). This aids in selection of worms that have a certain maximal 
optical density and a certain length above the set threshold avoiding unwanted 
objects. Next, we viewed green PeakWidth vs green PeakHeight parameters in 
the sort dot plot that enabled us to view the different populations of worms: 
homozygous phb-2 worms (non - GFP in the pharynx), heterozygous wild type 
(GFP expression in the pharynx) and dumpy worms (GFP expression in the 
pharynx)( see Figure 26, lower dot plot). This reflects the relative green 
fluorescence within the earlier gated population. We select and sort the 
nonGFP homozygous worms (Figure 27, A and B) from the mixed population. 
Once, sorting parameters were successfully established, we sorted around 40 
PHB homozygous larvae per well in a 96-well microtitre plate. Under ideal 
working conditions, one plate took approximately 40 minutes. Worms were 
grown till the young adult stage in bacteria producing dsRNA supplemented 
with Nile Red. In order to quantify the intensity of Nile Red staining, we 






Figure 26: Screenshot of the dot plot view with the established gating (upper) and sorting (lower) 
conditions for phb-2(tm2998) mutants. The scale, gains, thresholds, photomultiplier tube (PMT) 
control levels, the sort delay and width are values that were adjusted based on several sorting 
tests and specific values were chosen that are best for the sample being analyzed.  
                    A                                                                 B 
 
Figure 27: Screenshot of the sorting regions. Sorting dot plot of  A.  phb-2(tm2998)/mIn1 
balanced animals, where the population of phb-2(tm2998) homozygous L1 larvae that are sorted 
is marked by a circle and B. phb-2(tm2998);daf-2(e1370)/mIn1 balanced animals, where the phb-
2(tm2998);daf-2(e1370) homozygous L1 larvae is marked by a square. 
2.2 High-throughput imaging strategies  
2.2.1 Image acquisition and analysis  
Image acquisition was done using the IN Cell Analyzer 2000, an inverted 
microscope designed for automated fluorescent imaging and analysis of cells. 





Building an imaging protocol starts with an acquisition protocol that 
establishes the plates and selection of wells to be imaged, amongst other 
parameters such as wavelengths and exposure times to use. Once an 
established protocol is run, the system works without user input to complete 
the imaging. Once worms reached the desired stage, here, the young adult (YA) 
stage, images were acquired by utilizing the 2x objective, in three different 
channels – brightfield, FITC/GFP and Cy3/Red at identical settings and 
exposure times (see Materials and Methods). Image analysis for quantification 
of Nile Red intensity was performed with a user-defined protocol created using 
the Developer Toolbox software (version 1.9.2) (GE Healthcare). This software 
accompanies the IN Cell Analyzer 2000 and enables direct upload and 
automated analysis of image stacks. The FITC/GFP channel was added for well 
segmentation and to spot accidently sorted heterozygous worms with 
pharyngeal GFP expression which were then removed from the data analysis. 
The segmentation protocol was built from individual sets of targets which were 
then linked together to obtain all the required measurement regions in one 
target. Each target was created step by step -1) pre-processing to enhance the 
image prior to segmentation, 2) segmentation of the target to generate a 
mask, after which post processing operations were added to clean up the 
target mask. Once the targets had been created and optimized, measurements 
were made in the individual targets or the linked target sets. The following 
targets were created: thewell edge (used to subtract out any well debris), the 
worm and the dilated worm (used to calculate background intensities adjacent 
to the worm). First, intensity based well segmentation was done using the auto 
fluorescence of the well edge in the FITC/GFP channel and after post-
processing refinement steps, the resultant segmentation mask was inverted to 
give the well edge (Figure 28A). Next, the bright field image was enhanced 
using a pre-processing step to achieve better segmentation of worms in the 
brightfield channel (Figure 28B). After post processing, refinement of the worm 
mask and subtraction of the well edge to remove well artefacts, acceptance 
criteria based on morphological parameters were applied to remove unwanted 
worms and debris (Figure 28C). The worm mask was transferred sequentially to 
the Cy3/Red channel which enabled additional acceptance criteria based on 
intensity measures to be applied if necessary to further refine the final worm 





generate a region around the worm to enable calculation of immediate 
backgroundintensity (Figure 28E). 
 
Figure 28: Outline of the image segmentation protocol for balanced mutants. A. Well 
segmentation was done in the GFP channel based on intensity and then the image was inverted. 
B. The image in the brightfield channel was subjected to pre-processing to enhance the contrast, 
to enable ease of segmentation. The segmented worms were tagged in blue. To select worms 
and to exclude artefacts/debris, acceptance criteria based on morphological parameters were 
applied (these can be modulated as per user requirement).C. Next, the well edge was subtracted 
from the segmented worms (blue) and overlapping worms (yellow) were excluded. D. This 
segmented worm mask was transferred to the Cy3/Red channel. E. For background subtraction, 
the segmented worms were dilated in order to measure theintensity of the immediate 
background. 
In the final sequence, the targets, worm and background, were linked together 
to get both measurements together in one target. The software links two 
targets at a time and there must be at least one pixel overlap to achieve a 





in a target which has both measurement regions - worm mask and dilated 
worm mask (Figure 29A). By the dilation of the worm, we can measure and 
subtract the intensity of the immediate background. This feature is very useful 
when screenings require usage of dyes (such as the one used in this thesis), as 
dyes can stain plastic and can cause different background intensities 
depending on the area of the well being measured. A comprehensive list of 
measures for each worm was collected covering morphological and Intensity 
based measures from the Cy3/Red channels (Figure 29B). 
For experiments that involved older worms, the analysis protocol was checked 
at each step and the segmentation parameters, post processing steps and 





Figure 29:  Target linking and background subtraction A. Target linking to compose a final target. 
Worm mask and dilated worm were linked together. The final target shows the two 
measurement regions: the worms outlined in blue, the immediate background outlined in cyan. 
B. Identified targets with the corresponding measurements. The output sheet from the 
Developer toolbox with the segmented worms and their measures such as fiber length (Fiber 
length worm), Intensity of the worm (Int Worm), intensity of the immediate background (Int 
Bkgd Cy3), background subtraction (Int Worm - Bkgd) and the area of the worm (area). 
Additional measures like major axis length, X/Y position, form factor can be added as per user 





2.2.2 Improved image analysis incorporating identification of heterozygous 
worms using Developer Toolbox 
The above image acquisition and segmentation protocol has been modified to 
incorporate a step that correctly identifies unwanted heterozygous worms with 
green pharynx. This was required as the sorting with the COPAS might not 
always be efficient, resulting in eventual heterozygous worms with pharyngeal 
GFP expression in the screening plates. This modified protocol follows the 
same initial steps of well segmentation in the green channel image and 
segmentation of worms in the brightfield image, followed by subtraction of the 
well edge (Figure 28). Once worms were well delineated, green heads of the 
heterozygous worms with pharyngeal GFP were segmented in the FITC/GFP 
channel image and acceptance criteria based in area and intensity were used 
to better define green heads (Figure 30 and 31A). In the final sequence, the 
targets were linked together to get all three measurement regions together in 
one target. Here, Final Worm Mask was linked to Dilated Worm Mask, Worm-
Green Head was linked to Dilated Worm Mask, then using a composed link 
these two groups were linked together to result in a target which has all three 
measurement regions, final worm mask,the dilated worm and the worm minus 
green head linked together ( Figure 30 and 31B).  User defined morphological 
and intensity based measurementswere collected for each worm from both 







Figure 30: Outline of the protocol for identification of heterozygous worms with GFP expression 
in the pharynx. Briefly, post well segmentation in the green channel, the worms were segmented 
after enhancing the contrast in the Brightfield Channel (Image A). Acceptance criteria were 
applied to remove artefacts (Blue accepted, Yellow rejected). The worm mask was transferred to 
the green image to identify, if needed, worms with green heads based on the green head ID 
(Image B and C). The final worm mask dilated (Image E), the dilated region around the worm, 
was used to calculate the immediate background intensity. Finally, the targets labelled by 
asterisks  are linked together to get all three measurement regions, i.e,  Dilated worm, Worm 














Figure  31: Identification of heterozygous animals (Green Head ID). A. After worm delineation in 
the brightfield channel, green heads were segmented and tagged in red. In the next step, the 
identified green heads were subtracted from the worm bodies. As a result, segmented worms 
appear blue without the green heads, thus, “worm minus green head”.Segmented worms are 
dilated (bottom panel) in order to facilitate measurement of the intensity of the immediate 
background. B. A balanced heterozygous animal expressing pharyngeal GFP has been identified 
(red arrow) within a population of homozygous phb-2 mutants. The heterozygous animal 
exhibits increased Nile Red staining in comparison to the homozygous phb-2 mutants.C. 
Segmentation analysis output of the analysis for balanced mutants. Intensity of the worm 
subtracting the background intensity in the green image (Int Worm - Bkgd FITC), identification of 
green head (green head ID) and intensity of the worm subtracting the background intensity in 
the red image (Int Worm - Bkgd Red) are depicted in the analysis output.  Target 12 is the 








2.3 Open-sourcing of the segmentation protocol through CellProfiler                   
These segmentation protocols built via the Developer toolbox limits their 
usage to researchers with access to the GE Healthcare platform. To get around 
this disadvantage, we implemented the protocol in the free and open source 
CellProfiler software (Hernando-Rodriguez et al. 2018), thus, providing an 
analysis pipeline to identify green head worms, and capable of measuring 
intensities in both green and red channels.  
We compared worm segmentation outputs resulting from the Developer 
Toolbox and CellProfiler and found them comparable (Figure 32B). We 
evaluated wild type and phb-2 mutants after Nile Red staining and observed 
lower Nile Red staining in phb-2 mutants irrespective of the software used for 
segmentation (Figure  32C), hence, validating this method. The image analysis 
protocol generated through the CellProfiler software is easily adaptable to the 







Figure 32: Open sourced segmentation protocol (CellProfiler).A.Representative images of wild 
type and phb-2(tm2998) mutants taken sequentially in the brightfield, GFP and Cy3 channels 
using the IN Cell Anlayzer 2000.B.Comparison of the image segmentation output for wild type 
and phb-2(tm2998) mutants generated from Developer toolbox (GE Heathcare) versus 
CellProfiler. C. Quantification ofNile Red staining of phb-2(tm2998) mutants versus wild type 
animals. Graphical representation of data obtained from the Developer toolbox and CellProfiler 
protocols. As previously shown, depletion of phb-2 reduces Nile Red staining using both of the 





3. A kinase RNAi screen to identify genetic interactors of mitochondrial 
prohibtins  
 
The opposing ageing phenotypes elicited by lack of PHBs provided an 
opportunity to understand which cellular signalling pathways may differentially 
regulate ageing depending on external or internal energy demands (Artal-Sanz 
and Tavernarakis 2009b). This project was aimed at identifying genes that 
might play a role in regulating metabolic responses to prohibitin depletion 
under conditions in which PHB depletion affects ageing in an opposite manner.  
We performed an RNAi screen to identify relevant signalling pathways involved 
in PHB-mediated phenotypes, by screening the contribution of all kinases 
represented in the ORFeome RNAi library (Rual et al. 2004). Kinases are 
conserved signalling molecules modulating cellular processes and popular 
targets for drug discovery. Moreover, the C. elegans  kinome has 81% 
homology with human kinases (Manning 2005). We utilised phb-2 and phb-2; 
daf-2 mutants for the screening and exploited the reduced Nile Red staining 
phenotype observed upon PHB depletion in wild type and IIS mutants (Figure 
24) (Artal-Sanz and Tavernarakis 2009b) as a read out. Despite the 
discrepancies surrounding vital Nile Red staining (O'Rourke et al. 2009b; 
Soukas et al. 2013; Wang et al. 2014) it is extremely convenient for screening 
strategies and has helped identify gene inactivations that modulate fat 
metabolism (Ashrafi et al. 2003).  
As mentioned earlier, the PHB mutants are balanced strains and require a 
laborious selection of homozygous PHB mutants. Hence, we grew worms in 
liquid cultures to scale up the worm populationand employed the worm sorter, 
COPAS, for sorting worms of interest. The ORFeome kinase sub-library 
contained 264 kinases, 32 clones did not grow and hence, the total number of 
analyzed kinases is 232. The 232 kinases are housed in three 96 well plates 
where the last row has been left empty to house controls. For quantification of 
the Nile Red staining, a worm segmentation protocol was developed for the 








Figure 33:  Overview of the RNAi screening strategy. Worms are grown in liquid media to 
generate large populations.  Homozygous PHB mutants are sorted at L1 stage from a mixed 
population of balanced heterozygous animals into multiwell plates using the COPAS Biosort 
“worm sorting”.  Next, bacteria containing the ORFeome kinase RNAi sublibrary are added to the 
wells, supplemented with Nile Red and worms are incubated at 20°C. When worms reach the 
desired stage, plates are washed to clear bacteria and they are imaged in brightfield and 
fluorescent channels using an automated microscope, IN Cell Analyzer (GE Healthcare). A user-
defined image segmentation protocol is used to define potential hits based on the intensity of 
Nile Red staining of worms in comparison with the control.  
We screened for RNAi clones that increase Nile Red staining and, thus, 
suppress the reduced Nile Red phenotype of phb-2 deletion in otherwise wild 
type animals and in daf-2 insulin receptor mutants. The empty vector pL4440 
stained with 100nM was run in all the plates as negative control. In order to 
ensure the effectiveness of the RNAi screen, additionally a positive control was 
established -sgk-1(RNAi) that increases Nile Red staining (Jones et al. 2009). 
The primary screen comprised two biological replicates using phb-2 and phb-2; 
daf-2 mutants. 4-6 wells with empty vector and 2 wells with positive control 
were run in the primary screen. 41 RNAi clones that were above the range 
representing +1SD from the mean of the control (empty vector) and were 
recurring in both sets of biological repeats were chosen to be screened a third 
and final time. The 41 candidates were re-tested in a liquid format and resulted 








Figure 34: Heatmap depicting the 
behaviour of the 26 kinases 
identified from the RNAi screen 
upon Nile Red staining in PHB 
deficient backgrounds. These 
clones cause a significant 
difference in Nile Red staining 
with respect to the control, in 
any of the two genetic 
backgrounds (One way ANOVA, 
Dunn’s multiple comparison test, 
ns = not significant p>0.05, 
*=p<0.01, ** = p<0.01, *** = p< 
0.001) 
We only recovered kinases that suppressed the reduced Nile Red staining 
phenotype of PHB mutants. We did not observe any kinases enhancing this 
phenotype. The identified kinases could be put into 18 functional groups with a 
bulk related to phosphorylation (Figure 35), followed by kinases whose 
function is related to reproduction and development, where PHB has been 
shown to be essential (Artal-Sanz et al. 2003). We also observed kinases 
related to lipid storage and the Wnt signalling pathway. Amongst the 
candidates, we also encountered kinases that have been previously shown to 
modulate longevity and fat metabolism and previously shown to interact with 
PHB, such as SGK-1, the serum and glucocorticoid kinase 1,regulates fat 
metabolism in C. elegans (Jones et al. 2009; Soukas et al. 2009) and interacts 
with PHB to regulate lifespan and the mitochondrial unfolded protein response 
(UPRmt)(Gatsi et al. 2014). Apart from this, we also identified the S6 
kinase/RSKS-1, a conserved substrate of the mechanistic Target of Rapamycin 
(mTOR) complex 1 (Laplante and Sabatini 2012) that regulates fat (Shi et al. 
2013) and interacts with PHB to regulate lifespan in yeast (Schleit et al. 2013). 
Another kinase that was identified in the screening was MTK-1, an ortholog of 
human MAP3K4 (mitogen activated protein kinase kinase kinase 4) that also 
interacts with PHB. PHB mutants subjected to mtk-1 RNAi exhibit increased 
UPRmt (Villringer and Artal-Sanz, unpublished data). Among the kinases related 





3. GSK-3 is a conserved serine/threonine kinase that is phosphorylated upon 
prohibitin depletion in mice hippocampus (Merkwirth et al. 2012). Here, we 
observed that lack of gsk-3 suppresses the reduced Nile Red staining 
phenotype of PHB mutants.  
 
Figure 35:  Classification of the identified 26 kinases according to function built using DAVID 
Bioinformatics Resource 6.8. Significantly enriched GO terms (p<0.05) have been represented.  
As our goal was to ultimately identify genes involved in the lifespan phenotype 
conferred by PHB depletion, we pre-selected certain candidates to ascertain 
















4. Establishing the role of GSK-3 in longevity and metabolism  
Among the pre-selected candidates, GSK-3 was chosen for further analysis. 
GSK-3 is a multifaceted conserved kinase and a known target of AKT that 
regulates systemic metabolism (Cross et al. 1995; Cohen and Frame 2001). 
GSK-3 has many substrates and is involved in many other processes including 
in Wnt signalling and in disease pathologies (Kaidanovich-Beilin and Woodgett 
2011; Sutherland 2011; Patel and Woodgett 2017). Additionally, the role of 
GSK-3 has been studied immensely in early nematode development 
(Schlesinger et al. 1999; Maduro et al. 2001; Nishi and Lin 2005; Arur et al. 
2009; Maro et al. 2009; Cabello et al. 2010) and while GSK-3 has established 
functions in metabolic regulation in other organisms (MacAulay et al. 2007; 
Alon et al. 2011; Zimmermann et al. 2013; Castillo-Quan et al. 2016; Chen et al. 
2016; Sieber et al. 2016; Markussen et al. 2018), a role for GSK-3 in metabolism 
in C. elegans is unknown. Based on these observations, we decided to ascertain 
the role of GSK-3 with a focus on how its depletion might alter the longevity 
and metabolism seen upon mitochondrial prohibitin depletion and also 
compromised IIS signalling.  
4.1 GSK-3 differentially regulates lifespan in C. elegans depending on the 
metabolic status 
Previously, gsk-3(nr2047) mutants have been shown to exhibit reduced 
lifespan at 25°C (McColl et al. 2008). Wild type animals on gsk-3 RNAi showed a 
mild reduction in lifespan (Figure 36) as observed in gsk-3(nr2047) mutants, 
while the long lifespan of IIS mutants was almost fully suppressed upon GSK-3 
depletion, showing for the first time that GSK-3 is essential for the long lived 
phenotype of insulin mutants (Figure 36, Table 4). The lifespan of phb-2 
mutants on gsk-3 RNAi was only very mildly affected, while the double phb-2; 
daf-2 mutants showed a strong reduction, similar to daf-2 mutants. Thus, GSK-
3 depletion resulted in a differential reduction in lifespan across all genetic 
backgrounds. This phenotype was similar irrespective of addition of FUdR, to 
prevent progeny production (Refer Appendix 2.1, Table 4). We also inhibited 
GSK-3 by addition of lithium (a chemical compound previously shown to inhibit 
GSK-3 (Stambolic et al. 1996)) in wild type and daf-2(e1370) mutants, and 
observed suppression of lifespan at 20°C, contrary to published data (Refer 





All genetic backgrounds exhibited vulval bursting on gsk-3(RNAi), the 
phenotype being more severe in wild type animals (Table 4). Though we 
censored worms that exhibited vulval explosion during lifespan assays (like 
most laboratories), this phenomenon has been described in detail as age 
associated vulval integrity defects (Avid) by the Kaeberlein Lab and has been 
proposed as a marker for healthspan in nematodes (Leiser et al. 2016).  





























Figure 36: Lifespan analysis 
of wild type, daf-2, phb-2, 
and phb-2;daf-2 subjected 
to gsk-3(RNAi) post 
embryogenesis. Average of 
two independent lifespan 
curves has been 
represented here. 
GSK-3 function is essential during early embryonic development (Maduro et al. 
2001; Nishi and Lin 2005; Shirayama et al. 2006). We noticed a slight 
developmental delay in worms grown on gsk-3(RNAi) from the L1 larval stage. 
In order to avoid deleterious developmental effects and to monitor whether 
GSK-3 functions during ageing, we assayed the effect of GSK-3 depletion from 
adulthood. We observed that mean lifespans wereincreased when worms 
weresubjected to gsk-3(RNAi) from adulthood (Figure 37) in comparison to 
post embryogenesis confirming a role for GSK-3 during development.  





























Figure 37: Lifespan analysis 
of wild type, daf-2, phb-2 
and phb-2; daf-2 mutants 
subjected to gsk-3(RNAi) 
during adulthood. Average 
of two independent 






Wild type animals subjected to gsk-3 RNAi exhibited significantly reduced 
lifespan (17%), whereas GSK-3 depletion in IIS daf-2 mutants led to a 
pronounced decrease (34%) in lifespan, confirmingthat GSK-3 is essential for 
the extended longevity of daf-2 mutants. Interestingly, depletion of GSK-3 did 
not affect phb-2 mutants, while the lifespan of phb-2; daf-2 mutants decreased 
by 22 % upon gsk-3(RNAi) (Figure 37 and Table 4).  
Remarkably, we observed that prohibitin deletion conferred a survival benefit 
to GSK-3 depleted animals, both in wild type and daf-2 mutant backgrounds, 
regardless of whether gene knockdown via RNAi treatment was initiated post 
embryogenesis or from adulthood (Figure 36 and 37, Table 4).  
4.1.1 Loss of Wnt components, KIN-19 and BAR-1 elicits a similar lifespan 
phenotype as seen upon gsk-3(RNAi) 
GSK-3 is a component of the destruction complex in canonical Wnt signalling in 
C. elegans, whereit functions along with Axin, the tumor suppressor gene 
product APC, and the casein kinase CK1 to degrade β-catenin and thus, 
suppresses the expression of specific target genes. In worms, the kinase CK1 
and β-catenin are encoded by kin-19 and bar-1. We investigated the role of 
KIN-19 and BAR-1 in lifespan regulation to determine if the GSK-3 phenotypes 
were mediated by Wnt signalling. 
Loss of KIN-19 elicited a similar response as GSK-3 depletion during ageing, as 
inhibiting kin-19 from adulthood by using RNAi led to a lifespan decrease 
across all backgrounds with the exception of phb-2 mutants and being the 
effect stronger in daf-2 mutant backgrounds (Figure 38, upper panel, Table 5). 
Moreover, the beneficial effect in lifespan seen upon loss of GSK-3 in 
mitochondrial mutants was also observed upon loss of KIN-19. Similarly, loss of 
BAR-1 significantly reduced lifespan in IIS mutant backgrounds (Figure 38, 
lower panel), though the observed decreases were much milder than those 
observed upon loss of GSK-3 and KIN-19 (Table 4 and 5).Consistent with the 
role of BAR-1 in vulval cell specification, we observed vulval rupture in worms 
grown on bar-1(RNAi). Loss of KIN-19 also led to vulval ruptures, similar to the 
loss of GSK-3 phenotype. Worms that were lost from the analyses due to this 































































Figure 38:  Knockdown of 
components of the Wnt 
signalling pathway, KIN-
19 and BAR-1.  Survival 
curves of mutant animal 
populations subjected to 
kin-19 (RNAi) (upper 
panel) and bar-1(RNAi) 
(lower panel) are shown. 
Average of two 
independent lifespan 
curves has been 
represented here. 
4.2 Knockdown of GSK-3 leads to embryonic lethality in wild type and IIS 
mutants 
It had been noted previously that reducing gsk-3 expression by RNAi causes 
embryonic lethality, though this phenotype has not been quantified (An et al. 
2005). More recently, it has been shown that GSK-3 promotes adult germline 
stem and progenitor cells (GSCs) proliferation in a germline autonomous and 
kinase-dependent manner.  Adult GSCs support gamete production and sustain 
germline development in the worm. Not only do adult gsk-3 mutant germlines 
contain lower GSCs, compared to wild type, it is so from early larval stages 
such as L3 and L4. As this occurs throughout development, it is indicative that 
the germline output would also be reduced (Furuta et al. 2018).  
Post embryonic depletion of GSK-3 by means of RNAi in wild type animals was 
characterised by a reduced brood size and embryonic lethality post day 1 of 
egg-laying. On the other hand, daf-2 mutants upon gsk-3(RNAi) exhibited a 
stronger reduction in brood size and 100% embryonic lethality (Figure 
39).These stronger phenotypes are in accordance with the more severe 





daf-2(e1370) mutants produced fewer progeny in comparison to wild type 
animals (Kenyon et al. 1993).  
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Figure 39: Effect of GSK-3 depletion on brood size and embryonic lethality.  A. Comparison of 
total brood size (unhatched eggs and larvae) in wild type and daf-2 (e1370) mutants on 
control(RNAi) and gsk-3(RNAi) (The blue portions of the bars represent unhatched eggs; the red 
portions indicate hatched eggs or larvae, Mean±SD) B. Number of progeny per day in wild type 
and daf-2 mutants upon GSK-3 depletion. One of two independent reproductive brood size 
assays has been represented here (n ≥ 8 worms for all conditions).    
                                                     
4.3 Ubiquitous expression of GSK-3  
 In order to study the expression pattern of gsk-3, we constructed the strain, 
Pgsk-3::GFP::gsk-3,  using the SapTrap methodology for  CRISPR-Cas9 
(Schwartz and Jorgensen 2016) system. The advantage of this technique is that 
it reduces the time for assembling repair templates and sgRNAs and utilizes a 
combined tag and selectable marker that aids in direct identification of 
modified worms. To build a translational reporter of GSK-3, we utilized a tag 
plus marker plasmid (Munoz-Jimenez et al. 2017) that incorporates FLP-
mediated gene knockout. Hence, this reporter strain we generated can be used 
to study tissue-specific inhibition of gene expression by crossing it with 
transgenic strains that express FLP in a tissue specific manner.  
GSK-3 is ubiquitously expressed and showed a tissue dependent sub-cellular 
localisation. GSK-3 was detected in embryos both, in the nucleus and the 
cytoplasm (Figure 40A). At the adult stage, expression was prominent in head 
and tail neurons (Figure 40B,C), intestine (Figure 40D), muscles (Figure 40E) 
and in the P-granules in the germ line (Figure 40G). Apart from these, the 
sperm (Figure 40F) and vulval precursor cells (Figure 40H) also exhibited strong 






Figure 40: Expression pattern of GFP::GSK-3 transgenic worms.  Expression can be observed in A. 
embryos, B.and C.  the nervous system – head and tail neurons respectively, D. the intestine 
(white rectangle) and E.muscles (white arrows).In the germline, GSK-3 is expressed strongly in F. 
sperm (white arrow), G.within P granules (white arrow) in the germline and H. in vulval 
precurcor (refer white arrow) cells. *Images were taken by Dr.F J Garcia. 
We checked if the expression pattern of GSK-3 was altered in IIS defective 
animals or upon phb-1(RNAi). We did not observe obvious changes in the 
expression pattern (Figure 41A), while, quantification of total GSK-3::GFP 
revealed that GSK-3 levels are increased in PHB depleted worms and daf-2  
mutants (Figure 41B). These increased levels of GSK-3 might not be indicative 













   
Figure 41: Expression of GSK-3. A.GSK-3 expression in the head, tail and germline of wild type 
and daf-2 mutants transgenic for GFP::gsk-3 on control(RNAi) and phb-1(RNAi).B. Quantification 
of GSK-3 expression levels in insulin daf-2(e1370) and  PHB depleted backgrounds. One of two 






4.4 Metabolic alterations upon GSK-3 depletion 
Studies in both mammals and nematodes have suggested that age related 
modulations in carbohydrate and lipid metabolism can influence the ageing 
process and optimal usage of energy stores is critical for organismal survival 
(Hansen et al. 2013; Watts and Ristow 2017). Moreover, GSK-3 is expressed 
strongly in the intestine, the major metabolic organ in worms. This prompted 
us to investigate whether metabolic changes are associated with the decreased 
longevity phenotype observed under conditions of GSK-3 depletion across wild 
type animals and worms with compromised insulin signalling and 
mitochondrial function. We looked at metabolic stores and key genes involved 
in carbohydrate and triglyceride metabolism.  
4.4.1 Glycogen stores are differentially altered in insulin and mitochondrial 
mutants upon GSK-3 depletion 
GSK-3 is a key regulator of glycogen metabolism (Embi et al. 1980). Briefly, IIS 
signalling inhibits GSK-3, dephosphorylating glycogen synthase responsible for 
glycogen synthesis (Parker et al. 1983; Cross et al. 1995). In Drosophila, it has 
been observed that insulin signalling represses mitochondrial quiescence and 
glycogen accumulation by inhibiting the AKT target gene, GSK3 (Sieber et al. 
2016). In order to analyse glycogen content in worms upon gsk-3(RNAi), we 
utilized iodine vapor staining.  As reported by others, we also observed 
increased glycogen content in daf-2 mutants compared to wild type worms 
(Frazier and Roth 2009; Depuydt et al. 2014).  GSK-3 depletion in wild type 
animals did not alter glycogen content, whereas, in daf-2 mutants, we 
observed a further increase in glycogen content upon GSK-3 depletion (Figure 
42A,B).  
On the contrary, GSK-3 depletion reduces glycogen content in PHB mutant 
backgrounds, both in phb-2 and phb-2;daf-2 double mutants (Figure 42A,B). 
PHB-2 deletion resulted in decreased glycogen content, both in otherwise wild 
type worms and in daf-2 mutants, a likely consequence of a higher reliance on 
glycolytic metabolism due to defective mitochondrial functioning. As the 
reduced glycogen content observed upon GSK-3 depletion occurs specifically 
upon PHB deletion, it is plausible that the benefits of depleting PHB in GSK-3 
deficient worms could be linked to an increased reliance on glycogen for 
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Figure  42: Glycogen storage in C. elegans  viewed using iodine vapor staining A. Representative 
images of glycogen stores across wild type, daf-2, phb-2 and phb-2;daf-2 mutants subjected to 
control and gsk-3(RNAi) B. Scatter plot representing quantification of glycogen stores (Animals 
were imaged at Day1 of adulthood in all conditions, Mean±SD, Unpaired t- test, ns = not 
significant p>0.05, * = p<0.05, ** = p<0.01, *** = p< 0.001,  n ≥ 41 worms for all conditions, 
average of  three independent experiments represented).  
In order to distinguish the latter from the former, we looked at the expression 
of fructose 1, 6 - biphosphatase, encoded by fbp-1 in C. elegans, a non- 
reversible enzyme involved in gluconeogenesis. We observed that upon GSK-3 
depletion, the expression of Pfbp-1::GFP is reduced in both, wild type and PHB 
mutants (Figure 43A). Additionally, PHB depletion was observed to also have 
less expression of FBP-1 in comparison to wild type worms. This low expression 
of the FBP-1 reporter in PHB depleted worms on control and on gsk-3(RNAi), 





glycogen phenotype observed. Despite the fact that glycogen stores were 
unaltered in wild type animals depleted of GSK-3 (Figure 42), we observed 
reduced expression of fbp-1(Figure 43A). In order to confirm whether gsk-3 
depletion reduces the expression of gluconeogenic genes we looked at the 
mRNA levels of other genes involved in gluconeogenesis, mdh-1 and icl-1, both 
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Figure 43: Reduced gluconeogenesis upon GSK-3 knockdown. A. Quantification of expression of 
the transgenic strain, Pfbp-1::GFP , in wild type and PHB depleted wild type animals grown on 
control(RNAi) and gsk-3(RNAi) (Animals were imaged at Day1 of adulthood in all conditions, 
Mean±SD, One way ANOVA, *** = p< 0.001,  n >130 worms for all conditions,  scatter plot 
representative of three independent experiments) B-C. qRT-PCR of gluconeogenic genes, mdh-2 
and icl-1 in B. wild type and C. IIS mutants grown on control(RNAi) and gsk-3(RNAi) (Mean±SEM, 
Unpaired t-test, * = p<0.05,*** = p< 0.001,  graph representative of three independent 
experiments, each with 2-3 technical repeats)  
Additionally, we found that daf-2 mutants grown on gsk-3(RNAi) also exhibit 
low expression of mdh-2 and icl-1 (Figure 43C). As both genes are part of the 
glyoxylate shunt that allows carbohydrate synthesis via gluconeogenesis, this is 





in glycogen stores in IIS mutants grown on gsk-3(RNAi) might result from 
increased glycogen synthase activity instead.   
4.4.2 Triglyceride content is reduced upon gsk-3(RNAi), except in daf-2 
(e1370) mutants 
Apart from glycogen/carbohydrates, triglycerides constitute the major energy 
storage in nematodes. Also, they are efficient energy storage molecules due to 
their reduced state (Ashrafi 2007; Watts and Ristow 2017). Using fixative Oil-
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Figure 44: Whole body triglyceride levels in wild type, daf-2, phb-2 and phb-2;daf-2 mutants 
subjected to gsk-3(RNAi) A. Representative images of worms subjected to fixative Oil-Red-O 
staining B. Quantification of Oil-Red-O staining (Animals were imaged at Day1 of adulthood in all 
conditions, Mean±SD, One way ANOVA, ns = not significant p>0.05, ** = p<0.01, *** = p< 0.001,  





As reported earlier, daf-2 (e1370) mutants exhibited increased triglycerides 
(Yen et al. 2010). We observed that phb-2(tm2998) deletion mutants contain 
higher triglyceride levels compared to wildtype and phb-2 deletionfurther 
increases the triglyceride content of daf-2(e1370) mutants. Interestingly, 
depletion of GSK-3 reduced triglycerides in all genetic backgrounds except in 
daf-2(e1370) mutants (Figure 44). The reduced Oil-Red-O staining observed in 
wild type upon loss of GSK-3 is similar to the decreased whole-body 
triglyceride levels in Drosophila upon addition of lithium - a known inhibitor of 
GSK-3 (Castillo-Quan et al. 2016). 
4.4.3 Knockdown of GSK-3 leads to increased lipolysis   
Mobilization of stored fat through β-fatty acid oxidation is dependent on 
liberated fatty acids from triacylglycerides through the activity of lipases. Since, 
we observed decreased ORO staining, we investigated if that indicates 
increased lipid breakdown. We checked for alterations in expression of adipose 
triglyceride lipase, ATGL-1(Zimmermann et al. 2004; Gronke et al. 2005; 
Kershaw et al. 2006), known to localize to lipid droplets (Zhang et al. 2010a; 
Lee et al. 2014). Depletion of GSK-3 results in increased ATGL-1::GFP levels 
(Figure 45A,B)across all genetic backgroundsexcept in PHB depleted otherwise 
wildtype animals, where agtl-1 expression levels are unaltered. PHB depleted 
animals already show increased atgl-1 expression compared to wild type 
worms (Figure 45).  
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Figure 45: GSK-3 deficient animals exhibit increased hydrolysis of lipids. A. Representative 
images of alteration in ATGL-1 protein levels upon loss of GSK-3 across different genetic 
backgrounds. B.Scatter plots represent mean fluorescence of ATGL-1::GFP  as seen in wild type 
(left panel) and IIS depleted animals (right panel)  grown on control(RNAi), gsk-3(RNAi),phb-
1(RNAi) or a combination (Animals were imaged at Day1 of adulthood in all conditions, 
Mean±SD, One way ANOVA, Dunn’s multiple comparison test, ns = not significant p>0.05,  *** = 
p< 0.001,  n ≥ 58 worms for all conditions, one of  two independent experiments represented).  
The increased expression levels of ATGL upon gsk-3(RNAi) is in accordance with 
the reduced Oil -Red-O staining observed earlier. Being an exception daf-2 
mutants that exhibit increased expression of ATGL-1 upon GSK-3 depletion, 
although no alterations in triglyceride content was observed. 
4.4.4 Fatty acid oxidation is reduced upon gsk-3(RNAi) 
In order to get insight on whether GSK-3 depleted worms utilised energy from 
β-fatty acid oxidation from triglycerides, we looked at the expression of certain 
genes involved in fatty acid oxidation (Figure 46A,B). acdh-1 encodes for a 
short-chain acyl-CoA dehydrogenase, a mitochondrial enzyme that catalyzes 
the first step of fatty acid β-oxidation. We looked at the expression of acdh-1 
by utilising a transgenic strain, Pacdh-1::GFP. We found that the GFP 
expression is dramatically reduced upon GSK-3 depletion in wild type (Figure 
46A,B; left panel). Additionally, we crossed the phb-2(tm2998) mutants to the 
metabolic reporter Pacdh-1::GFP, and observed a strong repression in GFP 
signal, which intensified upon gsk-3(RNAi) (Figure 46, left panel). Similarly, in 





Pacdh-1::GFP expression both, in the presence and absence of PHB (Figure 46, 
A and B, right panel).  
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Figure  46: Reduced fatty acid β-oxidation upon gsk-3(RNAi) A.Expression of Pacdh-1::GFP in 





and phb-1;gsk-3 double RNAi (right panel) B. Scatter plot representing quantification of Pacdh-
1::GFP levels from images shown in A. Animals were imaged at Day1 of adulthood in all 
conditions, in A- n≥51  for all conditions, one of  two independent experiments represented; in 
B- n≥85, one of two independent experiments, each having two biological repeats has been 
represented  C. Expression of acdh-1 at day 5 of adulthood. Scatter plots represent  the 
quantification of Pacdh-1::GFP levels in otherwise wild type and PHB depleted worms grown on 
control and gsk-3(RNAi) (left panel) and in daf-2(e1370) mutants upon GSK-3 or PHB depletion or 
when both GSK-3 and PHB-1 are depleted using double RNAi (right panel), n≥23 for all 
conditions, average of two independent experiments (For B, C Mean±SD, One way ANOVA, 
Dunn’s multiple comparison test,  ns = not significant, **=p<0.01, *** = p< 0.001) D. Expression 
of acdh-1,-9, -12; acs-17;  cpt-2 in wild type and IIS mutants grown on gsk-3(RNAi) compared to 
control(RNAi) (Mean ±SEM, Unpaired t-test, *=p<0.05, **=p<0.01, *** = p< 0.001, **** = p< 
0.0001,  graph representative of three independent experiments, each with 2-3 technical 
repeats).           
This experiment was continued until day 5 of adulthood and similar reductions 
were observed (Figure 46C). Thus, nematodes depleted of GSK-3 or PHB might 
be averse to utilising energy derived from breakdown of short chain fatty acids. 
In addition, we observed a downregulation of other genes involved in fatty acid 
oxidation in wild type worms and IIS defective daf-2 mutants upon loss of GSK-
3 (Figure 46D). In particular, expression of acyl-CoA dehydrogenases - acdh-1, -
9, -12; acyl-CoA synthetase - acs-17 and the carintine pamiltoyltransferase cpt-
2 were found to be reduced (Figure 46D, left and right panel).                                                                                              
Thus, despite the increased rate of lipolysis (Figure 45) upon loss of GSK-3, the 
fatty acids are not being utilised in fatty acid oxidation as observed by the 
reduced expression of the genes above. This is of significance as nematodes 
obtain major dietary requirements from bacterial diet and not from de novo 
fatty acid synthesis. Several of the genes involved in fatty acid metabolism are 
expressed in the intestine, epidermis or both. Also, there are multiple family 
members that encode for the genes involved in fat metabolism. Additional 
metabolic genes involved in fatty acid oxidation and in de novo fat synthesis 
were analysed in conditions of loss of GSK-3 or PHB-1, and many were found to 
be differentially regulated (Appendix 3, A3.2,A3.3). We were able to conclude 
that while loss of GSK-3 led to a strong downregulation of short-/medium-/ 
long- chain oxidation of fatty acids in all backgrounds tested, loss of PHB-1 led 
to strong decreases only in genes involved in short chain fatty acid 





novo fat synthesis were also found to be repressed upon gsk-3(RNAi) 
(Appendix 3, A3.4) which can be a potential cause of reduced lipid storage in 
GSK-3 depleted worms. 
Thus, the extensive modulations in several core genes involved in fatty acid 
metabolism upon gsk-3(RNAi) across genetic backgrounds and specifically in 
wild type animals implicate GSK-3 as having a prominent role in metabolism in 
C. elegans in lipid synthesis and degradation, the latter being essential for 
energy generation.  
4.4.5 Vitellogenesis is reduced when GSK-3 is depleted 
Reproduction has a complex interplay with metabolism and ageing (Hansen et 
al. 2013), as it is an energy consuming process causing alterations in lipid 
metabolism, thus influencing organismal survival. Lipids are mobilised in 
worms during reproduction in a process called vitellogenesis, wherein 
vitellogenins (VIT) transport stored lipids in the form of yolk to the oocytes 
from the intestine. VIT genes are expressed in the intestine in adult 
hermaphrodites (Kimble and Sharrock 1983). Analysis of the long-lived IIS daf-2 
mutants has shown that these animals accumulate substantially less VIT 
(DePina et al. 2011) and their long lifespan is compromised upon over 
expression of VIT (Seah et al. 2016). GSK-3 depletion is characterised by a 
reduction in lifespan, along with defective reproduction leading to embryonic 
lethality (Figure 36,37,39) as well as modulations in fat metabolism (Figure  
44). Hence, we investigated if vitellogenesis was altered upon GSK-3 
knockdown by checking the expression levels of a member of the vitellogenin 
family, VIT-6. The expression of VIT-6 was observed to be decreased upon GSK-
3 depletion across all genetic backgrounds (Figure  47A, B). As shown earlier, 
we observed low vitellogenesis in daf-2(e1370) mutants compared to wild type 
(DePina et al. 2011). Incidentally, the PHB depletion in otherwise wild type 
animals led to decreased VIT-6 expression (Figure  47A), whereas the same in 
IIS depleted worms had no significant effect  (Figure 47B). 
As VIT proteins mediate transport of lipids from the intestine to the gonad, the 
reduction in vitellogenesis is consistent with the low lipid content seen using 
ORO staining upon loss of GSK-3. The reduced vitellogenesis in wildtype and IIS 
mutants on gsk-3(RNAi) is also in accordance with GSK-3 depleted animals 



























































Figure  47 : Decreased vitellogenesis upon GSK-3 depletion. A. The transgenic strain Pvit-6::GFP 
and B. daf-2(e1370);Pvit-6::GFP were utilized to check for alterations in vit-6 expression upon 
GSK-3 knockdown in worms grown on control and phb-1(RNAi). The scatter plot to the right of A. 
and B.  represents the quantification of GFP intensity (Animals were imaged at Day1 of 
adulthood in all conditions, Mean±SD, One way ANOVA - Dunn’s multiple comparison test, *** = 
p< 0.001. In A. n ≥ 78 worms for all conditions, one of three independent experiments. In B. n ≥ 
98 worms for all conditions, one of two independent experiments)  
 
4.5 GSK-3 depletion compromises mitochondrial respiration 
Depletion of GSK-3 leads to alterations in energy stores and decreased fatty 
acid oxidation. We decided to directly measure mitochondrial metabolic 
activity in whole worms by utilizing the Seahorse XFp Analyzer (Luz et al. 2015; 





oxygen consumption rate (OCR) of worms, the result of mitochondrial 
respiration through oxidative phosphorylation.  
Key mitochondrial parameters, basal and maximal respiration were 
determined by means of OCR measurements. To interpret the data and 
compare strains or RNAi treatments, the OCR per well was converted to OCR 
per worm (by directly counting the number of worms after the assay). In our 
case, the mitochondrial mutants and the gsk-3(RNAi) treated worms were 
smaller than their controls at the YA stage and at Day 5. As worm size was 
significantly different among the studied genetic backgrounds both at YA and 
at day 5 (Figure 48 A, B), we corrected OCR per worms for worm area.  
We observed that compared to wild type nematodes, daf-2 mutants exhibited 
less basal respiration at the YA stage (Figure 48C), while phb-2 deletion did not 
affect basal respiration neither in wild type nor in daf-2 mutants. However, the 
phb-2 mutants exhibit increased OCR compared to the phb-2; daf-2 double 
mutants. No alterations were detected in basal respiration upon GSK-3 
depletion across the different genetic backgrounds except a decrease in phb-2; 
daf-2mutants (Figure 48C). 
Respiration changes significantly during development and ageing. We observed 
that at day 5, basal respiration decreased in the wild type (Figure 48D) 
(Braeckman et al. 2002a; Braeckman et al. 2002b), but not in IIS defective daf-2 
mutants, which at day 5 respired at par with wild type. phb-2 mutants 
exhibited increased OCR compared to wild type animals probably a result of 
accumulating faulty mitochondria through ageing, whereas the IIS defective 
mutants depleted of PHB exhibit decreased OCR compared to daf-2  mutants. 
GSK-3 depletion, however, reduced respiration during ageing as observed at 
day 5 exclusively in daf-2 mutants (Figure 48D).  
We also examined maximal respiratory capacity by addition of the 
mitochondrial uncoupler, carbonyl cyanide 4-(trifluoromethoxy) 
phenylhydrazone (FCCP)(Figure 48E,F). FCCP is added to fully uncouple 
mitochondrial respiration, i.e., it dissipates the proton gradient in the 
mitochondrial membrane and hence, in an attempt to re-establish the proton 
gradient, the worm increases oxygen consumption. This is a reflection of 





maximal respiration is significantly higher than basal respiration in all genetic 
backgrounds at the YA stage and at Day 5 (Appendix 4, Figure A4.1). 
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Figure 48: Alterations in mitochondrial metabolism upon depletion of GSK-3. A-B Comparison of 
worm area in wild type, daf-2, phb-2 and phb-2;daf-2 during ageing, A. Young adult, B. Day 5, 
grown on control(RNAi) and gsk-3(RNAi) (1 way ANOVA, Dunn’s multiple comparison test, ns = 
not significant p>0.05,  *** = p< 0.001, Mean± SD, n > 190 worms at YA stage and n >18 worms 
at day 5 for all conditions represented). C-F Variations in consumption rate (OCR) across all four 
genetic backgrounds grown on control(RNAi) and gsk-3(RNAi). Basal respiration at young adult 
(YA) stage(C.)  and during ageing, at day 5 of adulthood (D.) and maximal oxygen consumption 
rate (OCR) as observed by treatment using FCCP at YA stage  (E)and at day 5 (F). Data has been 
depicted  normalised to worm area in all cases (Unpaired t-test, ns=not significant p>0.05, * = 
p<0.05, ** = p<0.01, *** = p< 0.001, mean±SD, n = at least 3 independent experiments 
consisting of 3-4 wells each of control(RNAi) and gsk-3(RNAi) for each genetic background 
tested).  
The deletion of PHB in otherwise wild type animals had no significant effect on 
maximal respiration, while the same in IIS defective mutants led to a decrease 





respiration (Figure 48C), respired at par with wild type indicating they are 
capable of responding to external stress (Figure 48E). GSK-3 depletion caused 
an increase in maximal OCR in phb-2 mutants and a strong decrease in daf-2 
mutants not affecting wild type animals or phb-2;daf-2 mutants (Figure 48E). 
During ageing PHB depletion modulates OCR differentially in wild type and IIS 
defective mutants, increasing and decreasing respectively, similar to basal 
respiration at day 5 (Figure 48F), while no significant differences were 
observed for daf-2 mutants compared to wild type. Mitochondrial mutants on 
gsk-3(RNAi) were unaffected upon FCCP addition, although a tendency to 
increase maximal OCR is observed. Maximal respiration upon GSK-3 depletion 
wasstrongly reduced again in daf-2 mutants at day 5, just like at the YA stage 
(Figure 48F). Loss of GSK-3 also compromised maximal respiration in wild type 










































Figure 49: Change in rate of respiration of all genetic 
backgrounds grown in control(RNAi)and gsk-3(RNAi), 
through ageing, from young adult to day 5 of 
adulthood, A.basal and B. maximal. (The ***, **, *, ns 
indicate significant changes from YA to day 5 n each 
genetic background. Unpaired t-test, ns=not significant 










































                                                  
To summarise, IIS mutants tend to not change their basal or maximal rate of 
respiration from young adult to day 5, unlike wild type that exhibit a reduction 
(Figure 49A,B). While the phb-2 mutants also show unaltered respiration 





slightly decreased. Loss of GSK-3, prominently reduced basal and maximal 
respiration in wild type and IIS mutants, while having no effect on 
mitochondrial phb-2 mutants. Interestingly, the basal and maximal OCR of IIS 
mutants on gsk-3(RNAi) are quite similar through the course of ageing (Figure  
A4.1). Upon addition of FCCP, only phb-2 mutants on gsk-3(RNAi) show a 
strong increase in OCR during ageing. An increased capacity to respond to 
external stress might be of importance as these are the only mutants that are 
unaffected in terms of survival (Figure 36,37) upon GSK-3 depletion.  
4.6 Selective induction of the mitochondrial unfolded protein response 
(UPRmt) upon gsk-3(RNAi)  
The observed altered mitochondrial bioenergetics upon gsk-3 depletion might 
be associated with additional signs of mitochondrial stress. Mitochondrial 
dysfunction is detected by a surveillance pathway specific to the mitochondria, 
the UPRmt, that involves induction of mitochondrial chaperone genes such 
as hsp-6 or hsp-60. Prohibitins have a prominent role in maintenance of 
mitochondrial structure and function, and prohibitin depletion strongly induces 
the UPRmt. This is accompanied by increased mitochondrial content in wildtype 
animals on phb-1(RNAi), whereas the same is suppressed in PHB depleted IIS 
daf-2 mutants (Artal-Sanz and Tavernarakis 2009b; Gatsi et al. 2014). 
We assayed the expression of Phsp-6::GFP reporter in wildtype, daf-2 mutants 
on control and gsk-3(RNAi) and upon PHB depletion. As observed earlier with 
phb-1(RNAi) (Gatsi et al. 2014) and phb-2(RNAi) (Schleit et al. 2013), phb-2 
deletion strongly induced the UPRmt (Hernando-Rodriguez et al. 2018), while 
the UPRmtwas suppressed in the double mutant phb-2;daf-2 (Figure 50B). 
Depletion of GSK-3 strongly induces the UPRmt in wildtype (Figure 50A) worms, 
while metabolically compromised daf-2 mutants were unaffected upon GSK-3 
depletion. The phb-2 mutants do not further induce the UPRmt upon GSK-3 loss 
(Figure 50B), while daf-2 mutants depleted of PHB show a slight, albeit 
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Figure 50: Induction of UPR
mt
reporter, Phsp-6::GFP. Fluorescent microscopy images of transgenic 
animals grown on control(RNAi) and gsk-3(RNAi) A. Phsp-6::GFP and daf-2(e1370);Phsp-6::GFP 
(left panel), quantification of hsp-6::GFP  expression (right panel)  and B. phb-2(tm2998);Phsp-
6::GFP and phb-2(tm2998);daf-2(e1370);Phsp-6::GFP (left panel) and quantification of hsp-6::GFP  
expression (right panel) (Mean ± SD; n > 135 in all conditions, 1 way ANOVA, Dunn’s multiple 
comparison test, ns = not significant p>0.05,  *** = p< 0.001. Average of two independent 
experiments has been shown) 
4.7 GSK-3 is essential for ER homeostasis and mitochondrial membrane lipid 
composition  
Like the mitochondria, the endoplasmic reticulum also synthesizes, folds and 
secretes proteins. The unfolded protein response of the endoplasmic reticulum 
(UPRER), is a stress response specific to the ER, allowing it to adapt to 
proteostatic imbalances. Moreover, the ER is also a site of lipid synthesis, in 
particular phospholipids and sterols. We wondered whether GSK-3 might also 
be essential in maintaining ER stabililty. In metazoans, activation of the IRE-1 
branch of the UPRER results in increased splicing of the mRNA encoding the 





target genes such as the ER-specific chaperone and heat-shock protein hsp-
4/BiP (Ron and Walter 2007). We found that loss of GSK-3 via RNAi resulted in 
activation of UPRER, as indicated by an increase in Phsp-4::GFP expression levels 
























Figure 51: Induction of UPR
ER 
reporter, Phsp-4::GFP. Representative images of Phsp-4::GFP 
transgenic strain on control(RNAi) and gsk-3(RNAi) (left panel).  Scatterplot represents the GFP 
quantification (right panel) (Mean ± SD; n > 190 in both conditions, Unpaired t-test, *** = p< 
0.001. Average of three independent experiments has been shown) 
This activation of the UPRER, while an indication of imbalance in proteostasis, 
might also be a reflection of perturbations in membrane lipid composition. 
Mitochondria synthesize some lipids on their own, particularly, 
phosphatidylglycerol (PG), cardiolipin (CL), phosphatidylethanolamine (PE), and 
phosphatidic acid (PA). They depend also on the transfer and assembly of lipids 
mainly formed in the endoplasmic reticulum (ER) like phosphatidylinositol (PI), 
phosphatidylserine (PS) and phosphatidylcholine (PC), sterols and sphingolipids 
and hence, a continuous supply and exchange of lipids is required for 
maintaining mitochondrial membrane integrity and overall cellular function 
(Horvath and Daum 2013).   
In light of this, we found alterations in the amount and composition of 
membrane lipids, especially the most abundant phospholipids – PE, PC, PS, 
when GSK-3 was depleted both, in wild type and in daf-2 mutants (Figure 52). 
phb-2 mutants displayed increased levels of phospholipids compared to wild 
type, whereas in the double mutant phb-2;daf-2 some phospholipid species 
were decreased in comparison to daf-2 mutants. Interestingly, we also 
detected alterations in cardiolipin levels, a unique phospholipid exclusively 
located in the inner mitochondrial membrane (Paradies et al. 2014). Cardiolipin 





apoptosis and mitophagy. Loss of GSK-3 tends to increase CL levels particularly 
in wild type and daf-2 mutants (Figure 52). Similarly, sphingolipids such as 
ceramides were also upregulated upon loss of GSK-3 in wild type animalsand 
daf-2 mutants, with milder increases in the other backgrounds. 
  
Figure   52: Altered membrane lipid compostitions across genetic backgrounds. Worms were 
grown in control(RNAi) and gsk-3(RNAi) or a combination of both at the young adult stage. PS -
phosphatidylserine; PE -phosphatidylethanolamine; PC -phosphatidylcholine; CL - cardiolipin; 
CER- Ceramide (Phospholipids are designated as phospholipid(AB-CD), where AB-CD denotes 
the total number of carbon atoms in the fatty acyl chains, n = at least 3-4 independent 






These membrane perturbations are despite the fact that mitotracker analysis 
revealed no significant alterations in mitochondrial content when GSK-3 is 
depleted across these genetic backgrounds (Appendix 4, Figure A4.3).  
 4.8 Intestinal GSK-3 is essential for the longevity daf-2(e1370) mutants 
The C. elegans intestine is a central metabolic organ in the nematode, mainly 
responsible for digestion of food, nutrient uptake and synthesis and storage of 
macromolecules. There are several evidences that implicate the intestine as 
having a major role in healthy ageing and lifespan regulation (Rera et al. 2013). 
The intestine is a major site of fat storage and modulations in the same have 
been observed in mutants of the IIS signalling pathway. For example, 
reestablishment of DAF-16 expression only in the intestine ofdaf-2;daf-
16 mutants, extends lifespan (Libina et al. 2003).Dietary restriction increases 
lifespan in C. elegans as in other organisms and autophagy in the intestine has 
been shown to have a role in ensuring this lifespan extension in the 
worm(Gelino et al. 2016). 
Based on the expression pattern of GSK-3 and the observable expression in the 
intestine, an intestine specific RNAi system was used to knockdownGSK-3 
solely in the intestine. For this, we used an RNAi DEfective, rde-1 mutant strain, 
whererde-1has been rescued only in the intestine. Hence, these animals are 
refractory to RNAi in all tissues expect the intestine (Espelt et al. 2005).  
We observed that depletion of GSK-3 in the gut alone was sufficient to cause a 
significant reduction in lifespan across all backgrounds (Figure 53 A-D). We 
observed that there was an average decrease in mean lifespan of 7% for wild 
type, 58% for daf-2, 22% for phb-2and 20% for phb-2;daf-2 (Table 4) upon gsk-
3(RNAi). The IIS mutant lifespan was reduced below that of wild type on GSK-3 
attenuation (Figure 53A, B; also Refer Table 4), indicating that active GSK-3 in 
the intestine was absolutely essential to the long lived phenotype of daf-2 
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Figure 53: Intestine-specific GSK-3 depletion accelerates ageing in A. wild type B. daf-2(e1370) C. 
phb-2(tm2998) and D. phb-2(tm2998);daf-2(tm2998) mutants. Lifespan analysis carried out 
using an intestine specific RNAi system, rde-1(ne219);kbIs7. Average of at least two independent 
lifespan curves has been represented here.  
The intestine of the worm is also a major site for responses to stress. The 
transcription factor SKN-1, is known to regulate intestinal genes that are 
involved in detoxifications and protect against ROS.  
4.9 SKN-1 activity measured via expression of Pgst-4::GFP 
The C. elegans SKN-1 (ortholog of the mammalian Nuclear factor E2-related 
factor (Nrf) protein family) is a key transcription factor involved in the 
protection against oxidative and xenobiotic stresses (Blackwell et al. 2015). It 
has been proposed that under normal conditions, GSK-3 inhibits SKN-1 
localization and subsequent target gene induction, whereas, in response to 
oxidative stress, SKN-1 is phosphorylated by PMK-1/p38 MAPK in the 
cytoplasm, after which it goes to the nucleus and induces the expression of a 
wide range of antioxidant and detoxifying enzymes such as gst-4 (encoding for 
the drug-metabolizing enzyme glutathione S-transferase 4). The SKN-1 
transcriptional response to oxidative stress is well-conserved between species 





The transcriptional activity of SKN-1 can be indirectly assayed via a 
transcriptional reporter of the gst-4 promoter which shows increased GFP 
levels when transcription is activated in vivo.  We examined expression of GST-
4 when GSK-3 was inhibited across otherwise wildtype and PHB depleted 
worms. Additionally, we crossed the Pgst-4::GFP reporter strain to daf-2 
mutants.We observed induction of Pgst-4::GFP upon gsk-3(RNAi)in wildtype 
and PHB depleted animals. On the contrary,GSK-3 attenuation reduces GST-4 
expression in daf-2 and daf-2;phb-2mutants (Figure 54A, B). The induction of 
gst-4 in wildtype animals upon GSK-3 depletion is in accordance with earlier 
reports (An et al. 2005), and hence, an indication that SKN-1 is active.  While it 
is known that SKN-1responsive genes, such as gst-4 are upregulated in daf-2 L4 
larvae (Tullet et al. 2008), we refrain from commenting on this as wild type and 
IIS mutants were not compared in the same experiment, and we looked at 
Day1 animals. The mitochondrial PHB mutants, phb-2 and phb2;daf-2 exhibited 
a mild reduction to no effect respectively in terms of GST-4::GFP expression.  
The suppression of Pgst-4::GFP upon gsk-3(RNAi) in daf-2mutant backgrounds 
(Figure 54B), might indicate regulation of GST-4 or SKN-1  from other inputs.  





















































Figure 54: Pgst-4::GFP expression(mean GFP intensity) in A.Wild type and B. daf-2(e1370) 
mutants upon PHB and GSK-3 depletion (Animals imaged at Day 1 of adulthood, Mean±SD, One 
way ANOVA, Dunn’s multiple comparison test,  ns =not significant, *=p<0.05,*** = p< 0.001 , for 
A. n≥80, average of two independent experiments and for B. n≥85, one of two independent 
experiments has been represented) 
Nonetheless,  recent studies have revealed that the use of GST-4 as a sole 
readout for SKN-1 activation and subsequent interpretation of results should 
be done with caution as gst-4 can also be transcriptionally activated by EOR-1, 
a transcription factor mediating effects of the epidermal growth factor (EGF) 





Although this result cannot contribute to an explanation of the differential 
ageing phenotype observed upon depletion of GSK-3, utilizing the SKN-1::GFP 
transgenic strain in the future might help confirm whether SKN-1 is actually 
localized to intestinal nuclei across PHB-1 and/or IIS depleted animals on gsk-3 
(RNAi). This might better indicate any potential modulation of oxidative stress 

































Automated image acquisition and analysis for essential genes 
Caenorhabditis elegans is an exceptional genetically tractable organism that is 
easy to maintain and has a short, well defined life cycle. More importantly, the 
worm genome shares high homology with that of humans. These features 
make it an amenable platform for high-throughput and high-content screens 
(Boutros and Ahringer 2008; O'Rourke et al. 2009a; O'Reilly et al. 2016). 
Despite these significant advantages, large-scale studies in C. elegans with 
respect to investigation of essential genes are still not well developed. Though 
there exist temperature-sensitive alleles that allow the temporal suppression 
of gene function; very few essential genes have a ts allele (Housden et al. 2017; 
Mok et al. 2017). A way out, is the  use of chromosome balancers, which 
already cover 85% of the genome, with additional efforts aimed at having 
fluorescently labelled balancers for all C. elegans essential genes via CRISPR 
(Iwata et al. 2016). 
The conserved mitochondrial prohibitin (PHB) complex composed of two 
subunits, PHB-1 and PHB-2, is located in the inner mitochondrial membrane 
and both subunits are interdependent for the formation of the complex. 
Phenotypes observed upon either phb-1 or phb-2 via RNAi are similar. Also, 
both subunits of the PHB complex have been confirmed as absent in both phb-
1(tm2571) and phb-2(tm2998) mutants (Hernando-Rodriguez et al. 2018). 
Prohibitin proteins are essential for embryonic development in C. elegans 
(Artal-Sanz et al. 2003) and homozygous phb-1 and phb-2 deletion mutants are 
sterile due to maternal contribution. Therefore, deletion mutants need to be 
maintained as balanced heterozygous. 
As the task of distinguishing the homozygous phb-2 worms from the 
heterozygous wild type is difficult, these mutants are not suitable for large 
scale experiments, such as for the purpose of RNAi screenings. Hence, we 
developed and present here a successful strategy in this regard, for automated 
whole animal image-based RNAi screening that can be applied to essential 
genes when carrying a fluorescently labelled balancer. Developing this 
automated pipeline involved two major steps. First, sorting non GFP 
homozygous mutant animals from a GFP-marked balanced population at the 
first larval stage (L1) in order to identify genes acting during early larval 





segmentation protocol using a microscopy platform not previously utilized for 
C. elegans. COPAS is a convenient approach for high-throughput analysis 
involving balanced strains, as it facilitates a task that manually would be 
impracticable. In the past, GFP balanced strains have been sorted at older 
larval stages such as L3,L4 (Latorre et al. 2015; Ruegger et al. 2015); but not for 
the purposes of screening. 
Previously, high-throughput imaging strategies specific to C. elegans have been 
designed using various microscopy platforms (Moy et al. 2009; Gosai et al. 
2010; Wahlby et al. 2012; Maia et al. 2015). Similar to others, the IN Cell 
Analyzer (GE Healthcare) used in this thesis utilizes a combination of 
brightfield- and fluorescence-based imaging. Image acquisition has been 
optimised to include an entire well of a 96-well plate in a single image, 
ensuring even brightfield illumination by sealing the plate with a transparent 
seal. The optimised autofocus and scanning times of the IN Cell Analyzer 
enable image acquisition of an entire 96-well plate in three channels in less 
than 15 min. We have designed an automated segmentation protocol for 
balanced strains in C. elegans. This user-defined, user-friendly protocol was 
built using the Developer Toolbox (GE Healthcare) software that allows 
intensity based measurements apart from other measures defined by the user 
like area, length, curvature, etc. It can be used for any strain without the need 
of transgenesis, as segmentation is done in the brightfield image. A novelty of 
this segmentation protocol is the measurement of the background surrounding 
each target. By dilating the targeted worm, we can easily measure and subtract 
the intensity of the immediate background. This is very appropriate in the 
cases of dyes, such as Nile Red in this thesis, that stain plastic and can cause 
different background intensities depending on the area of the well. Another 
feature of the improved image analysis protocol is the successful identification 
of worms carrying a pharyngeal GFP element. When COPAS sorting is not 100% 
efficient, heterozygous worms will develop into fertile adults and lay progeny 
in the wells; hence, the need of distinguishing worms carrying the GFP balancer 
from homozygous mutants.  
As mentioned, segmentation of worms is done in the brightfield and the 
protocol can be adapted for any strain. These protocols are not restricted to 





involving dyes or transgenic GFP strains as image acquisition and analysis is 
faster and surpasses the traditional time consuming manner of mounting 
worms on slides and of manually segmenting worms. This thesis has also 
utilised the segmentation protocols built using the Developer toolbox for 
image analyses in additional experiments.   
Though COPAS can serve as an alternative to microscopy based measurements, 
as it can measure length, optical density and fluorescence emission of single 
worms (Squiban et al. 2012; Zugasti et al. 2016), image-based microscopy 
platforms are far more advantageous. They are faster and images are stored, 
making them accessible for re-analysis. Also, a much smaller number of 
animals can be used for image based assays as compared to the COPAS, 
allowing exploration of a large number of different treatments in parallel, such 
as RNAi or drug screens. Image-based screens also ensure that multiple 
outputs can be examined from the image, e.g. fluorescent intensities in 
different channels, size and shape measurements. This could also be used to 
detect other phenotypes such as sterility by classifying the small worms as 
progeny based on worm length measurement, or to distinguish between thin 
and fat worms based on worm width measurement. We have translated the 
image analysis protocol for Cell-Profiler (Carpenter et al. 2006), a free and 
open source image analysis software, making the protocol available to the 
scientific community. In doing so, we broaden the features of the CellProfiler 
“WormToolbox” for high-throughput screening of image-based C. elegans 
phenotypes (Wahlby et al. 2012; Wahlby et al. 2014). We provide validation 
that both protocols produce comparable results. Although the segmentation 
output is not exactly the same in terms of number of worms being segmented, 
the level of stringency in the segmentation criteria can be modulated with ease 
for both protocols. 
A kinase RNAi screen reveals potential mediators of the effect of PHB 
depletion on metabolism and longevity.  
We performed an RNAi screen utilising a kinase RNAi library looking for PHB 
genetic interactors. We used vital Nile Red staining as a read out for the RNAi 
screen, as a strong metabolic feature exhibited by PHB deletion both, in wild 
type and IIS mutants, is low Nile Red accumulation (Figure 24). Using this 





reduced NR staining phenotype of the mitochondrial PHB mutants, but did not 
encounter any that further enhanced the low NR phenotype.  
With respect to the NR staining method used as a readout for the RNAi screen, 
the status of this vital stain as to whether it stains true fat reserves or infact 
lysosomal related organelles (LROs) has been debated. Vital NR, when fed to 
nematodes was believed to indicating fat stores (Ashrafi et al. 2003), though 
now it has been shown that the compartments within the worm being stained 
by NR are different from netrual lipid stores in C. elegans (O'Rourke et al. 
2009b; Yen et al. 2010; Klapper et al. 2011). Infact, staining with Oil-Red-O 
revealed that depletion of PHB resulted in increased accumulation of 
triglycerides in both wild type and IIS defective daf-2 mutants (Figure 25). As 
mitochondria are involved in fat oxidation, mitochondrial dysfunction may lead 
to accumulation of lipids. The ORO staining is in accordance with data from 
metabolomic studies (unpublished data, Lourenço et.al). Previously, Sudan 
Black staining for triglycerides in aged worms devoid of PHB has revealed 
decreased staining (Artal-Sanz and Tavernarakis 2009b), but as the Oil-Red-O 
staining is done in younger worms, it is probable that the differences are a 
result of age based changes in fat accumulation.  
NR co-localises with autofluorescent intestinal granules, thus it is believed that 
LRO are the site of age pigment/lipofuscin accumulation (Hermann et al. 2005; 
Schroeder et al. 2007). High levels of lipofuscin might indicate a physiologically 
aged state (it is not yet clear whether high levels cause ageing or are a 
symptom of ageing), as seen from many mutants with altered LRO biology that 
have altered lifespan. Example, short-lived strains such as daf-16, rict-1, kat-1 
have increased LRO autofluorescence and NR, and long-lived strains such as 
daf-2, daf-7, eat-2 tend to have lower levels of both (O'Rourke et al. 2009b; 
Soukas et al. 2009). But, this is not the case for all long-lived or short lived 
mutants, and hence, cannot be taken as a co-relation (Samuelson et al. 2007). 
But if lysosomal function is impacted due to increased age pigment buildup, it 
might lead to alterations in vesicular trafficking and autophagy, both of which 
can contribute to accelerated ageing. However, other reports suggest that 
rather than lipofuscin (Brunk and Terman 2002; Gerstbrein et al. 2005), the 
autofluorescent substance in C.elegans LROs is anthranilate, a breakdown 





stained LRO’s are sites of zinc or cholesterol storage (Roh et al. 2012; Wang et 
al. 2014). Alterations in zinc have been linked to lifespan (Kumar et al. 2016), 
and stored zinc can aid in detoxification and be a source of zinc during dietary 
deficiency (Roh et al. 2012). However, regardless of the stain status, vital NR 
staining is reproducible and sensitive to genetic manipulations that are 
expected to alter staining and thus, provides a useful tool to screen for genetic 
interactors. Previously, vital Nile Red has been utilized in different model 
systems to identify genes that alter fat and to identify pathways involved in fat 
regulation (Greenspan et al. 1985; Ashrafi et al. 2003; McKay et al. 2003; Van 
Gilst et al. 2005a; Jones et al. 2008; Lemieux et al. 2011). 
Amongst the identified kinases in the screening, a majority are involved in 
phosphorylation (except dhs-31, osm-11, inos-1, ceh-20, unc-60) and in 
organism development, signal transduction, reproduction, Wnt signalling, lipid 
storage, locomotion, etc (Figure 35). Though we did not encounter any GO 
terms relate to ageing, ire-1, akt-1, rsks-1, osm-11, ceh-20, unc-60, gsk-3, sgk-1 
(Hertweck et al. 2004; Hamilton et al. 2005; Hansen et al. 2007; Samuelson et 
al. 2007; McColl et al. 2008; Henis-Korenblit et al. 2010; Walter et al. 2011; 
Dresen et al. 2015) are genes that have been shown previously to influence 
worm lifespan.  In addition to finding genes previously shown to be involved in 
metabolism such as vps-15, kin-1, ire-1, inos-1, akt-1, sgk-1, we also found 
genes that have been previously described to interact with PHBs in the past 
such as rsks-1, sgk-1, mtk-1 and gsk-3. While both SGK-1 and RSKS-1 have been 
shown to interact with PHBs to regulate lifespan (Schleit et al. 2013; Gatsi et al. 
2014),  we show here that depletion of MTK-1 leads to an opposing longevity 
phenotype in  phb-2 and phb-2;daf-2 mutants (Figure A1.2). Thus, the presence 
of these known genes previously implicated in metabolism and longevity 
regulation and/or showing an interaction with PHB validates the screening. 
Further study of these PHB interacting genes found in this study will yield 
additional insight into the diverse functions of the mitochondrial prohibitins. 
GSK-3 deficiency causes differential shortening of lifespan and defective 
reproduction 
The focus of this thesis is GSK-3, a kinase that when knocked down produces 
an increase in the NR staining phenotype of phb-2 and phb-2;daf-2 mutants. As 





to point us towards potential interactors of PHBs, probing if and why GSK-3 is 
involved in regulating LRO biology is beyond the scope of this thesis. However, 
we did observe from transciptomic analyses done in the lab (data not shown), 
that the expression of kat-1, a mitochondrial ketothiolase, a key gene involved 
in the regulation of LRO biology (Soukas et al. 2013) was downregulated upon 
gsk-3(RNAi) in the mitochondrial PHB mutants. Interestingly, KAT-1 is a highly 
conserved enzyme in the mitochondrial fatty acid β-oxidation pathway and is 
known to act in the intestine (Mak et al. 2006).  
This multifunctional serine threonine kinase is highly conserved in evolution 
and has been described to regulate several signalling cascades. Besides its 
prominent role in glycogen metabolism, GSK-3 has been implicated in diseases 
such as diabetes, Alzheimer’s disease, bipolar disorder and cancer, making it a 
tempting therapeutic target. Importantly, GSK-3 is regulated in response to 
PHB deficiency in Phb2KO mice, where GSK-3β was inactivated by 
phosphorylation at Ser position 9 in hippocampal tissue lysates (Merkwirth et 
al. 2012). While the function of GSK-3 in C. elegans has been studied majorly 
during early development, it has not been well elaborated in C. elegans with 
emphasis on ageing and metabolism. Herein, we investigated how gsk-3(RNAi) 
impacts ageing and metabolism under conditions of reduced IIS signalling and 
in mitochondrial prohibitin mutants. 
We present evidence that loss of GSK-3 accerelates ageing differentially 
depending on the metabolic status of the animal. Published studies in the past 
have established that loss of the conserved GSK-3 shortens lifespan in 
maternally rescued gsk-3 null C. elegans (McColl et al. 2008) and in mice (Zhou 
et al. 2013). In accordance, we observed that gsk-3(RNAi) reduces wild type 
lifespan significantly; however, the same does not impact phb-2 mutant 
survival. GSK-3 function is essential for the long lived IIS daf-2 and phb-2; daf-2 
double mutants (Figure 36). Particularly, the impact of decrease upon gsk-
3(RNAi) is striking for daf-2 mutant, implying that GSK-3 is essential for the 
extended longevity of IIS mutants. The shortening of the phb-2;daf-2 mutants 
on loss of GSK-3 can be attributed to DAF-2,as PHB-2 is unaffected. What was 
intriguing about the effect of gsk-3(RNAi) was that its effect on shortening 
survival of wildtype worms was  significantly higher than its effect on 





daf-2 mutants. As GSK-3 is implicated in metabolism in other systems, it is 
quite possible that the ageing phenotype seen in worms is subject to metabolic 
perturbations.  
GSK-3 loss results in embryonic lethality and reduced brood size in wild type 
worms, (Figure 39) indicating reduced fitness, in line with reports of lethality 
and developmental defects in mice, Drososphila (Bourouis et al. 1990; Hoeflich 
et al. 2000) and in worms upon GSK-3 disruption. In worms, lethality is 
attributed to abnormal C blastomere differentiation and Wnt signalling (An et 
al. 2005; Gleason et al. 2006). Worms devoid of the GSK-3 and the Wnt 
component, APR-1 also exhibit distorted gonads (Cabello et al. 2010). GSK-3 is 
required for OMA-1 degradation, a regulator of oocyte to embryo transition 
(Nishi and Lin 2005) and the phenotype oma-1(zu405) mutant embryos are 
similar to that of GSK-3 depleted embryos (Schlesinger et al. 1999; Maduro et 
al. 2001; Lin 2003). Thus, embryonic defects upon loss of GSK-3 could be due to 
failure of timely degradation of OMA-1. Also, adult gsk-3 mutant germlines 
have lower GSCs essential for germline development (Furuta et al. 2018), 
further implicating GSK-3 in early development. A more drastic lethal 
phenotype is exhibited by daf-2(e1370) mutants upon depletion of GSK-3 
(Figure 39). Based on IIS signalling inhibition of GSK-3, daf-2 mutants are likely 
to have active GSK-3, and hence, an active GSK-3 is required for normal 
reproduction in these worms. In Drosophila, late stage oocytes (conditions 
when IIS signalling is lost) subjected to gsk-3(RNAi), were inviable (Sieber et al. 
2016), similar to the effect seen by us in daf-2(e1370) mutants, implying the 
importance of GSK-3 in conditions of low IIS signalling. Additionally, a 
developmental role for GSK-3 across all genetic backgrounds is also confirmed 
by the fact the mean lifespans are increased when worms are exposed to gsk-
3(RNAi) from adulthood (Figure 37) rather than from embryos.  
In addition to the described dynamics of GSK-3, we observe expression of GSK-
3 in the sperm. The worm embryo has distinct embryonic anteroposterior (AP) 
asymmetries.  The sperm, probably via its associated centrosome, establishes 
the AP axis through the control of cytoplasmic rearrangement and final 
polarization of the zygote requires basic elements of the cytoskeleton 
(Goldstein and Hird 1996). Additionally, Wnt signalling is involved in inducing 





Hence, there might be a link with sperm expression of GSK-3 to the observed 
embryonic defects. 
A major role for GSK-3 is as a key negative regulator of Wnt signalling, as a 
member of the destruction complex. Other components of the destruction 
complex include kin-19 and pry-1. Loss of KIN-19 elicits a similar accerelation of 
ageing across all backgrounds, as observed upon gsk-3(RNAi) (Figure 38A).  
Incidently, pry-1 mutants have a low brood size much like GSK-3 depleted 
worms and are short-lived (Ranawade et.al, bioRxiv, pre-print). Interestingly, 
we found that decreasing Wnt signalling via loss of BAR-1, also elicits the same 
lifespan phenotype (Figure 38B) as observed upon gsk-3(RNAi) and kin-19 
(RNAi) (Table 4,5). It has been shown previously that upon loss of BAR-1, the 
Wnt-signalling pathway is activated implying a compensation mechanism (van 
der Bent et al. 2014). Additionally, experiments in the lab showed that bar-1 
(RNAi) downregulates GSK-3. This could indicate why loss of Wnt components 
leads to a similar reduced longevity phenotype across the four genetic 
backgrounds.  
GSK-3 is a well-documented target of lithium (Stambolic et al. 1996; Ryves and 
Harwood 2001; De Sarno et al. 2002) and the effects of lithium on ageing have 
been studied in yeast and C. elegans, with lithium extending lifespan (McColl et 
al. 2008; Zarse et al. 2011; Sofola-Adesakin et al. 2014; Tam et al. 2014). 
Though effects of lithium on Drosophila ageing were previously inconclusive 
(Matsagas et al. 2009; Zhu et al. 2015), now there is evidence of lifespan 
extension (Castillo-Quan et al. 2016). Lithium concentration in the drinking 
water of a large Japanese population has been associated with reduced overall 
mortality (Zarse et al. 2011), suggesting that lithium may be a bona fide anti-
ageing drug. Lithium is a popular drug used to treat mood affect disorders, but 
has a narrow therapeutic range beyond which there is risk of tissue damage 
(Malhi and Tanious 2011). Evidence from work in flies and worms suggest the 
same is true for lifespan extension; lower doses extend lifespan, whereas 
higher concentrations are detrimental (McColl et al. 2008; Zhu et al. 2015; 
Castillo-Quan et al. 2016). We used a concentration of lithium previously 
shown to extend lifespan in both worms and flies with contradictory results 
(Figure A2.2). Importantly, in our experiments done at 20 °C,  lithium addition 





lifespan against the previous observation where lithium extended wild type 
and daf-2(e1368) median lifespan by 36 % and 19%  respectively (McColl et al. 
2008). The authors had concluded that the effect of lithium on lifespan was not 
due to reduced IIS signalling, as daf-16(mu86) mutants show a 50% extension 
in lifespan upon LiCl addition. In this work, we used the daf-2(e1370) strain, 
and temperature is different, so results are not comparable. Though, our 
reduced longevity upon lithium addition is in accordance with our results using 
gsk-3(RNAi). Therefore, our results call for caution regarding the use of lithium 
as an anti-ageing agent, more so as lithium is the only GSK-3 inhibitor approved 
for human use (Williams and Harwood 2000; Meijer et al. 2004; Martinez et al. 
2011). Incidentally, in studies wherein the authors performed lithium 
experiments at 20 °C but exposed worms to a lower concentration of LiCl - wild 
type worms exhibit only a mild increase in survival (Zarse et al. 2011); and 
there was downregulation of metabolic genes including fasn-1, acs-17, acdh-8, 
ech-9 and vitellogenin genes including vit-5, vit-6 (Inokuchi et al. 2015), the 
latter being similar to our metabolic observations upon gsk-3(RNAi) in wild 
type animals, and points to lithium targeting GSK-3. Ofcourse, we will need 
further evidence to back our preliminary claim and explore the possibility of 
lithium having an additional target apart from GSK-3.   
Altered carbohydrate metabolism upon loss of GSK-3  
In order to understand the differential effect of GSK-3 on lifespan regulation 
we looked at energy stores and metabolism. Reduced GSK-3 activity results in 
increased activity of glycogen synthase, leading to increase in glycogen (Embi 
et al. 1980; Parker et al. 1983; Woodgett and Cohen 1984; Cross et al. 1995), 
hence, in order to ascertain whether loss of GSK-3 alters glycogen stores, we 
measured glycogen stores using iodine vapor staining. While this technique is 
easier than biochemical assays as it allows detection of whole body glycogen in 
vivo, it involves simultaneous exposure of worms of interest to the iodine 
vapors (Frazier and Roth 2009; LaMacchia et al. 2015; Gusarov et al. 2017; Seo 
et al. 2018). This method can stain more than one population of animals at a 
time and one can control the time of exposure. The glycogen content revealed 
by iodine vapor staining correlates well with biochemical methods as reported 





it only stains glycogen in the gut (Hanover et al. 2005; Forsythe et al. 2006; 
LaRue and Padilla 2011).  
 Here, we noted that lack of GSK-3 does not affect the whole body glycogen 
content in wild type contrary to the expected increase on the basis of the role 
established for GSK-3 (active insulin signalling inhibits GSK-3 and activates 
glycogen synthase). Inhibiting GSK-3 via lithium addition in flies also resulted in 
unaltered levels of glycogen (Castillo-Quan et al. 2016). However, daf-2 
mutants have increased glycogen stores (Figure 42) as observed by us and 
others (Depuydt et al. 2014)  and GSK-3 loss led to a further increase of 
glycogen.  daf-2 mutants are metabolically different to wild type and have 
many metabolic pathways like glycolysis and gluconeogenesis upregulated 
(Depuydt et al. 2014). Glycogen synthesis impairment via glycogen synthase - 1 
(gsy-1) RNAi suppresses the enhanced survival of daf-2 mutants in a 
hypoosmotic-anoxic environment, while RNAi against glycogen phosphorylase 
(pyg-1 or T22F3.3) does not affect their survival (LaMacchia et al. 2015). Also, 
gsy-1(RNAi) reduces longevity in daf-2  mutants (Gusarov et al. 2017), while 
pyg-1(RNAi) leading to increased glycogen mildly extends daf-2 longevity. 
However, lifespan of wild type animals is mildly increased upon RNAi against 
both gsy-1 and pyg-1. These reports imply that alterations in glycogen 
synthesis and storage are more vital in case of reduced daf-2 signalling than 
glycogen breakdown, unlike wild type worms. If glycogen synthesis and storage 
upon low insulin signalling is controlled by GSK-3, probably via inhibition of 
glycogen synthase, which upon GSK-3 depletion becomes activated, then a 
further increase in glycogen than what is required by daf-2 mutants might also 
be detrimental.   
Interestingly, in wild type animals, GSK-3 loss downregulates gluconeogenesis 
as per low expression of fbp-1 (Figure 43A), and this is supported by RNA-seq 
analysis as fbp-1 and additionally, pck-1 were also downregulated upon gsk-3 
(RNAi). However, despite this, glycogen stores are not affected in these 
animals. Also, glyoxylate shunt genes, icl-1 and mdh-2 upon gsk-3(RNAi) in wild 
type and daf-2 mutants are decreased, implying decreased metabolism of fatty 
acids to promote gluconeogenesis.  
On the other hand, PHB depletion led to decreased glycogen in otherwise wild 





worms. Analysis from RNA-seq data in our lab has revealed that upon phb-1 
(RNAi), there is an upregulation of glycolytic pathways, and hence, the reduced 
glycogen is likely a reflection of increased glycolytic metabolism as 
mitochondria in these animals is impaired.  Moreover, we also observed that 
expression levels of fbp-1, a gluconeogenic enzyme was downregulated in 
worms grown on phb-1(RNAi) and phb-1;gsk-3(RNAi) (Figure 43A). As less 
glucose is generated, the result is less glycogen. This is supported by RNA-seq 
analysis that revealed that upon gsk-3(RNAi), there is significant decrease of 
key gluconeogenic genes including fbp-1 in phb-2 and phb-2;daf-2 mutants.  
A major effector of glycogen in several organisms is AMPK and it has a complex 
regulation. Acute activation of AMPK inhibits glycogen synthase (GS) to 
suppress glycogen biosynthesis (Carling and Hardie 1989; Wojtaszewski et al. 
2002; Jorgensen et al. 2004; Miyamoto et al. 2007), while chronic activation of 
AMPK results in glycogen accumulation (Luptak et al. 2007; Hunter et al. 2011). 
However, glycogen does not shorten lifespan on a normal diet, as seen in daf-2 
mutants that store more glycogen, have an active AMPK and live longer (Apfeld 
et al. 2004). Our efforts to check whether AMPK is active upon gsk-3(RNAi) 
were unsuccessful owing to variability amongst experiments (Appendix 5). Wild 
type, daf-2 and the mitochondrial PHB mutants on control and gsk-3(RNAi) 
were analysed with an antibody that recognizes the phosphorylated T172 on 
AMPK, an important response to cellular metabolic stress (Hardie 2004; Hardie 
et al. 2012). The general trend was that AMPK was active in all genetic 
backgrounds except wild type upon gsk-3(RNAi). Previously, AMPK has been 
shown to be activated in phb-2 mutants (Zubovych et al. 2010).  
gsk-3(RNAi) strongly downregulates fat degradation  
Additonally, we observed reductions in whole body triglycerides (Figure 44) 
upon depletion of GSK-3 except in daf-2 mutants. Accordingly, reducing GSK-3 
activity via lithium addition has been observed to decrease whole body 
triglycerides, the main lipid storage in flies, in a dose-dependent manner 
(Castillo-Quan et al. 2016). Low triglyceride content could be due to either 
decreased lipogenesis or increased fatty acid oxidation. Using the atgl-1p::atgl-
1::gfp translational reporter, we found that gsk-3(RNAi) increased ATGL-1::GFP 





Despite the availability of fatty acids as inferred by increased ATGL-1 levels, 
expression of several acyl CoA synthases, acs-19 and acs-13 and 
dehydrogenases acdh-1/-2/-7, also the mitochondrial cpt-2 involved in transfer 
of medium- /long- chain fatty acids from cytosol to mitochondria, (Figure 46, 
A3.2, A3.3, A3.3) were downregulated upon gsk-3(RNAi). Acyl CoA synthases 
and dehydrogenases are amongst the most abundant proteins identified in 
purified lipid droplets (Zhang et al. 2012), indicating a physical association 
between organelles of fat storage and mobilization. Specifically, the 
mitochondrial acdh-1 exhibited a decrease across all genetic backgrounds upon 
GSK-3 loss (Figure 46). The decreases in β-oxidation genes upon loss of GSK-3 
found in our study are also reflected at the transcript level.  
Previously, PHB loss in wild type animals has been shown to have increased 
content of short chain and saturated fatty acids, with a decrease of long chain 
and unsaturated fatty acids (Lourenco et al. 2015). In line with this, we 
observed that PHB depleted nematodes only showed strong decrease of short 
chain fatty acid oxidation, acdh-1 and -2 and acs-19; whereas, genes involved 
in medium-/long- chain fat oxidation, acdh-7, acs-13 were unaffected. Also 
unaffected was the expression of cpt-2, suggesting  no issues with regard to 
import of medium-/long- chain fatty acids into the mitochondria (Figure 46, 
A3.2, A3.3, A3.3). This implies that there is a preference for the β-oxidation of 
medium and long chain fatty acids for energy production rather than short 
chain fatty acids when PHB is depleted.  
Fatty acid oxidation occurs in the mitochondria and peroxisomes, the major 
metabolic organelles, and is a conserved mechanism of energy generation. 
While at the moment we lack information about oxidation processes in the 
peroxisomes upon gsk-3(RNAi), the consequences of the reduced levels of the 
different genes tested indicate reduced fat breakdown upon loss of GSK-3 and 
such a deregulation in fat oxidation could cause energetic deficits. However, 
these observations do not explain the reduced ORO staining. 
ACDH-1 is involved in β-oxidation of short chain fatty acids (human homolog, 
SCAD) (Van Gilst et al. 2005b) and also in branched chain amino acid (BCAA) 
breakdown (human homolog, ACADSB) (Murphy et al. 2003). Based on 





2013). The transgenic strain, Pacdh-1::GFP, used in this thesis has strong 
expression in the intestine and hypodermis  (Arda et al. 2010; MacNeil et al. 
2013). As Pacdh-1::GFP levels  were very low upon both GSK-3 and/or PHB-1 
depletion in both wild type and daf-2 backgrounds, we were concerned 
whether this strain can reflect changes in oxidation of short chain fatty acids. 
Hence, additionally we show that acdh-2 (homologous to acdh-1) (MacNeil et 
al. 2013), also exhibits a reduction in expression levels similar to acdh-1 when 
worms are subjected to gsk-3 or phb-1(RNAi) (Figure A3.2). In addition, Pacdh-
1::GFP levels are increased in animals with low glycogen stores indicating a 
change in response. Though we will need to further verify whether this 
increased Pacdh-1::GFP  expression in worms grown on gsy-1(RNAi) indicates 
increased short chain fatty acid oxidation (Figure A3.1,A).  
Indeed, the transgenic strain Pacdh-1::GFP is an established reporter of dietary 
vitamin B12 status, as GFP is highly expressed when vitamin B12 is low (such as 
in E. coli OP50 and HT115) and is repressed when vitamin B12 is high (such as 
in Comamonas DA1877)(MacNeil et al. 2013; Watson et al. 2013; Watson et al. 
2014; Watson et al. 2016). acdh-1 is at the top of the alternate propionate 
shunt that includes ech-6, hach-1, hphd-1 and alh-8. This shunt is 
transcriptionally activated when vitamin B12 is in low supply (Watson et al. 
2016). An active propionate shunt prevents toxic build up of propionate, a 
byproduct of fat and protein breakdown and enables survival on a vitamin B12 
deficient diet. Based on this, we can speculate that the very low expression of 
Pacdh-1::GFP upon loss of GSK-3 and/or PHB-1, indicates a compromised 
propionate shunt. This is backed with evidence from RNA-seq analyses in our 
lab that all the genes involved in the propionate shunt are significantly 
downregulated in wildtype and mitochondrial PHB mutants upon gsk-3(RNAi). 
Incidentally, some genes involved in vitamin B12 dependent propionyl CoA 
breakdown, pcca-1, pccb-1, mce-1, mmcm-1 were also downregulated upon 
GSK-3 loss. As these worms are grown on HT115 bacteria lacking vitamin B12, it 
is possible that active ACDH-1 indicates breakdown of fat or proteins as seen in 
wild type and IIS mutants. However, in worms devoid of GSK-3, there is 
compromised fat or protein breakdown as indicated by a low acdh-1 
expression. Previously, PHB depleted worms have been observed to show 
alteration in amino acid metabolism (Lourenco et al. 2015), hence, altered 





Intriguingly, knockdown of acdh-1 in wild type animals does not affect lifespan. 
(Yuan et al. 2012) and there is evidence that daf-2 mutant has increased levels 
of propionate and exhibit significantly increased abundance of the propionate 
catabolic enzymes MCE-1, MMCM-1, PCCA-1 and PCCB-1(Depuydt et al. 2014). 
Hence, an activation of this breakdown pathway indicates increased catabolism 
of fatty acids or branched chain amino acids in the daf-2 mutant.  
Interestingly, the human homolog of acdh-1, ACADSB was found amongst 
metabolic proteins that associate specifically with GSK3β1. Hence, it could be a 
potential mediator in the atypical functions of GSK3β1 (Gao et al. 2013). 
Fat synthesis is a key requirement of growth and GSK-3 depletion reduces de 
novo fat synthesis in wild type as seen from the expression levels of the 
transgenic strain Ppod-2:GFP (Figure A3.5), but not in PHB depleted animals. 
This behavior might be linked to the ageing phenotype but we miss 
information about daf-2 and phb-2;daf-2 mutants. However, RNA seq analyses 
done in the lab indicate that pod-2 is unaffected in phb-2;daf-2 mutants on  
gsk-3(RNAi).  In wild type and IIS defective daf-2 mutants, upon gsk-3(RNAi) 
expression levels of fasn-1 and fat-7 were downregulated respectively. Thus, 
the reduction in whole body ORO staining upon loss of GSK-3 could be a result 
of decrease in expression of de novo fat synthesis genes.  
As proper breakdown of fats is required for the mitochondria to utilize in 
energy production, a deregulation of lipid breakdown as seen upon GSK-3 loss 
could  fail to meet to the energy demands of these worms. Additionally, worms 
depleted of GSK-3 are less active phenotypically from control animals, 
especially daf-2 mutants. While the consequences of GSK-3 depletion on 
mitochondrial function are not evident across genetic backgrounds while 
worms are young, on day 5 in aged worms, wild type and IIS mutants exhibit 
strong decreases in respiration, while PHB depleted animals modulate 
respiration differentially. Moreover, the accumulation of fatty acids as a result 
of irregular lipid breakdown during ageing could lead to lipotoxicity, often 
associated with age-related disorders and metabolic syndromes. 
Similar to the altered fat metabolism seen in wild type worms on gsk-3(RNAi), 
pry-1 mutants (component of Wnt destruction complex) also exhibit drastically 





such as the desaturases, fasn-1, fat-5, and -6 and elongases, elo-3 and -6; and 
also those involved in fatty acid oxidation such as  acdh-1, -6, -11, -23;  acs-2, -
11, -17; cpt-1, -4, and ech-9 (Ranawade et.al, bioRxiv, pre-print). The authors 
also recorded that yolk lipoprotein vitellogenins (VITs), vit-1, -2, -3, -4, -5, and -
6, important for lipid distribution were also differentially regulated. In line with 
this we also observed that loss of GSK-3 led to decreased expression of VIT-6 
across all genetic backgrounds (Figure 47). Additional investigation of the other 
VITs and their alterations during ageing might yield more information on 
whether deregualtion of these contributes to the metabolic defects seen upon 
gsk-3(RNAi). These observations indicate a possible mediation by Wnt 
signalling in lipid metabolism. 
Lack of GSK-3 perturbs mitochondrial lipid composition  
In yeast cells deficient of PHB, survival depends on lipid composition of 
mitochondrial membranes, especially alterations in CL and PE (Osman et al. 
2009). Also, reduction in fat-7 expression limits monounsaturated fatty acid 
synthesis that maintains fatty acid levels and could potentially alter cellular and 
membrane lipid composition, particularly, that of the mitochondria (Osman et 
al. 2011). In accordance with this, GSK-3 depletion leads to alterations in 
mitochondrial membrane lipids, i.e. strong increases in PLs in wild type and 
daf-2 mutants (Figure 52). It has been described that increased accumulation 
of PLs in the mitochondria depends on lipid transport between the ER and 
mitochondria.  Additionally this could  involve  intramitochondrial lipid 
trafficking  (Osman et al. 2011). Mitochondrial phospholipid composition varies 
little among different cells, indicating that major changes might not be 
tolerated. Altered phospholipid levels and phospholipid damage have been 
linked to a variety of human disease states (Chicco and Sparagna, 2007; Joshi 
et al., 2009). In yeast, GSK-3 positively regulates Elo2 phosphorylation, a fatty 
acid elongase protein. Phophorylation of Elo2 is important for very long chain 
fatty acid (VLCFA) synthesis that in turn is essential for ceramide synthesis 
(Zimmermann et al. 2013). 
With respect to the alterations in membrane lipids, of particular interest are 
two classes, Phosphatidylcholine (PC) and cardiolipins (CL). Regarding the 
former, PC are increased strongly across genetic backgrounds upon gsk-3 





SAM (encoded as sams-1 in nematodes). In line with the increased PC levels, 
RNA seq analyses revealed that sams-1 is upregulated in wild type, phb-2 and 
phb-2;daf-2 mutants upon loss of GSK-3. Moreover, SAMS-1 has been 
implicated in a conserved regulation involving the transcription factor SREBP-
1/SBP-1 in lipogenesis, such that under conditions of low SAM or decreased PC, 
lipogenesis is promoted by nuclear accumulation of SBP-1(Walker et al. 2011; 
Ding et al. 2015). Also, knocking down sams-1 extends longevity (Hansen et al. 
2005). In our case, an increased sams-1 and increase in the phospholipid PC, 
could potentially inhibit SBP-1 and block lipogenesis, as seen from the 
reduction in fat stores upon gsk-3(RNAi). 
Cardiolipins have an important role in mitochondrial bioenergetic processes. 
Also, they have been shown to interact with a number of proteins, including 
the respiratory chain complexes, generation of the inner membrane potential 
and are essential for mitochondrial structure and integrity (Paradies et al. 
2014). gsk-3(RNAi) alters CL composition more in wild type and in conditions of 
low IIS signalling in comparison to the PHB mutants. CL is required for 
mitochondrial fusion and fission, a key step in separating mitochondria that are 
not functional for mitophagy - selective degradation of mitochondria by 
autophagy. Incidentally, other PLs derived from the mitochondria like 
phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) are also vital for 
the autophagy (Shatz et al. 2016; Hsu and Shi 2017). Thus, changes in PL 
compositions could be linked to autophagy dysregulation.  
In agreement, gsk-3(RNAi) leads to an increase in autophagy (Lehmann et al. 
2013) via observation of accumulation of the autophagic vesicle marker LGG-1. 
Autophagy is a conserved cellular homeostasis and stress response mechanism 
to degrade long-lived proteins, molecules and organelles. It is a multistep 
process that involves vesicular transport events leading to tethering and fusion 
of autophagic vesicles with several intracellular compartments (Megalou and 
Tavernarakis 2009; Amaya et al. 2015). Interestingly, we have evidence from 
RNAseq data that lack of GSK-3 upregulates processes related to membrane 
vesicle trafficking across all genetic backgrounds.  In C. elegans, autophagy is 
involved in many processes through embryonic and larval development and 





ageing and longevity are dependent on autophagy (Melendez et al. 2003; 
Melendez and Levine 2009; Chen et al. 2017).  
 Altered mitochondrial membrane lipid composition has also been implicated 
in ageing in other systems. Broadly, alterations could be due to disturbance of 
enzymes involved in phospholipid remodeling, as well as changes in the dietary 
fatty acids and this can have bioenergetic costs, by affecting mitochondrial 
capacity and function (Schenkel and Bakovic 2014; Valencak and Azzu 2014; 
Medkour et al. 2017) . 
Mitochondrial bioenergetics during ageing upon GSK-3 depletion  
To investigate if GSK-3 affects mitochondrial function during ageing, we 
measured basal and maximal oxygen consumption rate (OCR). For assessing 
mitochondrial function, some time consuming methods are in use - 
biochemical analysis of extracts (Krijgsveld et al. 2003), in vivo ATP level 
analysis via transgenic reporter (Lagido et al. 2008), in vivo mitochondrial 
membrane potential analysis (Gaskova et al. 2007) and analysis of basal oxygen 
consumption (Braeckman et al. 2002a); but these measure one specific aspect 
of mitochondrial function and might not give a clear picture of overall 
mitochondrial health. Seahorse Extracellular Flux Analyzers (Luz et al. 2015; 
Koopman et al. 2016) offer real-time oxygen consumption measures and also 
of other parameters like maximal respiratory capacity, spare respiratory 
capacity, ATP coupled respiration and proton leak in whole worms in multi-well 
formats without the need for lysing cells or isolating mitochondria.  
Our OCR data normalized by worm number and corrected for worm area show 
that it is under low daf-2 signalling that GSK-3 loss strongly impairs basal 
respiration during ageing (Figure 48). Exposure to FCCP, a mitochondrial 
uncoupler revealed that maximal respiratory capacities in wild type and daf-2 
mutants were strongly compromised upon gsk-3(RNAi) (Figure 48), indicating 
that GSK-3 function is also important for mitochondrial function in wild type 
animals. Additionally, mRNA levels of ucp-4, an uncoupling protein was 
downregulated in IIS mutants grown on gsk-3(RNAi) (Figure A4.4), signifying a 
prospect that mitochondria might be compromised. Strong alterations in 
maximal OCR were only observed in phb-2 mutants that exhibited an increase 





responses to GSK-3 loss. The long lived phb-2;daf-2 mutants do not show 
changes in respiraton upon GSK-3 depletion except a significant decrease at YA 
stage, but oxygen consumption reduces during ageing slightly. Though, overall 
they always exhibit a low oxygen consumption rate.  
We additionally normalised OCR data only to number of worms and observed 
that it changes result interpretation substantially owing to the size differences 
among the different genetic backgrounds (Annexure 4, Figure A4.2). Loss of 
GSK-3 in wild type and IIS mutants elicits similar effects with respect to basal 
and maximal OCR irrespective of normalisation as they do not exhibit 
significant changes in size. However, the decreased basal OCR in the 
mitochondrial mutants, phb-2 and phb-2;daf-2 with respect to wildtype and 
daf-2 mutants at the YA stage (Annexure 4, Figure A4.2) might be attributed to  
faulty mitochondria but its more likely a result of the small size of these 
mutants as these are not observed when the data is corrected for worm area 
(Figure 48). Also, during ageing at day 5, the increased basal and maximal 
respiration of the short lived phb-2 compared to wild type is missed when not 
corrected for area. The long lived double mutants phb-2;daf-2  respire lower 
than the IIS depleted mutants irrespective of method of normalisation. phb-2 
and phb-2;daf-2 mutants on gsk-3(RNAi) tend to respire less,  without 
corrections for size differences (Annexure 4, Figure A4.2), implying that their 
low OCR is not because they have potentially faulty mitochondria upon GSK-3 
loss but that in fact their respiration is unaffected. Similarly, GSK-3 depletion 
does not affect the maximal respiration of phb-2  mutants, and decreases the 
same during ageing (Annexure 4, Figure A4.2) but area normalisation reveals 
that in fact these worms respire much more when younger and are unaffected 
at day 5.  
These data present important points towards the fact that careful review is 
required with respect to results gathered from such metabolic analyses as they 
depend on the manner of normalisation, as shown here. Normalizing to size is 
essential for cases wherein the experimental backgrounds being tested show 
obvious and significant differences - such as ours (Figure 48). Nematode 
respiratory rates have been normalized by several ways, such as worm 
number, worm volume, worm length, total protein and mitochondrial copy 





respective age-matched controls, correcting for protein levels provides extra 
information. Although it has been reported that mitochondrial dysfunction via 
RNAi led to reduced respiration with both worm number and protein 
normalization (Wu et al. 2014) and hence, one can normalize to mitochondrial 
DNA content to account for differences in mitochondrial activity (Weimer et al. 
2014). Though our mitotracker staining at the YA stage (A4.3) reveals that the 
dysfunctional mitochondrial mutants, phb-2 and phb-2;daf-2 with respect to 
wildtype and daf-2 mutants have less mitochondrial content and this is 
reflected at the basal OCR at YA stage irrespective of normalization. However, 
mitotracker staining is not indicative of mitochondrial activity and hence, it is 
better to use mitochondrial DNA copy number to normalize.   
Reductions in size and alterations in oxygen consumption are potential 
consequences of mitochondrial stress. While we have been unable to check 
ATP levels in these backgrounds, we did observe that depletion of GSK-3 
activates UPRmt selectively (Figure 50). Loss of GSK-3, induces hsp-6 expression 
in wild type animals while daf-2 mutants are unaffected.  The mitochondrial 
PHB mutants induce the UPRmt, but loss of GSK-3 further induces hsp-6 
expression only in the phb-2; daf-2 double mutants. Activation of UPRmt is also 
known to cause metabolic restructuring, such as activating glycolytic genes and 
repressing those of oxidative phosphorylation (Nargund et al. 2012; Nargund et 
al. 2015). As we have evidence in the lab that atleast in phb-2 and phb-2;daf-2 
mutants, glycolytic pathways are upregulated, cases where UPRmt is active; one 
can contemplate that it is likely that GSK-3 depleted animals that are capable 
of inducing hsp-6 expression could also potentially rely on glycolysis.  
Tissue specific analysis of GSK-3 with a focus on ageing 
Though GSK-3 has ubiquitous expression (Figure 40), in line with its impact on 
metabolism, depleting GSK-3 solely in the intestine leads to reduction in 
lifespan across all genetic backgrounds and strongly so in the daf-2 mutants 
(Figure 53). This implies an important intestinal role for GSK-3, the major 
metabolic organ in worms. We also noted that loss of gsk-3  in the intestine did 
not recapitulate the embryonic lethality observed in wild type animals 
subjected to whole animal gsk-3(RNAi), but the same worsened the lethal 
phenotype ofdaf-2 mutants as they barely laid eggs (observation not 





whole body and in the intestine, when IIS signalling is low.The genomic tagging 
of GSK-3 via CRIPSR-Cas9 utilising the SapTrap protocol (Schwartz and 
Jorgensen 2016) incorporates a compatible GFP KO cassette (Munoz-Jimenez 
et al. 2017). This has been further developed in the lab to generate tissue 
specific GSK-3 KO strains to observe the lifespan phenotype when this kinase is 
knocked out in three tissues, namely, intestine, muscles and neurons. We 
confirmed that wild type and PHB depleted animals exhibit decreased 
longevity only when GSK-3 is inactivated in the intestine, and are unaffected 
upon neuronal and muscle GSK-3 loss. IIS defective daf-2 mutants exhibit a 
decrease when GSK-3 is knocked out in intestine andmuscles, whereas, daf-2 
mutants devoid of PHB exhibit a reduced lifespan upon GSK-3 KO in all tested 
tissues, intestine, neurons and muscles. These differential alterations in 
lifespanupon tissue specific GSK-3 KO across different genetic backgrounds 
imply relevance of GSK-3 function in specific tissues.  
Recently, it was shown in dissected ovaries of Drosophila that during late 
oogenesis when IIS activity is reduced, GSK3 promotes mitochondrial 
quiescence and glycogen accumulation (Sieber et al. 2016). This is different 
from studies in whole Drosophila wherein no alterations in glycogen were seen 
when GSK-3 was inhibited via Lithium (Castillo-Quan et al. 2016). Previous data 
using in vitro experiments does indicate that not only there might be distinct 
roles for GSK-3α and GSK-3β, but also tissue-specific phenotypes associated 
with each of these isoforms (Ciaraldi et al. 2006; Patel et al. 2008). Hence, 
these tissue specific C. elegans GSK-3 KO strains can be utilised as new genetic 
tools in the future to further analyse tissue-specific roles of GSK-3 in regulation 
of development, ageing and lipid and carbohydrate metabolism. 
Limitations of this study  
GSK-3 is a kinase that is inactivated upon phosphorylation at Ser9 in GSK-3β in 
vertebrates (Sutherland et al. 1993; Cross et al. 1995; Frame et al. 2001; 
Afanas'ev 2010). This thesis is unable to demonstrate whether the acivity of 
GSK-3 is subject to a similar regulation in vivo, due to lack of a good antibody; 
and whether or not Ser9 is conserved in C. elegans. The status of 
phophorylation is of importance as it has been seen that PI3 kinase-resistant 
GSK3 (gsk3KI) mice with enhanced adiponectin production are protected 





(Chen et al. 2016). Also, a recent paper established that active GSK-3 inhibits 
AMPK function, a key regulator of cellular homeostasis. Interestingly the 
authors showed that insulin signalling a conserved inhibitory pathway for GSK-
3 promotes GSK3-dependent AMPK phosphorylation and inhibition (Suzuki et 
al. 2013),that leads to metabolic fluctuations resulting in catabolism of fatty 
acids in vitro. These reports highlight the importance of this unusual kinase, 
GSK-3 and its physiological relevance.  
An area of research wherein GSK-3 has a role is tauopathies, including 
Alzheimer’s disease (AD), Down syndrome, Parkinson’s amongst others. Tau 
are microtubule-associated proteins (MAP) found in neuronal axons. Tau 
protein binds to microtubules (MTs) and stimulates MT polymerization and 
promotes stabilization. In diseased states, tau is hyperphosphorylated and 
dissociates from MTs and tau forms filaments that aggregate in neurons. In a 
genome wide screen carried out by Kraemer et. al, to identify potential 
modifiers of tau-induced pathologic phenotype, gsk-3(RNAi) was found to 
further enhance the tau-induced Unc phenotype (Kraemer et al. 2006). GSK-3 
is a component of the canonical Wnt signalling pathway and is known to 
regulate MT stability, and hence, it is possible that certain functions are 
mediated through Wnt as well. While the role of kinases in tauopathies has 
been done using transgenic animal models, not all the results obtained were 
consistent. In mice, there are conflicting studies wherein conditional 
overexpression of GSK-3β has been detrimental or protective. On the other 
hand, in Drosophila, results were consistent with GSK-3β promoting tau-
induced neurodegeneration and lack of GSK-3β or use of GSK-3β inhibitors 
supressing the tau phentoypes (Gotz et al. 2010). In the work done in C. 
elegans, RNAi of GSK-3 enhances tau-induced phenotypes, implying that at 
least in this system, GSK-3 is protective (Kraemer et al. 2006).  
Incidentally, loss of PHB2 in the forebrain of mice leads to neurodegeneration 
and tau hyperphosphorylation, while GSK-3β was found to be inactivated by 
phosphorylation at Ser9, accompanied by the activation of the upstream 
kinase, AKT. This implied that GSK-3 might not be the cause for the increased 
tau pathology in Phb2NKO mice (Merkwirth et al. 2012). It will be interesting to 
check whether loss of GSK-3 in worms under conditions of reduced IIS function 






As the semi-automated screening strategy used by us was successful, the same 
can applied at a larger scale to an OrthoList RNAi library that has been built in 
the lab (Hernando-Rodriguez et al. 2018) utilising the automated data analysis 
platform. This can be of considerable advantage in the future for researchers 
to streamline RNAi screens by focusing on genes with translational potential to 
human health and provide insights into the mechanisms on biological 
processes in humans. 
Given the stong reduction in lifespan and drastic embryonic lethality when 
GSK-3 is depleted in the intestine, especially in daf-2 mutants, it would be 
worth to see if an intestine specific expression of GSK-3 could rescue these 
phenotypes. It would also help establish the intestine as a key site of GSK-3 
function under impaired insulin signalling. 
There are serveral lines of evidence linking GSK-3 to metabolism and ageing. 
However, in worms, the most known downstream effector of GSK-3 is SKN-1 
(An et al. 2005). Identification of other downstream effectors of GSK-3 would 
be crucial for better understanding the hypometabolic phenotype and 
accerelated ageing observed upon GSK-3 loss. Another thing to investigate 
would be if there are possible mediations in these by components of Wnt 
signalling. 
An observation that requires further exploration is the potential role of GSK-3 
in LRO biology by checking the same in wild type and IIS deficient backgrounds. 
The fact that we observe downregulation of kat-1 in PHB deletion mutants 
could be related to the premature ageing phenotype of GSK-3 depleted worms. 
Lack of kat-1 shortens lifespan but was found dispensable for the long lived 
daf-2(e1370) mutants. Also, KAT-1 loss leads to increase in accumulation of 
lipofuscin pigment and also encodes for ketoacyl thiolase, a conserved 
metabolic enzyme that catalyzes the last step of fatty acid oxidation 
(Berdichevsky et al. 2010). The accerelation in ageing observed upon GSK-3 
loss, could be a result of decreased fat oxidation, but one cannot rule out the 
the other possibility, such as due to increased accumulation of lipofuscin. 






As per downregulation of acdh-1, which could be indicating irregular BCAA 
breakdown, it would be worth to check level of protein aggregation in GSK-3 
depleted conditions. Previously, a kinome screen has implicated GSK-3 being 
essential in proteostasis (Lehmann et al. 2013). The same authors also implied 
that lack of GSK-3 leads to accumulaton of autophagic vesicles. As autophagy 
involves lysosomes, we could potentially also utilize Electron Microscopy (EM) 
for a more reliable observation of the different autophagic structures such as 
autophagosomes or autolysosomes.  
We observe strong alterations in mitochondrial lipid components and in 
respiration, despite the fact that mitochondrial content is not impacted upon 
loss of GSK-3. However, we might gain more information from studying 
mitochondrial structure. More so, as previously, PHB deficient worms have 
been shown to have abnormal mitochondrial morphology (Artal-Sanz et al. 
2003)and GSK-3 was identified as required for normal maintenance of 
mitochondrial network structure in adult muscle (Lehmann et al. 2013). 
Lithium addition elicits a response similar to gsk-3(RNAi) in our hands. 
Incidentally, in vitro studies indicate that lithium treatment results in nuclear 
translocation of β-catenin and hence, Wnt activation (Sinha et al. 2005). It is 
quite probable that Wnt components that elicit the same longevity phenotype 
could also be targets of lithium in worms as well. 
Based on the indications that loss of GSK-3 could activate glycolysis, additional 
data can be gained by investigating in vitro enzymatic activities of genes 






















1.  Mitochondrial prohibitin (PHB) deletion mutants, phb-2(tm2998) and phb-2 
(tm2998);daf-2(e1370) show an opposing longevity phenotype and low in vivo 
Nile Red staining. These mutants are developmentally delayed with reduced 
pharyngeal pumping and increased fat stores. 
2. Customized imaging and segmentation protocols were created for the 
balanced prohibitin mutants for high throughput screening. These can be 
potentially exploited for any strain or dye as the segmentation is done in the 
brightfield channel. 
3. A semi-automated kinase RNAi screen was performed using a kinase sub-
library in phb-2 and phb-2;daf-2 mutants. This resulted in identification of 26 
kinases that suppressed the low Nile Red staining phenotype of PHB mutants in 
either one or both backgrounds.  
4. Amongst the candidates, we provide evidence for the function of GSK-3, 
whose loss causes a differential accerelation in ageing. GSK-3 is essential for 
the long lifespan of IIS defective daf-2 and phb-2;daf-2 mutants, while its 
depletion does not affect the lifespan of phb-2 mutants and only mildly 
shortens wild type lifespan. 
5. Depletion of KIN-19 and BAR-1, members of the Wnt signalling pathway 
elicits a similar differential ageing phenotype as seen upon loss of GSK-3. 
6. GSK-3 depletion further increases the glycogen stores in the long-lived 
insulin signalling mutants, and further depletes glycogen in mitochondrial PHB 
mutants. Glycogen stores in wild type animals were not affected.   
7. With respect to carbohydrate metabolism, GSK-3 loss downregulates 
gluconeogenesis in wild type and PHB-1 depleted worms. 
8. GSK-3 loss reduces the main lipid storage - triglycerides across all genetic 
backgrounds except in IIS daf-2 mutants. 
9. GSK-3 influences lipid synthesis and breakdown pathways in C. elegans.  Loss 
of GSK-3 reduced short chain fatty acid oxidation across all genetic 
backgrounds. Also, oxidation of medium-/long- chain fatty acids was decreased 
across wild type, daf-2 and phb-2 mutants devoid of GSK-3. phb-2 mutants 





short chain fatty acid oxidation, while oxidation of medium-/long- chain fatty 
acids was unaffected. 
10. Fat synthesis is reduced in wild type and daf-2 mutants upon loss of GSK-3. 
However, PHB depleted worms were unaffected. 
11. GSK-3 strongly decreases vitellogenesis across all genetic backgrounds. 
12. GSK-3 loss impacts mitochondrial health through ageing. It deteriorates 
strongly in IIS daf-2 mutants and wild type worms, whereas PHB depleted 
worms, show an increased capacity to respire upon GSK-3 depletion. phb-2; 
daf-2 are unaffected by GSK-3 loss, keeping extremely low respiration levels.  
13. Mitochondrial membrane lipid composition was altered upon loss of GSK-3 
in a background specific manner, with significant alterations in wild type and 
IIS defective mutants.   
14. Mitochondrial UPR is induced in a background specific manner upon GSK-3 
loss. While it was strongly induced in wild type animals, daf-2 mutants were 
unresponsive. The already active mitochondrial UPR in phb-2 was unaffected 
and phb-2;daf-2 mutants further induced UPRmt on gsk-3(RNAi). 
15. Intestinal function of GSK-3 is required for normal lifespan across wild type 
and PHB deletion mutants but is indispensable for daf-2(e1370) lifespan, as 
intestinal depletion of GSK-3 fully suppresses the long lifespan of daf-2 
mutants. 
16. GSK-3 is ubiquitously expressed in C. elegans. Strong expression is seen in 
the embryos, intestine, muscles and the nervous system. It is also seen in the 






























1. C. elegans maintainence  
All nematode strains were maintained and cultured at 20°C on Nematode 
Growth Medium (NGM) plates seeded with Escherichia coli strain OP50, under 
standard conditions (Brenner 1974). E. coli OP50 is a uracil auxotroph whose 
growth is limited on NGM plates. This property allows worms to be visualized 
easily on the plates. The frequency with which various C. elegans strains should 
be transferred and maintained depends on their genotype, and also at the 
temperature at which they are being maintained. It is best to maintain them 
without starvation/ contamination of the OP50 bacteria.  
Commonly used maintenance methods are picking and chunking. These can be 
carried out with ease under a stereomicroscope. Picking involves transferring 
worms with a worm picker. A worm picker/pick is a flame sterilized platinum 
wire looped into a Pasteur pipette. Chunking involves usage of a sterilized 
spatula to remove a chunk of agar from an old plate to a fresh plate with 
bacteria. The worms will crawl out of the old piece of agar (chunk) and onto 
the bacterial lawn of the new plate. Chunking works well for the transfer of 
homozygous populations but is not advisable for heterozygous stocks 
(Stiernagle 2006). 
2. Strains used  










Bristol N2 MRS1 N2( wild-type Bristol isolate) CGC 
CB1370 MRS 88 daf-2(e1370) III CGC 








BR6206 MRS 49 phb-2(tm2998);mln1[mls14 dpy-10(e128)]II; 
daf-2(e1370)III 
NBRP 




VL749 MRS348 wwIs24[acdh-1p::GFP + unc-119(+)] CGC 
 MRS415 daf-2(e1370) III; wwIs24[acdh-1p ::GFP + unc-
119(+)] 
This study 
 MRS444 phb-2(tm2998);mln1[mls14 dpy-10 (e128)]II; 
wwIs24[acdh-1p::GFP + unc-119(+)] 
This study 
 MRS458 fpIs107(acdh-2p::GFP) Jarriault Lab 
CL2166 MRS179 dvIs19 [(pAF15)gst-4p::GFP::NLS] III CGC 
 MRS482 daf-2(e1370); dvIs19 [(pAF15)gst-4p::GFP: : 
NLS] III 
This study 
SJ4005 MRS85 zcIs4[hsp-4::GFP] V CGC 
PE255 MRS 186 feIs5[sur-5::luc+::gfp; rol-6(su1006)]V Dr. C.Lagido 
 MRS 210 daf-2(e1370)III ;feIs5[sur-5::luc+::gfp; rol-6 
(su1006)]X 
Dr. M.Olmedo 
 MRS 229 phb-2(tm2998);mln1[mls14 dpy-10 
(e128)]II;feIs5[sur-5::luc+::gfp; rol-6(su1006)]X 
This study 




SJ4100 MRS 57 zcls13[Phsp-6::GFP]V CGC 
BR6296 MRS 64 daf-2(e1370)III, zcls13[Phsp-6::GFP]V Dr. Artal-Sanz 
 MRS106 phb-2(tm2998);mln1[mls14 dpy-10 (e128)]II; 
zcls13[Phsp-6::GFP]V 
Dr. Artal-Sanz 
 MRS60 phb-2(tm2998);mln1[mls14 dpy-10 (e128)]II; 
daf-2(e1370)III; zcls13[Phsp-6::GFP]V 
Dr. Artal-Sanz 
VP303 MRS198 rde-1(ne219)V;kbIs7 CGC 
 MRS419 daf-2(e1370)III; rde-1(ne219)V;kbIs7 This study 
 MRS418 phb-2(tm2998);mln1[mls14 dpy-10 (e128)]II; 
rde-1(ne219)V;kbIs7 
This study 
 MRS447 phb-2(tm2998);mln1[mls14 dpy-10 (e128)]II; 
daf-2(e1370)III; rde-1(ne219)V;kbIs7 
This study 
BC13916 MRS 452 sEx13916 [rCesW09B6.1::GFP + pCeh361] - 
pod-2::GFP 
CGC 
BC11281 MRS 453 sEx11281 [rCes R07H5.2::GFP + pCeh361] - 
cpt-2::GFP 
CGC 
BC12611 MRS 456 sIs11096 [rCes T25G12.5::GFP + pCeh361] -
acdh-7::GFP 
CGC 
BC10604 MRS 450 sIs10325 [rCesC36A4.9::GFP + pCeh361]  - acs-
19::GFP 
CGC 
BC10191 MRS451 sEx10191[rCesY65B4BL.5::GFP + pCeh361] -
acs-13::GFP 
CGC 
BC11264 MRS 455 sIs11264 [rCesK07A3.1::GFP + pCeh361] - fbp-
1::GFP 
CGC 




 MRS 481 Pgsk-3::GFP::gsk-3 This study 
 MRS 500 daf-2(e1370); Pgsk-3::GFP::gsk-3 This study 
VS20 MRS 218 hjls67[atgl-1p::atgl-1::GFP+mec-7::RFP] CGC 
 MRS 270 daf2(e1370); hjls67[atgl-1p::atgl-1::GFP+mec-
7::RFP] 
Dr. Lourenço 
BC12843 MRS 401 sIs11286[rCesK07H8.6::GFP+pCeh361] -  
vit6::GFP 
CGC 
 MRS 402 daf-2(e1370); sIs11286 [rCesK07H8.6:: GFP+ 
pCeh361] - daf-2(e1370);vit6::GFP 
Dr. Lourenço 
* From Caenorhabditis Genetics Center (CGC) and National BioResource Project (NBRP)  
3. Worm synchronization by alkaline hypochlorite treatment (Bleaching) 
Alkaline hypochlorite solution, commonly called as bleach solution was made 
as follows - 6.5 ml H2O, 0.5ml 5M KOH and 3ml 5% Bleach (This recipe is for 10 
ml). The hypochlorite solution kills all worms not protected by the egg shell. A 
worm population with enough gravid adults was washed off using  M9 buffer 
(3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 ml 1 M MgSO4, H2O to 1 litre. Sterilize by 
autoclaving) into a 15ml tube. They were washed by centrifuging for 1min at 
1300g and 5 ml bleach solution was added to the worm pellet. This was 
incubated for 2mins with vigorous vortexing/shaking. The pellet was 
centrifuged for 1 min at 1300g, supernatant removed and re-suspended in 5ml 
of M9 buffer. Next, the supernatant was removed and the worm pellet was 
incubated in 1ml M9 buffer plus 4ml bleach solution for 40-60 secs with 
periodic vortexing/shaking till only embryos remained. 
Caution: Check the bleached worms under the stereoscope at this stage, if no 
worm cuticles are left, the sample should be centrifuged immediately. 
The pellet with embryos was washed four times in 5ml of M9 buffer (1min, 
1300g) to remove bleach, and finally re-suspended in M9. The eggs were taken 
and laid onto NGM or RNAi NGM plates, or left to hatch overnight at 20° C in 
M9 buffer (shaking incubator) to obtain synchronized L1 larvae.  
4. Growing C. elegans in liquid medium 
Large quantities of C. elegans can be grown on S Medium (20ml NaCl 5M, 50 
ml Potassium phosphate 1M pH 6, 10 ml 1M potassium citrate pH 6, 10 ml 
trace metals solution, 3 ml 1M CaCl2, 3 ml 1M MgSO4. Components were added 
using sterile technique; this should not be autoclaved) using concentrated E. 




coli OP50 as a food source (Stiernagle 2006). E. coli OP50 was inoculated in 1L 
of LB (500ml each in 2L flasks) and grown overnight at 37°C. The bacteria was 
pelleted down and concentrated by centrifuging at 3200 ×g for 20mins. The 
supernatant was discarded. The concentrated bacterial pellet was re-
suspended in S Medium (30g/L) supplemented with cholesterol (1ml/L). This 
OP50 suspension in S Medium can be stored at 4°C for upto 4 weeks.                                                                                                           
Concentrated E. coli OP50 can be prepared in advance and stored such that 
bacteria can be added as per requirement.   
To start a liquid culture of worms, worms from 1-2 large plates were washed 
out in M9 buffer / S Medium. The worm pellet was washed 2x times to clean 
out the bacteria from the plate. The clean worm pellet was now added to 50-
100ml of S Medium OP50. The worm culture was monitored, and additional E. 
coli OP50 was added as required.  
Cultures can be monitored by checking a drop of the culture under the 
microscope. If the food supply is depleted (the culture solution would no 
longer be visibly cloudy), one should add more concentrated E. coli OP50 
suspended in S Medium. When many gravid adult animals are spotted in each 
drop, the culture is ready to be bleached.  
Note: The amount of food needed will depend on the starting inoculum of 
worms and the genotype, and the length of time for which the worms are 
grown (2-3 generations).  
5. RNAi assays  
For RNAi assays on plate (Lifespan and imaging experiments), worms were 
placed on NGM plates seeded with HT115 (DE3) bacteria, either the pL4440 
empty vector or the required RNAi construct. The RNAi bacterial cultures of 
interest supplemented with tetracycline (15 µg/ml) and ampicillin (100 µg/ml) 
were grown overnight at 37°C, 180 rpm in a shaking incubator. Next day, 
diluted cultures supplemented with only ampicillin (100 µl/ml) or carbenicillin 
(25 µg/ml) were grown at 37°C, 180 rpm for 3 hours. 2 mM IPTG was added to 
the cultures to induce expression of dsRNA. Plates were seeded with the 
bacterial cultures and left overnight at room temperature. 
For mitochondrial fractions, the pre-inoculum and day culture was done as 
described above and then bacteria were induced in culture at 37°C, 180 rpm 




for 2 hours. This was then pelleted down by centrifugation at 3200 ×g at 4 °C 
for 20 min. Pellets were re-suspended in S Basal (5.85 g NaCl, 1g K2HPO4, 6g 
KH2PO4 , H2O to 1 litre. Sterilized by autoclaving) at 4 °C. Re-suspended pellets 
were centrifuged again at 3200×g for 20 min at 4°C. Bacterial stocks were 
prepared by re-suspending the pellets (30 g/L) in S Medium containing 
carbenicillin (25 µg/ml), IPTG (1 mM) and cholesterol (5 µg/ml). This can be 
stored 4 °C.  
For the kinase RNAi screen, frozen bacteria containing the RNAi clones from 
the ORFeome kinase sub-library (96-well plate) was left to thaw at room 
temperature briefly and replicated onto LB agar supplemented with ampicillin 
(100 µg/ml) and tetracycline (15µg/ml) using  a pin-replicator. Bacteria was 
grown overnight at 37°C. Growing the bacteria in solid media enables ease of 
visualization and identification of the clones where the bacteria did not grow. 
Bacteria was inoculated into 1ml of LB (100 µl/ml Amp; 15 µg/ml Tet) in deep 
well 96-well plates, grown overnight and next day induced using 2mM IPTG for 
2 hrs at 37°C, 180 rpm. The induced culture was pelleted down at 4000rpm for 
8mins. The bacterial pellet in each well, i.e., each RNAi clone was re-suspended 
in 250µl of S Medium with 2mM IPTG, 100nM Nile Red. 
6. Selection of homozygous phb-2 mutants using the COPAS worm sorter 
Gravid adult worms were bleached from a liquid culture. Embryos were left to 
hatch into L1 larvae overnight in S Medium (shaking incubator at 20°C, 120 
rpm). The COPAS was switched on left to stabilize and cleaned with MQ water 
and 70% EtOH before sorting. The L1 larvae were checked and filtered through 
40 μm nylon cell strainer to exclude debris like unbroken corpses/clumped 
unhatched eggs that might remain in the sample from the bleaching. A clean L1 
preparation aids in ease of sorting. Also, 0.01% Triton X-100 was added to 
avoid worms sticking within the tubes or the sample cup of the COPAS. The 
concentration of animals per milliliter was adjusted using a microscope. 
(Ideally 1worm/µL by diluting the sample). Sheath flow rate of 9.5 ml/min and 
worm concentration of 15–20 events per second was maintained during 
sorting. At the start of each experiment, a small sample was sorted and visually 
verified to confirm a correct sorting.  




Approximately 40 sorted homozygous phb-2 mutants per well were 
supplemented with 100µl RNAi bacteria plus Nile Red and incubated at 20°C 
(shaking) at 120 rpm till the desired imaging stage. Worms were imaged at the 
young adult (YA). Depending on the genotypes worms were grown on the RNAi 
plates for following times:                                                                                      
Wild type worms   - approximately 48 hrs                                                                                
daf-2(e1370) mutants   - approximately 72 hrs                                                                         
phb-2(tm2998) mutants  -approximately 96 hrs                                                                                        
phb-2(tm2998); daf-2(e1370) - approximately 144 hrs  
7. Oil Red O staining 
Quick ORO (qORO) was performed as described in Wahlby, C. et.al (Wahlby et 
al. 2014). Approximately 50 worms were seeded on NGM RNAi plates. Worms 
were washed off at the desired developmental stage by washing the plates 
twice with 200µl of S-basal using glass Pasteur pipettes to minimize loss of 
worms that might stick to the surface of plastic tips. Worms were transferred 
to 1.5mL tubes. After the worms settled to the bottom of the tubes, the 
supernatant (approx 175µl) was aspirated as much as possible without 
disturbing the worm pellet. The fixative was immediately added. 
For fixation, 200µl of high-quality 60% isopropanol was added to worms in the 
1.5mL tubes. After the worms settled to the bottom of the tubes, the 
supernatant was aspirated. 200µl of freshly filtered ORO working solution 
(60%ORO) was added. Worms were stained at 25°C in a wet chamber (wet 
paper towels in a parafilm-wrapped plastic box) for over 6 hrs. Then the 
supernatant was washed out and 250µl of 0.01% Triton X-100 in S-basal was 
added. Stained worms can be kept in this solution at 4°C for at least a month 
without altering quantities or distribution of fat. 
Long ORO staining was conducted as described previously in Soukas, A. et.al 
(Soukas et al. 2009) by washing synchronized 200–300 day 1 adult animals 
from plates. The worms were resuspended and washed twice with PBS and 
then suspended in 120 μL of PBS to which an equal volume of 2× MRWB buffer 
containing 2% paraformaldehyde was added (composition: 160 mM KCl, 40 
mM NaCl, 14 mM Na2EGTA, 1 mM Spermidine HCl, 0.4 mM Spermine, 30 mM 
Na PIPES at pH 7.4, 0.2% BME). The worms were taken through three freeze–




thaw cycles between dry-ice/ethanol and warm running tap water, followed by 
spinning at 14,000g, washing once in PBS to remove PFA, resuspension in 60% 
isopropanol to dehydrate, and addition of 60% Oil-Red-O stain (Oil-Red-O was 
prepared as follows: from 0.5 g/100 mL isopropanol stock solution equilibrated 
for several days, freshly diluted with 40% water, 60% stock, and allowed to sit 
10 min and filtered using 0.2 to 0.4 μm).  
8. Nile Red staining on plate 
Nile Red was dissolved in DMSO at 5 mg/ml and diluted in M9 to a final 
concentration of  0.02 µg/ml. This was spread on top of nematode growth 
media (NGM) plates seeded with HT115 (DE3) E. coli bacteria containing the 
appropriate RNAi plasmids. Synchronized eggs obtained by bleaching were 
allowed to develop to the desired stage at 20°C. Worms were grown 
continuously on Nile Red-containing plates (Artal-Sanz and Tavernarakis 
2009b). Nematodes were cultured at 20°C until the young adult /day 
5/10/20/25. 
9. Mitotracker staining  
Mitotracker Deep Red was dissolved in DMSO to make a stock solution of 1 
mM, which was diluted in water to a final concentration of 100 nM and spread 
on top of nematode growth media (NGM) plates seeded with HT115 (DE3) E. 
coli bacteria containing the appropriate RNAi plasmids. Synchronized animals 
were transferred to Mitotracker plates and stained overnight 20°C (Artal-Sanz 
and Tavernarakis 2009b) and imaged at YA stage. 
10. Iodine Staining  
Synchronized day 1 adult animals were transferred to 3% agarose pads and 
inverted over the opening in a 100g bottle of iodine crystals (Sigma) for 30-60 
secs. Worms were stained simultaneously and manipulated on the pad before 
imaging. This was done without a coverslip (LaMacchia et al. 2015; LaMacchia 
and Roth 2015; Possik et al. 2015).  
11. Worm imaging 
For the RNAi screen, on the day of imaging, worms were anesthetized using 
10mM (Tetramisole hydrochloride (Levamisole) and bacteria was washed off 
using the EL406 washer dispenser, BioTek using customised protocols. In order 




to acquire clear images, plates were subjected to sequential flushes of water, 
shaking to disaggregate the bacteria, sedimentation of the worms and 
aspiration of the supernatant. Each well was filled to the brim and sealed with 
transparent SealPlate (Sigma-Aldrich) to ensure the horizontal meniscus 
required to give uniform brightfield illumination across each well. The imaging 
was done using the INCA Analyser 2000 (GE Healthcare). We took images by 
utilizing the 2x objective, in three different channels – bright field, FITC/GFP 
and Cy3/Nile Red at identical settings and exposure times (see below). 
Exposure settings for imaging PHB mutant RNAi screens stained with Nile Red. 
Channel Exposure Offset Magnification 
Brightfield 0.015 40 2x 
FITC (GFP) 0.500 40 2x 
Cy3 (Nile Red) 1.300 -20 2x 
Segmenation of worms was done using the protocol mentioned in the results 
section 2.2.1, of this thesis. 
Analysis of worms expressing GFP (metabolic and stress reporters) was done 
using the INCA Analyser 2000 (GE Healthcare) as mentioned in Hernando-
Rodriguez. et.al.  (Hernando-Rodriguez et al. 2018). We took images utilizing 
the 2x objective, in two different channels – bright field, FITC/GFP at identical 
settings and exposure times (see below).  
Exposure settings for imaging transgenic worms expressing GFP 
Channel Exposure Offset Magnification 
Brightfield 0.015 50 2x 
FITC (GFP) 0.800 100 2x 
 
For worms stained using Mitotracker Red, images were obtained using the 2x 
objective with the INCA Analyser 2000 (GE Healthcare), in three different 
channels – bright field, FITC/GFP and Cy5/Red at identical settings and 
exposure times (see below). Segmenation of worms was done using the 
protocol mentioned in the results section 2.2.1, of this thesis. 
Exposure settings for imaging PHB mutant RNAi screens stained with 
Mitotracker Red. 
Channel Exposure Offset Magnification 
Brightfield 0.015 40 2x 
FITC (GFP) 0.500 40 2x 
Cy5  1.300 -35 2x 




For worms fixed with Quick Oil-Red-O, images were acquired using an Olympus 
Stereoscope equipped with a color camera using identical settings utilizing the 
bright field (1.6x objective and 2.5 zoom). For those fixed with with long Oil-
Red-O, images were acquired at 10x using a Zeiss microscope equipped with a 
color camera using identical settings utilizing the bright field.  Images were 
saved in .tif format. For image analysis Image J was utilized. The saved .tif 
images were opened and split into its RGB components. The green channel was 
selected and inverted, and worms were segmented and measured. The 
background was also segmented and measured, in order to subtract the 
intensity of the worm from that of the background.  
For worms subjected to Nile Red and grown on plates, worms were mounted in 
2-3μl of 10mM Levamisole (anesthetic) on 2% agarose pads, covered with a 
coverslip and images were acquired at 5x using an AxioCam MRm camera on a 
Zeiss ApoTome Microscope. The following exposure settings were used – 
bright field: 1m/s, Texas Red (Nile Red): 197m/s, and GFP: 81m/s. More than 
20 worms were sampled per condition. Image analysis was performed by 
quantifying the average pixel intensity using the ImageJ software.  
For nematodes subjected to iodine staining, animals were rapidly imaged using 
identical settings on an Olympus stereoscope (colour camera) utilizing the 
bright field (1.6x objective and 2.5 zoom). Intensity of staining over the whole 
body was quantified using ImageJ software. 
12. Lifespan assays                                                                                                                                             
All lifespans were done at 20°C. Synchronized eggs were obtained by 
hypochlorite treatment of adult hermaphrodites grown on OP50 plates and 
placed on NGM plates containing OP50 E. coli or seeded with HT115 (DE3) 
bacteria, either the pL4440 empty vector or the required RNAi construct. 
During the course of the lifespan, adult animals were transferred every day 
during their reproductive period and afterwards every alternate day. In case of 
balanced strains, homozygous mutants were selected at the L3 stage and 
transferred every alternate day. Worms were scored as dead when they 
stopped responding to prodding, while censored worms included exploded 
animals, those exhibiting bagging (internal hatching), protruding gonad or 
worms that dried out on the edge of the plates/crawled off the plate. Prism 




(GraphPad Software) was used to plot survival curves and significant increases 
or decreases in lifespan were determined by using the log-rank (Mantel–Cox) 
test. 
For lifespans that required addition of FUdR, a synchronized embryo 
population was allowed to grow up to young adult stage in the absence of 
FUdR and then transferred on NGM/RNAi plates containing 50 µM FUdR. 
For lifespans done on Lithium, wild type and daf2(e1370) mutants were 
cultured at 20°C until the L4 larval stage. L4 worms were then moved to NGM 
plates with or without 10mM LiCl (Sigma) and scored at 20 °C. For Lithium 
experiments at 25 °C, wild type and daf2(e1370) mutants were cultured at 20 
°C until the L4 larval stage. L4 worms were then moved to NGM plates with or 
without 10mM LiCl (Sigma) and scored at 25 °C (McColl et al. 2008). 
13. Egg laying/ fertility assay 
Wild-type and daf-2 (e1370) worms at L4 stage were placed on individual 
plates containing either control or gsk-3 RNAi (10 worms per condition) at 
20°C. The worms were transferred to new plates every day for 5-7 days while 
undergoing reproduction. Bagged or ruptured worms were censored. The 
progeny were left to develop for 48 hrs before counting.  
14. Luciferase assay 
The reporter strains PE255 (MRS186), MRS 210, MRS229 and MRS230 were 
utilised to measure larval developmental timing. In order to ensure all animals 
start development at the same time, arrested L1s were first manually pipetted 
to a well of a white 96-well plate (1 worm per well) containing 100 µl of S-basal 
with 100 µM D-Luciferin. Development was resumed by addition of 100 µl of S-
basal with 20 g/L E. coli OP50 and 100 µM D-Luciferin.Plates were sealed with a 
gas-permeable cover (Breathe Easier, Diversified Biotech). Luminescence was 
measured in a Berthold Centro LB960 XS3 for 1 sec, at 5-min intervals. 
Experiments were done inside temperature-controlled incubators (Panasonic 
MIR-154). The raw data from the luminometer was analyzed as described in 
Olmedo, M. et.al. (Olmedo et al. 2015). Briefly, the raw data was trend- 
corrected and used to generate heat maps. The trend corrected data was 
thresholded using 75% of the moving average to produce a binarized output in 
order to determine onset and offset of the molt. The data was evaluated for 




onset and offset of molting by detecting the transitions in the binarized data. 
To assess statistics, one way ANOVA was performed using GraphPad Prism 
software. Note- for synchronization of L1s, the bleached eggs were left 
overnight without food at a concentration of 20worms/µl. 
15. Seahorse Measurements 
Respiratory rates were analysed in live nematodes using the Seahorse XFp 
Analyzer (8 well plates). The evening before the actual experiment, the 
seahorse instrument was switched on. It is necessary to hydrate the probes 
prior to the experiment. For this, an unused utility plate was taken, the lid and 
the green sensor cartridge was removed and placed upside down so as not to 
scrape the probe surface. 200µl of seahorse bioscience XF calibrant (pH7.4) 
was added into the wells of the utility plate. 400µl of the same on the sides of 
the wells in the plate. The sensor cartridge was placed back into the utility 
plate so probes dip into the wells. The lid was placed back and the cartridge 
was incubated overnight at 20°C.  
The next day, C. elegans growing on the respective NGM RNAi plates were 
transferred to plates without food (2x) to remove bacteria. In the meantime, 
25μM oligomycin, 50μM FCCP and 40 μM sodium azide were pipetted into the 
appropriate injection ports of the hydrated utility plate with the sensor 
cartridge and calibrated on the seahorse instrument (Port A - 20μl of 250μM 
Oligomycin, Port B - 22μl of 500μM FCCP, Port C- 25μl of 400μM Sodium 
Azide). EPA water (Luz et al. 2015)(60mg MgSO4, 7H2O, 60mg CaSO4 .2H2O, 4mg 
KCl, ddH2O to 1L. Filtered in sterile conditions) was added to the seahorse cell 
culture microplate – 180µl within the wells and 400µl on the sides. Next, 
nematodes were picked to unbuffered EPA into an 8 well Seahorse microplate. 
8 oxygen consumption measurements were taken for determination of basal 
OCR. After this, drugs were injected - 9, 8 and 4 cycles of measurements were 
taken after addition of oligomycin, FCCP and sodium azide. Each cycle is – 3min 
mix - wait for 30 secs -measured for 3 min.   
All experiments were performed with synchronized YA animals and day 5 old 
adult animals.  Animals in control or gsk-3 RNAi were mounted side by side in 
the plate and on the same day. All drug stocks (10mM FCCP, 5mM Oligomycin) 
were made in EtOH. 1M sodium azide was in distilled water. 




16. Pharyngeal pumping 
Synchronized worms were placed on nematode growth media plates without 
food for 15 mins or so prior to counting pharyngeal pumping. Pumps per 
minute (ppm) were recorded for 1min under a regular stereomicroscope. At 
least 10 worms per condition were analyzed. Worms were analyzed for day 1 
and day 5 of adulthood. 
17. Mitochondrial Fractionation  
L1 larvae were obtained by hypochlorite treatment from liquid cultures of 
worms of desired genotype fed with HT115 (DE3) E. coli bacteria with the 
appropriate RNAi plasmid constructs. These were grown in the respective RNAi 
conditions on RNAi NGM plates (600µl bacteria/plate). Approximately 40,000 
(1000L1s/plate) worms were harvested at young adult (YA) stage. Worms were 
washed six times (3x with S Basal, 2x with double distilled water and 1x with 
MS-grade water, pelleted after each washing step by centrifugation at 800 ×g 
for 1 min at 20 °C and the final worm pellet was snap-frozen in liquid nitrogen 
and stored in the −80 °C freezer until further use.  
Mitochondrial fractionation was carried out as per (Grad et al. 2007) by Dr. A B 
Lourenço.  Instead of a Bead-Beater, a Polytron was used. The worms (in worm 
lysis buffer with protease inhibitor cocktail) were added to the chamber, and 
the chamber was filled to the top with cold worm lysis buffer. The rotor 
assembly was lowered into the chamber, displacing a small amount of liquid. 
All air should be excluded during the operation of the Polytron. The assembled 
chamber was surrounded with ice. Grinding/sonication was done at three 
pulses of 1 min each interspersed with 1-min intervals to allow for heat 
dissipation. A small aliquot of the supernatant was examined to assess the 
extent of breakage. The supernatant was recovered and homogenized by hand 
in a glass-Teflon homogenizer for 30 secs. Recovery was increased by rinsing 
the glass beads in worm lysis buffer and pooling the supernatants. The lysate 
was centrifuged at 2500g for 10 min at 4°C to pellet debris. The supernatant 
was centrifuged at 15,000g for 10 min at 4°C. The pellet was re-suspended in 
cold worm lysis buffer and centrifuged again at 15,000g for 30 min at 4°C. The 
pellet was re-suspended in a small volume of worm lysis buffer and 
homogenized briefly in a glass-Teflon homogenizer. The crude mitochondria 




were aliquoted into micro centrifuge tubes, frozen in liquid N2, and stored at -
80°C. 
18. CRISPR-Cas9 tagging of GSK-3, Sap Trap cloning  
For endogenous tagging of GSK-3, we utilised the CRISPR-Cas9 SapTrap 
technique by Schwartz et.al (Schwartz and Jorgensen 2016).  
Oligo Design for SapTrap Vectors 
First, an insertion site was identified (For N terminal tags, the tag should be 
inserted immediately after the start codon) (Figure 55A).  60 bases were 
acquired on each side of the DNA sequence flanking insertion site, and 
genomic sequence of the sgRNA binding site was checked to ensure that it 
does not contain a SapI recognition site.  
Next, candidate sgRNA binding sites were identified. The selected sgRNA 
binding site should cut within 25 bases of the desired insertion site and it 
should be ensured that the repair template cannot be targeted by the selected 
sgRNA. Ideally, an sgRNA binding site should be selected that straddles the 
insertion site. sgRNA specificity was evaluated and selected using the Zhang 
lab’s sgRNA design tool at http://crispr.mit.edu/.  
To design Oligos (Figure 55),  
a) Necessary mutations were introduced to the genomic sequence file, 
including PAM site or sgRNA binding site mutations required to immunize the 
repair template against the sgRNA. For gsk-3, we disrupted the PAM sequence 
with a silent G to C mutation to avoid re-cutting after repair (Figure 55B).                                                                                      
b) To design 5’ homology arm oligos, 57 bases immediately preceding the 
insertion site were selected. The “top” oligo is “TGG” followed by this 57 base 
sequence. The “bottom” oligo is “CAT” (N-terminal tag) followed by the 
reverse complement of the 57 base homology arm sequence.                                                      
c) To design 3’ homology arm oligos, 57 bases immediately following the 
insertion site were selected. The “top” oligo is “ACG” (N‐terminal tag) followed 
by this 57 base sequence. The “bottom” oligo is “TAC” followed by the reverse 
complement of the 57 base homology arm sequence.                                                                    
d) sgRNA oligos were designed by copying the 20 bases immediately preceding 
the “NGG” PAM sequence. The “top” oligo is “TTG” followed by this 20 base 




sequence. The “bottom” oligo is “AAC” followed by the reverse complement of 
the 20 base sequence. The PAM sequence was not included in the sgRNA 
construct. 
Verifying  the oligo sequences. It should be ensured that the oligo pairs will 
anneal to produce a product of 57 base‐pairs flanked by the correct 3-base 5’-
overhangs on each end (Figure 55B). Oligos will assemble with connector 
segments and tag segments from the SapTrap donor plasmid library to 
generate the desired repair templates (Figure  55C).  
List of oligos for N-terminal tagging 
MRS215 
N TER sg RNA 
Top 5´-3 TTG –aatcaaatcaatcagtagtg 
MRS216 
N TER sg RNA 
Bottom 5´-3 AAC – cactactgattgatttgatt 
MRS217 
N TER 5´HA 
Top 5´-3 TGG-agagctcatatatacacacacacacacaagaatcaaatcaatcagtagtgtcgtgtg 
MRS218 
N TER 5´HA 
Bottom 5´-3 CAT –acacgacactactgattgatttgattcttgtgtgtgtgtgtgtatatatgagctct 
MRS219 












Buffers and Reagents  
10x Oligo Annealing Buffer (OAB)  -  200 mM Tris-Cl pH 7.5, 500 mM NaCl,10 
mM MgCl2                                                                                                                                        
SapTrap Donor and Destination Plasmids - all plasmid preps were diluted to 50 
nM                                                                                                                                                     
SapTrap Enzyme Mix - prepared in advance and stored at -80°C in 2 µl aliquots.                 
Restriction enzymes for counter-selection of unreacted destination vector 
 





Figure 55:  Oligo Design for SapTrap Vectors  A. gsk-3 N-terminal insertion site. The native 
genomic sequence is shown for the desired insertion site flanked by 65 bases on each side. B. 
Oligo design. The same genomic region depicted in A is shown with theaddition of a PAM- site 
disrupting mutation for the selected sgRNA. The sequences used to generate the homology arm 




and sgRNA oligos are marked. C. Sequence of the repair template generated from the oligos 
depicted in B.  
Anneal oligos 
Oligo stocks were resuspended to 100μM in water. Complementary oligo pairs 
were mixed to a final concentration of 10 μM each in 100 µl of 1x OAB. Oligo 
mixtures were heated to >95°C in a heat block and incubated for 2.5 mins. The 
heat block was turned off and the block was allowed to cool slowly to room 
temperature. The 10 µM annealed oligo stocks can be stored at ‐20°C for 
future use or diluted and used immediately. The annealed oligos were diluted 
in water to 150 nM. All 3 annealed oligo pairs for a given reaction were diluted 
in a single aliquot of water such that the final solution contained 150 nM of 
each of the 3 annealed oligo species. 
SapTrap Assembly 
The following were combined and mixed thoroughly by pipetting: 
1 µl of 50nM Destination Vector  -pMLS256 (Dr.Askjaer’s Lab 1491)                                            
1 µl of 50nM connector vector                -pMLS288 (Dr.Askjaer’s Lab 1511)                                            
1 µl of 50nM tag and marker plasmid  - pBN312   (Dr.Askjaer’s Lab 1519)                                                                                                                                                         
1 µl of annealed, diluted oligo mixture (150nM each oligo species)                                             
1 µl of dH2O 
A 2 µl aliquot of SapTrap Enzyme Mix (10x Cutsmart buffer, H2O, 10 mM ATP, 1 
M DTT, 400U/ µl T4DNA ligase, 10U/ µl T4 polynucleotide kinase, 10 U/ µl SapI) 
was thawed. To this, 0.5 µl of the above DNA mix was added and mixed 
thoroughly by pipetting up and down using a 2 µl pipette. The reaction was 
incubated at 25°C overnight. The following day, the T4 DNA ligase was heat 
inactivated by incubation at 65°C for 30 mins. 
A solution of 1x Cutsmart buffer +1–2U/ µl of BamHI restriction enzyme was 
prepared ( BamHI is an appropriate counter-selection restriction enzyme, as 
this does not cut the desired final product). 2.5 µl of the 1x Cutsmart + enzyme 
solution was added to the 2.5 µl SapTrap reaction and mixed. This was 
incubated at 37°C for 1 hr.  
Transformation was performed using DH5α cells. To 50 µl of DH5α cells, 2 µl of 
the above Saptrap reaction solution was added. This was incubated for 20 mins 
on ice, and then at 42°C for 1 min. 250 µl of LB was added to the 52 µl reaction 




mix and incubated at 37°C (shaking) for 30 mins. Approximately 150 µl of the 
solution was plated onto an LB plate supplemented with Ampicillin and grown 
at 37°C overnight. The next day, individual colonies were selected and 
inoculated. Plasmids were mini-prepped and sent for sequencing with M13F, 
M13R and oMLS471.  
M13F (MRS 94): 5’ –TGTAAAACGACGGCCAGT 
M13R (MRS 95): 5’ –CAGGAAACAGCTATGACCATG 
oMLS471 (Dr.Askjaer’s Lab 975)   :5’–TCCAAGAACTCGTACAAAAATGCTC 
Injection and Isolation 
unc-119(ed3) worms were cultured at 15°C on OP50 bacteria. L4 worms were 
picked the night prior to the injections and transferred to a fresh OP50 NGM 
plate. 30-40 animals were injected with the following injection mix (see table), 
animals were kept on individual plates and incubated at 25°C for 7-10 days. 
Plates were screened post 7 days to identify motile (unc-119(+)) animals that 
lacked the co-injection markers. 
Insertion injection mix recipe 
Component Concentration Comments 
Combined repair 




Nter5- confirmed through sequencing 
Cas 9 Expression 
vector 




17.5ng/ µl 868 - pGH8- Plmn-1::mCherry::his-58 (neuronal 
red fluorescence )(10ng/ µl) 
885 - pCFJ104 – Pmyo-3::mCherry (body wall 
muscle red fluorescence) (5 ng/ µl ) 
879 - pCJ90 - Pmyo-2::mCherry (pharyngeal  
muscle red fluorescence) (2.5ng/ µl)  
Total  107.5 ng/ µl   -  
 
Removing the Cbr-unc-119 marker   
Worms selected from the above step have successful incorporation of the 
repair template containing the homology arms flanking the cleavage site and a 
genetic tag with a removable Cbr-unc-119 marker gene embedded in the 
intron. Insertions are selected by rescue of the Unc phenotype. The Cbr-unc-




119 can be excised by Cre recombinase- mediated site specific recombination, 
leaving a single LoxP site. For this purpose, homozygous young adult animals 
were injected with the following injection mix (see table). Array(+) F1 animals 
were selected.  5-10 array (+) worms were placed on up to 4 OP50 NGM plates. 
The F2 was screened and unc-119(-) animals were selected. The resultant 
strain was out crossed against the wild type to remove the ed3 allele (This 
portion as done by Dr. FJ Garcia). 
Removal of the Cbr-unc-119 marker - injection mix recipe 
Component Concentration Comments 




Dr.Askjaer’s Lab -1493- pMLS328 




17.5ng/ µl 868 - pGH8- Plmn-1::mCherry::his-58 
(neuronal red fluorescence )(10ng/ µl)  
 885 - pCFJ104 – Pmyo-3::mCherry (body wall 
muscle red fluorescence) (5 ng/ µl) 
879 - pCJ90 - Pmyo-2::mCherry (pharyngeal  
muscle red fluorescence) (2.5ng/ µl)                                                        
Total  100 ng/ µl  -  
 
19. Quantitative RT-PCR 
Total RNA was isolated from approximately 1500 synchronized wild type and 
daf-2 (e1370) mutants at the young adult stage grown on control and gsk-3 
RNAi. After harvest, the animals were flash frozen in liquid nitrogen. RNA was 
extracted based on a protocol modified from “easy RNA isolation from C. 
elegans : A TRIZOL based method” (Worm Breeder’s Gazette 14:10).  cDNA was 
prepared using INVITROGEN DNAse KIT reagents. Reverse transcription (1 µg 
per sample) was performed using Multiscribe reverse transcriptase and 
random 9-mer primers (Applied Biosystems). Quantitative PCR was performed 
using SYBR Green (Applied Biosystems) Master Mix in a CFX Connect Real Time 
System, Biorad at an annealing temperature of 60°C and 40 cycles. Relative 
gene expression, normalized to pmp-3 and cdc-42, was determined between 
worms treated with control RNAi and gsk-3 RNAi. Primers of target genes can 
be found in Table 7. Statistical difference was calculated with Student’s t-test 
(Excel). 




20. Western Blots 
A synchronised population of worms was grown at 20°C until they reached the 
young adult stage. Worms were transferred to NGM plates without food and 
allowed to crawl for half an hour in order to remove excess of bacteria. 60 
worms were collected in 10µl of M9 and flash frozen in liquid N2 and stored at 
-80°C. We added the same volume of sample buffer containing Ditiotreitol 
(DTT) and 2x LB (100mM Tris-HClph 6.8, 4% SDS, 0.005% Bromophenol Blue, 
20% Glycerol), vortexed, heated the sample for 3 min and vortexed again. All 
samples were centrifuged before loading. 16 l of each sample was run in a 4-
20% pre-cast gradient gel (Mini-protean TGX Stain Free Precast gel, Biorad). 
Following electrophoresis, proteins were transferred to a PVDF membrane 
(Trans Blot turbo mini PVDF transfer pack Biorad) using a wet Trans-Blot 
system (Bio-Rad). The immunoblots were visualized by chemiluminescent 
detection (Molecular imager ChemiDoc XRS+ with image lab software Biorad). 
Independent assays repeated three times. The chemiluminescent signals were 
quantified using the software ImageLab (Bio-Rad) and normalized to actin 
signal levels. We incubated western blots with phospho-AMPKα Thr 172 (Santa 
Cruz Biotevhnology), diluted 1:300 (McQuary et al. 2016) and anti-actin (ICN, 
clone C4) diluted 1:1000. The data are represented as relative values 
















A1.1 Effect of FUdR on lifespan of wild type, IIS and mitochondrial mutants 
As we were working with four different genetic backgrounds, we reasoned we 
could reduce the laborious task of transferring worms during the course of 
their egg laying period during lifespan assays by addition of FUdR (5-Fluoro-2′-
deoxyuridine).FUdR supplementation helps to limit production and 
development of progeny by inhibiting DNA synthesis.  It would also help to 
reduce the number of worms lost during egg laying due to internal hatching. 
While addition of FUdR to wild type animals has not been shown to affect their 
lifespan, there have been conflicting reports that FUdR has no effect on 
lifespan or can extend lifespan in certain mutants (Aitlhadj and Sturzenbaum 
2010; Van Raamsdonk and Hekimi 2011; Rooney et al. 2014). Moreover, it can 
alter metabolic profiles in worms (Davies et al. 2012).  
We observed a significant shift in the mean lifespans of wild type , daf-2 and 
mitochondrial PHB mutants - a decrease in daf-2 and phb-2;daf-2 mutants and 
a increase in wild type and phb-2 mutants (Figure A1.1, Table 6). The opposing 
phenotype of PHB depletion was still retained on FUdR, i.e, phb-2(tm2998) is 
short-lived and phb-2(tm2998);daf-2(e1370) mutants exhibited increased 
lifespan.  



























Figure A1.1: Lifespan analysis 
with and without FUdR. Wild 
type, daf-2, phb-2 and phb-2; 
daf-2 mutants were grown on 
HT115 (DE3) bacteria 
containing the empty vector 
pL4440. Curves represent one 
lifespan assay.  
A1.2 mtk-1 (MTK-1/ MEKK-4 homolog) 
While depletion of MTK-1 has been observed to induce the UPRmt and Pgst-4 
::GFP  in the mitochondrial PHB mutants (data not shown), we observed that 
Nile Red staining is increased in the same upon mtk-1(RNAi). mtk-1 shares 





of the HOG1 mitogen-activated signalling pathway known to regulate glycerol 
synthesis, osmoregulation and stress response genes (Gustin et al. 1998). 
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Figure A1.2: Lifespan 
analysis of wild type, daf-2, 
phb-2 and phb-2; daf-2 
mutants subjected to mtk-1 
(RNAi). Average of two 
independent lifespan 
curves has been 
represented here. 
mtk-1(RNAi) increased lifespan of the phb-2 (tm2998) mutants while it 
shortened the lifespan of the phb-2(tm2998);daf-2(e1370) mutants (Figure 
A1.2, Table 6). Wild type and daf-2(e1370) mutants were not affected upon 
loss of MTK-1. In order to further investigate this opposing effect upon mtk-
1(RNAi), we have performed a lipidomics study focussed on mitochondrial lipid 
alterations. Mitochondria are essential for organismal metabolism and 
physiology and it has been shown that composition of mitochondrial 
membrane lipids can influence the ageing process in yeast and in nematodes 
(Hulbert 2010; Valencak and Azzu 2014; Medkour et al. 2017; Nielson and 
Rutter 2018). Incidentally, mtk-1(RNAi) also induces UPRmt in both phb-2 and 
phb-2;daf-2 mutants. A recent worm paper observed that mitochondrial UPR 
might delay ageing in worms via global remodeling of lipid metabolism that 
includes increase in cardiolipins and fatty acids (Kim et al. 2016). 
A1.3 S6 kinase/RSKS-1 
Inhibition of RSKS-1(S6K), a key molecule in the target of rapamycin (TOR) 
pathway is known to extend lifespan in multiple species, including the worm  
(Laplante and Sabatini 2012). daf-2(e1370);rsks-1 (ok1255)double mutants also 
exhibit increased lifespan which requires DAF-16 (Chen et al. 2013). Also, the 
deficiency of PHB-2 in an rsks-1(ok1255) mutant leads to an extension in 
longevity (Schleit et al. 2013). Hence, we wanted to examine the effect of 





We were only able to recapitulate the increase in longevity in phb-2 mutants 
upon depletion of RSKS-1(Figure A1.3, A). Though we noticed a mild increase 
when daf-2 mutants were subjected to rsks-1(RNAi), but did not observe an 
increase in wild type animals when RSKS-1 is depleted, in stark contrast to the 
published extension (Chen et al. 2013; Schleit et al. 2013). We were unable to 
conclude the behaviour of phb-2;daf-2  mutants upon rsks-1(RNAi) due to low 
“n”numbers, although a tendency to decrease was observed .  
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Figure A1.3: RSKS-1 
depletion leads to increased 
longevity in phb-2 mutants. 
Lifespan analysis of wild 
type, daf-2, phb-2, phb-2; 
daf-2 subjected to rsks-1 
(RNAi) A. without FUdR 
B.Upon addition of FUdR. 
Curves representative of 
one lifespan assay 
The published extension of lifespan upon loss of RSKS-1 in wild type, IIS and 
PHB defective backgrounds was carried out in the presence of FUdR. 
Therefore, we assayed the effect of rsks-1(RNAi) in all genetic backgrounds in 
the presence of FUdR (Figure A1.3, B). While we were able to again 
recapitulate the extension seen upon PHB depletion, wild type worms 
remained unaffected. IIS mutants showed a mild decrease upon depletion of 
RSKS-1 in the presence of FUdR going against earlier published data using daf-2 





mutants, phb-2 (tm2998); daf-2(e1370) were observed to have an increase in 
lifespan upon rsks-1(RNAi).  
A1.4 KIN-1 
kin-1 encodes multiple isoforms of a serine/threonine protein kinase that is 
orthologous to cAMP-dependent protein kinase (protein kinase A or PKA) 
catalytic subunits. They are involvedin several processes including lipid 
metabolism (Lee et al. 2014; Lee et al. 2016). Absence of kin-1 has been shown 
to increase Oil-red-O staining, implying high triglycerides (Lee et al. 2014). The 
PKA pathway is well conserved and suppression of PKA in worms results in 
deleterious phenotypes - short lifespan, decreased egg laying, and reduced 
locomotion. kin-1 is highly expressed in muscles, head and gonads (Lee et al. 
2016). PKA signalling is important for oocyte maturation (Kim et al. 2012). 
We found that despite starting the RNAi treatment at the L3/L4 stage, all 
genetic backgrounds depleted of kin-1 exhibited strong vulval rupturing leading 
to a premature death of almost the whole experimental population, especially 
in the case of wild type and daf-2(e1370) mutants (Table 6). The phb-2 mutants 
salvaged after the vulval bursting phenotype in kin-1 RNAi lived an even more 
reduced lifespan (Figure A1.4), whereas, the long lived phb-2;daf-2 mutants 
showed a sharp decline in lifespan. 
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Figure A1.4:  Lifespan 
analysis of PHB mutants, 
phb-2 and phb-2; daf-2, 
subjected to kin-1(RNAi). 
Curves represent one 
lifespan assay.  
 
Recently, a role has been established for PKA pathway as a contributor to 
innate immunity in worms by signalling from the nervous system to periphery 
tissues to protect the host against pathogens (Xiao et al. 2017). This is of 
interest as exposure to the pathogen Pseudomonas aeruginosa causes 





pathogens and initiates a protective innate immune response (Pellegrino et al. 
2014). 
A1.5 Y50D7A.3 
Y50D7A.3 is orthologous to the human Phosphorylase Kinase Gamma-2 
(PHKG2). Human PHKG2 phosphorylates and activates glycogen phosphorylase, 
which leads to the breakdown of glycogen. Mutations in PHKG2 are linked to 
cirrhosis and Glycogen storage disease. Not much is known about this gene in 
the nematode. Enzymes such as trehalose-6-phosphate synthase genes, 
related to carbohydrate metabolism have been known to modulate lifespan 
(Honda et al. 2010) in C. elegans, and we observed earlier that the kinase,  
GSK-3 known to phosphorylate and inhibit glycogen synthase also regulates 
lifespan. Hence, we investigated whether loss of this kinase could alter 
lifespan. However, we found that depletion of this kinase did not cause an 
alteration in lifespan (Figure A1.5, Table 6) in any of the genetic backgrounds. 




























Figure A1.5:  Lifespan 
analysis of wild type, daf-2 
and phb-2, phb-2; daf-2 
subjected to Y50D7A.3 
(RNAi).One of two 
independent experiments 














Appendix 2  
A2.1 Wild type, daf-2(e1370) and mitochondrial mutants – phb-2(tm2998) and 
phb-2(tm2998);daf-2(e1370) subjected to gsk-3(RNAi) in presence of 5-Fluoro-
2′-deoxyuridine (FUdR)  
We observed that the reduction in lifespans across wild type, daf-2(e1370) and 
the mitochondrial PHB mutants upon GSK-3 depletion was unchanged upon 
FUdR addition (Figure A2.1, Table 4).  




























Figure A2.1: Survival curves of 
GSK-3 depleted worms in the 
presence of FUdR.  
A2.2 Inhibition of GSK-3 using Lithium 
Previously, it has been established that Lithium affects diverse biological 
processes, ranging from developmental effects to metabolic alterations. A 
known molecular target of lithium is GSK-3, and it has been suggested that 
lithium acts through inhibition of GSK-3 (Ryves and Harwood 2001; De Sarno et 
al. 2002). Hence, we investigated whether inhibiting GSK-3 through lithium 
addition in worms would reduce lifespans in a similar manner as gsk-3(RNAi) 
(Figure A2.2,A, Table 4). In accordance with our experiments with gsk-3(RNAi), 
we observed reduced lifespan in wild type and IIS defective daf-2(e1370) 
mutants upon addition of Lithium Chloride.  
However, previous work showed that exposure to lithium increased lifespan in 
worms, flies and humans (McColl et al. 2008; Zarse et al. 2011; Castillo-Quan et 
al. 2016). In particular, wild type and daf-2(e1368) mutants have been shown 
to have an increased lifespan in presence of LiCl (McColl et al. 2008). A key 
difference in how these experiments were performed is with respect to the 
temperature.  McColl et al, performed experiments by moving L4 worms grown 
at 20°C on to NGM plates with LiCl and assayed at 25°C, as opposed to us that 





required to ascertain if indeed increased temperature is the cause for these 
differences, though we did see a tendency to increase lifespan at 25°C in wild 
type worms subjected to LiCl (Figure A2.2, B). 
A                                                                                    B 
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Figure A2.2:  Effect of LiCl on the lifespan of wild type and daf-2(e1370) mutants. Survival curves 





















Appendix 3 - Analysis of additional metabolic genes upon depletion of GSK-3  
A3.1 Increased expression of Pacdh-1::GFP in worms with low glycogen stores.  
In order to ascertain whether the Pacdh-1::GFP reporter is capable of reflecting 
changes in fatty acid oxidation, we subjected wild type and daf-2 mutants to 
gsy-1(RNAi). Knockdown of glycogen synthase (gsy-1) reduces glycogen 
content in C. elegans (Frazier and Roth 2009; LaMacchia et al. 2015) , both in 
wild type and daf-2 mutants (Figure A3.1,A). Knockdown of GSY-1 led to a 








































































                       
Figure A3.1: Worms with lower reserves of glycogen stores show increased short chain fatty acid 
oxidation A.Scatter plot representing quantification of glycogen stores in wild type and daf-2 
mutants depleted of GSY-1 viewed using iodine vapor staining (Mean±SD, Unpaired t- test, * = 





and daf-2 mutants upon gsy-1(RNAi) (top  panel) and scatter plot representing quantification of 
Pacdh-1::GFP levels of the respective images (bottom panel) (Mean±SD, One way ANOVA, 
Dunn’s multiple comparison test,* = p<0.05) (Animals were imaged at Day1 of adulthood in all 
conditions in both A and B) 
A3.2 Short- and medium- chain dehydrogenases  
We assessed expression of an additional mitochondrial short chain acyl-CoA 
dehydrogenase, acdh-2, also predicted to catalyse the first step of β-fatty acid 
oxidation (MacNeil et al. 2013). We observed a repression in Pacdh-2::GFP 
(similar to Pacdh-1::GFP (Figure 46,A-B)), upon gsk-3(RNAi) and  PHB depletion 













































































Figure A3.2: Reduced expression of acdh-2 and acdh-7 upon gsk-3(RNAi). A. Pacdh-2::GFP gene 
expression in otherwise wild type and PHB depleted worms grown on gsk-3(RNAi) versus control 
(RNAi) (left panel). Scatter plot (right panel) represents the quantification (Animals imaged at 
Day1 in all conditions, Mean±SD, One way ANOVA, Dunn’s multiple comparison test, **=p<0.01, 
*** = p< 0.001, n≥86, one of two independent experiments represented).B. Scatter plots 
depicting the expression of Pacdh-7::GFP on Day 1 (left panel, n≥64, one of two independent 





type and PHB depleted animals (Mean±SD, One way ANOVA, Dunn’s multiple comparison test,  
ns = not significant, *=p<0.05, *** = p< 0.001)  
Additionally, acdh-7, the nematode homolog of medium-chain acyl-CoA 
dehydrogenase as observed by Pacdh-7::GFP (Figure A3.2, left panel) was also 
reduced in both wild type and PHB depleted worms grown on gsk-3(RNAi). 
Interestingly, PHB depleted animals showed a mild increase in expression. 
During ageing (Figure 3.2, right panel), expression of acdh-7 increased in wild 
type animals with no significant alterations in PHB depleted worms, but 
remained repressed in wild type and PHB depleted worms grown on gsk-
3(RNAi).   
A3.3 Short- and long- chain acyl CoA synthetases  
Lipid metabolism involves lipases that breakdown triglycerides to free fatty 
acids. These are then activated by acyl-CoA synthetases to their acyl-CoA 
derivates which are then oxidised in the mitochondria by acyl CoA 
dehydrogenases or the peroxisomes by acyl CoA oxidases (Watkins and Ellis 
2012; Watts and Ristow 2017). As we observed reduction in expression of the 
acyl CoA dehydrogenases, acdh-1/-2/-7, we investigated whether acyl CoA 
synthatases are also downregulated. Consistent with our observation of 
decreased expression of short chain dehydrogenases, acdh-1 and -2 in PHB 
depleted worms and also upon gsk-3 depletion, we observed that these worms 
also exhibited low expression of ACS-19 (an ortholog of human ACSS2 (acyl-
CoA synthetase short-chain family member 2) (Figure A3.3, A-B, further 
indicating reduced fatty acid oxidation.  
Similarly, Pacs-13::GFP expression analysis (Figure A3.3, C) revealed that lackof 
GSK-3, both in wildtype and PHB depleted worms, results in low expression of 
the reporter. acs-13 encodes an ortholog of human ACSL5 (acyl-CoA 
synthetase long-chain family member 5).Interestingly, PHB depleted animals 
were unaffected. These results indicate that while GSK-3 depletion reduces 
expression of both short and long-chain acyl CoA synthethases (Figure 46, A3.2, 



















































































Figure A3.3: Expression of acyl CoA synthatases, acs-19 and acs-13. A. Representative images of 
acs-19 gene expression upon PHB and GSK-3 depletion (left panel) and quantification (right 
panel) at Day1 of adulthood (Mean±SD, One way ANOVA, Bonferroni’s multiple comparison test, 
*** = p< 0.001, n≥35, one of three independent experiments represented). B – C. Scatter plot of 
Pacs-19 ::GFP expression on Day 5 (n≥16) and Pacs-13::GFP expression on Day1 upon PHB and 
GSK-3 depletion (n≥30, one of two independent experiments represented) (Mean±SD, One way 
ANOVA,  Dunn’s multiple comparison test, ns = not significant, *** = p< 0.001)  
A3.4 Carnitine palmitoyltransferase, cpt-2  
Short-chain fatty acids are able to freely translocate between the cytosol and 
mitochondria, whereas medium- or long- chain fatty acids require the function 
of carnitine palmitoyltransferases, such as CPT-2 (Watts 2009; Yuan et al. 
2012). Consistent with our observation of decreased medium-chain fatty acid 
degradation upon GSK-3 depletion, we observed decreased Pcpt-2::GFP 
expression (Figure A3.4), implying low import of medium-/long-chain fatty 
acids into the mitochondria. However, PHB depleted worms do not exhibit any 





with the fact that medium chain dehydrogenase acdh-7 and long chain acyl 



























Figure A3.4: Expression of the carnitine palmitoyltransferase reporter, Pcpt-2::GFP.  
Representative images are shown for wild type worms upon GSK-3 and PHB depletion (left 
panel) and the scatter plot (right panel) represents GFP quantification (Worms  were imaged at 
Day1 of adulthood, Mean±SD, One way ANOVA, Dunn’s multiple comparison test, *** = p< 
0.001, ns=not significant,n≥61, one of two independent experiments has been represented). 
A3.5 de novo fat synthesis 
About 7–20% of C. elegans fatty acids are synthesized de novo from acetyl-
CoA, with the exception of the monomethyl fatty acids, which are synthesized 
when worms feed on E. coli OP50 (Perez and Van Gilst 2008). The remaining 
are incorporated or modified from diet. The de novo synthesis of fatty acyl 
chains using the two carbon subunit acetyl-CoA is achieved by the activity of 
fatty acid synthase (FAS), encoded by fasn-1. The rate-limiting step of de novo 
fatty acid synthesis is the generation of malonyl-CoA by acetyl-CoA carboxylase 
(ACC),encoded by the pod-2 gene in C. elegans (Watts and Ristow 2017). In 
addition to POD-2 and  FASN-1 we looked at FAT-7 (an essential delta-9 fatty 
acid desaturase required for synthesis of monostaurated fatty acids, along with 
FAT-6, responsible for producing oleic acid, 18C:1n-9).  
De novo fat synthesis based on the expression levels of Ppod-2::GFP was 
downregulated only upon GSK-3 depletion, whereas PHB depleted animals, 
which show reduced pod-2 expresssion (Figure A3.5,A) were not further 
affected by loss of GSK-3. Additionally, expression of fasn-1 and fat-7 was also 





2(e1370) mutants respectively. In particular, fat-7 downregulation indicates 
lower levels of oleic acid, a known precursor for the synthesis of 















































































          
Figure A3.5: Altered de novo fatty acid metabolism upon gsk-3(RNAi). A. pod-2 gene expression 
in otherwise wild type and upon PHB depletion grown on gsk-3(RNAi) compared to control(RNAi) 
(left panel).The scatter plot (right panel) represents the respective GFP quantification (Animals 
were imaged at Day1 of adulthood in all conditions, Mean±SD, One way ANOVA, Dunn’s multiple 
comparison test, *** = p< 0.001, ns=not significant , n≥87, one of two independent experiments 
has been represented) B-C. Expression of fasn-1 and fat-7 in wild type (B) and IIS mutants (C) 
grown on gsk-3(RNAi) compared to control(RNAi) (Mean ±SEM, Unpaired t-test, **=p<0.01, 









Appendix 4 - Assessing metabolic activity using Seahorse XFp Analyzer 



















































































Figure A4.1: FCCP treatment caused an increase in OCR across all conditions tested A. at young 
adult stage,  B. day 5 of ageing (Unpaired t-test, * = p<0.05, ** = p<0.01, *** = p< 0.001, bars 
represent ± SD, n = at least 3 independent experiments consisting of 3-4 wells each of 
control(RNAi) and gsk-3(RNAi) for each genetic background tested) 
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Figure A4.2: Basal and maximal oxygen consumption rates normalised to number of worms (A-D) 
across wild type, daf-2 (e1370) and the mitochondrial mutants – phb-2(tm2998) and phb-
2(tm2998);daf-2(e1370)grown on control(RNAi) and gsk-3(RNAi) at young adult(YA) stage and 
during ageing, at day 5 of adulthood. A-B. Basal respiration at YA and at Day 5 respectively; basal 
respiration reduces during ageing in wild type C-D. Maximal respiration as observed by 
treatment using FCCP, at young adult stage and at day 5 of adulthood (Unpaired t-test, ns = not 
significant p>0.05, * = p<0.05, ** = p<0.01, *** = p< 0.001, bars represent ± SD, n = at least 3 
independent experiments consisting of 3-4 wells each of control(RNAi) and gsk-3(RNAi) for each 
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Figure A4.3: Mitochondrial content in 
animals devoid of GSK-3 (Animals were 
imaged at young adult stage in all 
conditions, Mean±SD, One way ANOVA, 
Dunn’s multiple comparison test, ns=not 
significant , n≥50, one of two independent 


























Figure A4.4: Expression of ucp-4 in IIS mutants 
grown on gsk-3(RNAi) compared to control 
(RNAi) (Mean ±SEM, Unpaired t-test, 
**=p<0.01, graph representative of three 

















Appendix 5 – AMPK status  
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Figure A5.1: Levels of P-AMPK. Western blot analysis showing P-AMPK and actin protein levels in 
the different genetic backgrounds, in control and gsk-3(RNAi) (representative blot , top panel). 
Graphical representation of quantified P-AMPK intensity normalized to actin for the respective 
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Table 1:  Pathways that regulate ageing 
Pathway Description 
Nutrient sensing pathways 
An intervention to 
interrupt ageing is the 
process of dietary 
restriction (DR), a means 
of restricting food intake 
without malnutrition. DR 
has been shown to extend 
lifespan in various species. 
Longevity responses to 
dietary restriction are 






TOR signalling: TOR is a mechanistic or mammalian target of 
rapamycin responsible for regulation of cell growth, 
proliferation, motility and survival, protein synthesis, autophagy 
and transcription. This serine threonine  kinase is a major amino 
acid and nutrient sensor that supports growth and blocks 
autophagy when food is present in abundance (Wullschleger et al. 
2006). Inhibition of this pathway increases lifespan in yeast, flies, 
mice and in worms where it is mediated by the transcription 
factor PHA-4/FOXA. PHA-4 also regulates autophagy, a process 
that has a role in lifespan regulation (Sheaffer et al. 2008). 
Lifespan in worms is extended upto 150% upon inhibition of TOR 
(Vellai et al. 2003; Hansen et al. 2007). Additionally, the mutation 
of raptor, DAF-15 (regulatory associated protein of mTOR), leads to 
lifespan extension in worms. This is regulated by FOXO/DAF- 16, 
thus, there is cross-talk between IIS and TOR pathways (Jia et al. 
2004). Apart from this, TOR regulates translation by activating 
p70S6K (ribosomal subunit S6 kinase, RSKS-1) and inhibiting the 
translation repressor eIF4EBP. Inhibition of translational regulators 
or p70S6K (RSKS-1) in C. elegans extends worm lifespan (Hansen et 
al. 2007).  
AMP-activated protein kinase (AMPK): It is a conserved  nutrient 
and energy sensor that will activate catabolic pathways and 
repress anabolic pathways in an attempt to restore homeostasis 
(Hardie and Hawley 2001). Upon over expression of AMP kinase, 
lifespan is extended in C. elegans. AMP kinase is required for 
insulin/IGF-1 mutations to be able to extend worm lifespan (Apfeld 
et al. 2004). Also, the anti-diabetic drug metformin that activates 
AMP kinase can increase lifespan in mice(Onken and Driscoll 
2010).  Lately, neuronal AMPK activation was shown to regulate 
lifespan via catecholamine signalling in C. elegans (Burkewitz et 
al. 2015) It can also extend lifespan in a response to dietary 
restriction but is dispensable for chronic dietary restriction (eat-2 
mutants) (Greer et al. 2007a). AMPK acts partly via FOXO 
transcription factors to extend lifespan in worms (Greer et al. 
2007a)  
Sirtuins: These are nicotinamide adenine dinucleotide (NAD) - 
dependent protein deacetylases, and are directly linked to cellular 
nutrient signalling through NAD
+





over expression of the sirtuin gene sir-2.1 increases lifespan 
(Tissenbaum and Guarente 2001) in a DAF-16/FOXO-dependent 
manner (Berdichevsky et al. 2006). Lifespan extension was also 
seen in flies (Rogina and Helfand 2004), indicating evolutionary 
conservation of sirtuins.  However, on re-examining the effects of 
sirtuin overexpression on the lifespan in worms and flies abolished 
the pro-longevity observed earlier. The extension in lifespan was 
attributed to a background mutation in the transgenic animals 
used in these experiments (Burnett et al. 2011)  
Signals from the 
reproductive system 
The germline of C. elegans also influences ageing. When the worm 
germline is removed or through genetic manipulation, extension of 
lifespan is seen by 60% which requires DAF-16 activity, however, 
this effect is abolished when the somatic gonad is removed, 
suggesting that opposing signalling pathways might exist (Hsin and 
Kenyon 1999; Arantes-Oliveira et al. 2002). The extended lifespan 
upon germline removal is a result of signalling from the 
reproductive system to the intestine as DAF-16 accumulates within 
intestinal nuclei and functions in the intestine to increase life span 
when the germline is removed (Berman and Kenyon 2006). Signals 
from the reproductive system have been shown to mediate 
lifespan in flies and mice as well (Kenyon 2010a).  
Epigenetic mechanisms Epigenetic mechanisms like DNA methylation, histone 
modification and noncoding RNAs also regulate ageing. Histone-
modifying enzymes such as the SET domain proteins, SET-9 and 
SET-15 accelerate ageing (Hamilton et al. 2005; Greer et al. 
2010), while inhibition of  members of the histone H3K4 
methylation complex, ASH-2, WDR-5 and SET-2 and 
overexpression of RBR-2 (enzyme that mediates H3K4 
demethylation) are known to extend lifespan (Greer et al. 2010). 
Depletion of the histone demethylase, UTX-1 increases longevity 
by genetically interacting with the IIS pathway (Jin et al. 2011; 
Maures et al. 2011). Also, microRNA (miRNA), a class of 
noncoding RNA molecules also function in lifespan regulation, 
example, miRNA lin-4 and its target LIN-14. This was mediated 





Table 2: Methods for evaluating C. elegans  fat stores. Adapted from (Elle et 
















Nile Red Dye partitions to 
live tissue depots 
 
 
Benefits: Simple, fast, cheap; 
hence, ideal for screening 
experiments; uses standard 
microscopy techniques; allows 
live imaging.                                                                
Drawbacks:  fluorescence 
emission is sensitive to lipid 
composition; high variability; it 




(BODIPY - FA ) 
  
                        
Dye partitions to 
live tissue depots 
Benefits: Simple, fast, cheap; 
stains hypodermal and 
intestinal lipid stores; allows 
live imaging.                                                            
Drawbacks: gut granules stain 
strongest in the intestine; 
requires confocal microscopy. 




Oil Red O 
Colorimetric                      
(Sudan black, Oil 
Red O) 
Dye partitions to 
hydrophobic 
depots 
Benefits: cheap, standard light 
microscopy.                                                   
Drawbacks: requires fixation; 
time consuming; large 
variability; poor sensitivity; 






Dye partitions to 
hydrophobic 
depots 
Benefits: cheap, standard light 
microscopy; improved 
sensitivity; better range than 
colorimetric stains               
Drawbacks: requires fixation 
and time consuming; large 
variability; different fat depots 








Benefits: high resolution of cell 
structures         Drawbacks: 
requires fixation with harmful 
substances like glutaraldehyde 
and/or paraformaldehyde; 
time consuming; advanced 
equipment required. 














of total TAG, Phospholipids, 
free fatty acids etc.      
Drawbacks: Reductive; is 
inconsiderate of cell biological 
complexities; large population 












Benefits: Can quantify the 
abundance of individual fatty 
acid chains.                                      
Drawbacks: Reductive; is 
inconsiderate of cell biological 
complexities; large population 






(Hellerer et al. 
2007; Le et al. 
2010; Folick et al. 










Benefits: non invasive live 
animal staining, high 
resolution; microscopic 
detection of live tissue lipid 
depots; can be used to 
monitor the ratio of saturated 
to unsaturated fatty acids 
Drawbacks: Complex  
technique; is expensive ; more 
time consuming than 
fluorescence measurements; 
quantitation made difficult by 
non-resonant background and 
non-linear dependence of 
signal on underlying tissue; 
CARS signals arise from all 
lipid-rich structures  (including 
cell membrane, cellular 
organelles, free lipids, yolk 







improvements over CARS in 
background signal and linear 
relationship between 
underlying sample and signal 
received.                                           
Drawbacks: Complex 
technique; is expensive; 
technically a more demanding 
optical setup than CARS; not 








(Mak 2012; Mak 
















Benefits: live animal imaging; 
can be used to characterise 
lipid droplet size and number           
Drawbacks: requires confocal 
microscopy; may perturb the 
natural properties of lipid 
stores;  not every lipid droplet 
expresses the same lipid 
droplet proteins  
Dark field 
microscopy 
(Fouad et al. 
2017) 




used to estimate 
fat levels in 
worms. This is 
done by defining a 
metric based on 
the amount of 
light scattered per 
area. 
Benefits: no dyes or fixation. 
The light scattering metric is 
strongly correlated with worm 




Table 3: Summary of lifespan data of PHB deletion mutants, on E.coli OP50. 
* Maximum lifespan is the average of the longest-lived 10% of the animals assayed.                                             
† Confirmed death events, divided by the total number of animals included in lifespan assays. 
Total equals the number of animals that died plus the number of animals that were censored. 
The number of independent lifespan assays for each strain is shown in parentheses.                                          
‡ Compared to wild type animals. 
Strains Mean ± SEM Maximum* ± SEM Deaths/Total† P-value‡ 
Wild type 18±0 29.45±1.45 137/326(2) 
 phb-1(tm2571) 17±1 23.45±0.05 215/227(2) < 0.0001 
phb-2(tm2998) 14.5±0.5 25.30±1.307 302/313(2) < 0.0001 
daf-2(e1370) 30.5±2.5 57.31±1.312 134/333(2) < 0.0001 
phb-2(tm2998); 





Table 4: Summary of lifespan data upon depletion of GSK-3 
# compared to respective genetic background versus gsk-3(RNAi)                                                          
§ phb-2(tm2998) and daf-2(e1370) mutants compared to wild type                                                                          
ǂ phb-2(tm2998);daf-2(e1370) mutants compared to daf-2(e1370) mutants                                                              
‡ phb-2(tm2998);gsk-3(RNAi) versus wild type; gsk-3(RNAi)                                                                                      
‖ phb-2(tm2998);daf-2(e1370);gsk-3(RNAi) versus daf-2(e1370);gsk-3(RNAi)                                                       




















RNAi from eggs 










 36.84 % 







75 0.0015#   
< 0.0001‡ 18.75 % 



















87 < 0.0001# 
< 0.0001‖ 36.73 % 
RNAi from eggs (on FUdR) 
Wild type, N2 21 28.7 172/181(1) - - - 
gsk-3(RNAi) 16 21.8 53/206(1) 23.8 % 152 < 0.0001# 
phb-2(tm2998) 21 26.6 159/178(1) - - 0.0377§ 
phb-2(tm2998); 
gsk-3(RNAi) 
18 23.2 125/135(1) 14.2 % - <0.0001# 
< 0.0001‡ 







25 38.2 172/177(1) 32.4 % - < 0.0001# 
phb-2(tm2998); 
daf-2(e1370) 




25 42.6 30/80(1) 45.6 % - < 0.0001# 
0.0244‖ 
RNAi from Adulthood (Young Adult stage) 








 17.64 % 
phb-2(tm2998) 17±0 23.70±0.63 230/279(2) -  0.0093§ 
phb-2(tm2998); 
gsk-3(RNAi) 
17±0 22.82±0.17 290/378(2) 
No change 
18 ns #          
< 0.0001‡ No change 





















< 0.0001‖ 16.07 % 
Intestine specific RNAi system - rde-1(ne219);kbIs7 
rde-1(ne219); 
kbIs7 
14.5±0.5 21.23±0.68 233/298(2)  -  
rde-1(ne219); 


































14.5±2.2 25.8±1.74 230/716(4) 
68.57 % 














37±5 60.1±3.87 60/133(2) 
16.66 % 
- < 0.0001# 
25 % 
Inhibition of GSK-3 by addition of Lithium Chloride, 20°C 
Wild type; LiCl- 16 28.7 94/147(1) - -  
Wild type; LiCl+ 13 27.23 127/150(1) 18.75 % - < 0.0001# 
daf-2(e1370); 
LiCl - 
39 51.62 83/139(1) - -  
daf-2(e1370); 
LiCl + 
26 45.7 96/150(1) 33.33 % - < 0.0001# 
Inhibition of GSK-3 by addition of Lithium Chloride, 25°C 
Wild type; LiCl- 8 15.5 75/150(1) - -  














Table 5: Summary of lifespan data upon depletion of Wnt components 
# compared to respective genetic background versus test(RNAi)                                                            
§ phb-2(tm2998)  and daf-2(e1370) mutants compared to wild type                                                                          
ǂ phb-2(tm2998);daf-2(e1370) mutants compared to daf-2(e1370) mutants                                                              
‡ phb-2(tm2998);test(RNAi) versus wild type; test(RNAi)                                                                                      
‖ phb-2(tm2998); daf-2(e1370); test(RNAi) versus daf-2(e1370);test( RNAi)                                                       
















Depletion of kin-19 and bar-1 (RNAi from Adulthood) 
Wild type, N2 17±0 26.9±0.97 317/372(2) - - - 
kin-19(RNAi) 14±0 19.7±1.09 355/411(2) -17.64% 32 < 0.0001# 
bar-1(RNAi) 17±0 23.4±0.1 384/493(2) No change 38 < 0.0001# 





22.9±0.36 271/342(2) No change 8 




17±0 23.56±0.1 350/397(2) No change 10 
ns#           
ns‡ 
daf-2(e1370) 39.5±1.5 57.58±0.7 151/385(2)  - < 0.0001§ 
daf-2(e1370); 
kin-19(RNAi) 
23±1 36.3±1.91 338/380(2) -41.77% - < 0.0001# 
daf-2(e1370); 
bar-1(RNAi) 
33±5 51.61±2.0 179/423(2) -16.45% - < 0.0001# 
phb-2(tm2998); 
daf-2(e1370) 












44.5±6.5 69.41±1.9 154/213(2) -23.27% 40 








Table 6: Summary of lifespan data of additional screen candidates 
# compared to respective genetic background versus test(RNAi)                                                            
§ phb-2(tm2998)  and daf-2(e1370) mutants compared to wild type                                                                          
ǂ phb-2(tm2998);daf-2(e1370) mutants compared to daf-2(e1370) mutants                                                              
‡ phb-2(tm2998); test(RNAi) versus wild type; test(RNAi)                                                                                      
‖ phb-2(tm2998); daf-2(e1370); test(RNAi) versus daf-2(e1370);test( RNAi)                                                       

















Depletion of mtk-1 (RNAi from eggs) 
Wild type, N2 18.6±0.3 26.4±0.7 494/529(3) - - - 
mtk-1(RNAi) 19.3±0.8 26.4±1.0 479/498(3) - - ns# 
phb-2(tm2998) 18±0.5 24.8±0.6 405/464(3) - - 0.0018§ 
phb-2(tm2998); 
mtk-1(RNAi) 
22.3±1.8 33.8±0.2 269/465(3) +23.88% - <0.0001# 
< 0.0001‡ 
daf-2(e1370) 38±8 57.7±1.5 174/360(2) - - < 0.0001§ 
daf-2(e1370); 
mtk-1(RNAi) 
40.5±5.5 58.7±2.9 179/349(2) - - ns# 
phb-2(tm2998); 
daf-2(e1370) 




51.5±0.5 73.8±6.3 106/205(2) -11.20% - 0.0037# 
< 0.0001‖ 
Depletion of rsks-1 (RNAi from eggs) 
Wild type, N2 19 25.3 131/179(1) - -  
rsks-1(RNAi) 17 25 130/180(1) -10.52% - 0.0040# 
phb-2(tm2998) 17 24.3 105/128(1) - - 0.0078§ 
phb-2(tm2998); 
rsks-1(RNAi) 
21 32.3 94/149(1) +23.52% - <0.0001# 
daf-2(e1370) 40 57.8 60/210(1) - - <0.0001§ 
daf-2(e1370); 
rsks-1(RNAi) 
45 65.25 38/210(1) +11.11% - 0.0204# 
phb-2(tm2998); 
daf-2(e1370) 








54 77.5 24/163(1) -14.28% - 0.0675# 
Depletion of rsks-1 (RNAi from eggs, LS on FUdR) 
Wild type, N2 21 28.7 172/181(1) - -  
rsks-1(RNAi) 21 28.55 178/180(1) No effect - ns# 
phb-2(tm2998) 21 26.62 159/178(1) - - 0.0377§ 
phb-2(tm2998); 
rsks-1(RNAi) 
23 29.66 61/78(1) +8.69% - 0.0003# 
daf-2(e1370) 37 43.93 159/179(1) - - <0.0001§ 
daf-2(e1370); 
rsks-1(RNAi) 
28 48.7 165/184(1) -24.32% - 0.0233# 
phb-2(tm2998); 
daf-2(e1370) 




57 71.12 83/100 (1) +23.9% - <0.0001# 
Depletion of Y50D7A.3 (RNAi from eggs) 
Wild type, N2 19±0 26.5±0.6 443/508(3) - - - 
Y50D7A.3 (RNAi) 17.6±0.6 26.1±0.8 469/510(3) -7.36% - 0.0240# 
phb-2(tm2998) 17.6±0.6 25±0.4 428/489(3) - - <0.0001§ 
phb-2(tm2998); 
Y50D7A.3 (RNAi) 
18.3±0.6 26.5±1.0 400/536(3) +3.97% - <0.0001# 
daf-2(e1370) 43±3 58.5±0.6 119/377(2) - - <0.0001§ 
daf-2(e1370); 
Y50D7A.3 (RNAi) 
39.5±1.5 58±0.7 174/359(2) -8.13 - ns# 
phb-2(tm2998); 
daf-2(e1370) 




67.5±5.5 86.4±4.0 55/191(2) +8% - ns# 
Depletion of kin-1 (RNAi from L3/L4) 
Wild type, N2 18 24.9 182/200(1) - - - 
kin-1(RNAi) population lost due to vulval bursting 
phb-2(tm2998) 18 23.6 82/103(1) - - ns§ 
phb-2(tm2998); 
kin-1(RNAi) 
13 18 24/136(1) -27.77% 110 <0.0001# 







population lost due to vulval bursting 
phb-2(tm2998); 
daf-2(e1370) 




30 54.3 31/158(1) -44.44% 75 <0.0001# 
Supplementation of FUdR 
Wild type, N2 19 27.5 138/149(1) - - - 
Wild type, N2; 
FUdR 
24 30 144/151(1) +26.31% - <0.0001# 
phb-2(tm2998) 17 25.8 147/151(1) - - - 
phb-2(tm2998); 
FUdR 
19 25.7 141/150(1) +11.76% - <0.0001# 
daf-2(e1370) 46 51.66 59/167(1) - - - 
daf-2(e1370); 
FUdR 
39 49 162/180(1) -15.21% - <0.0001# 
phb-2(tm2998); 
daf-2(e1370) 





















Table 7: Primer information for genes listed in this thesis  
Gene MRS code Sequences (5’-3’) 
cpt-2 173 
174 
Forward - GCAAGATGGATTCGGTATTGG 
Reverse - TCACGTTTCGACTTATTGCTC 
fat-7 181 
182 
Forward - GCTCTCTATGTGTTCTCAGG 
Reverse - CAATGATGTCGTTTTGAAGAGC 
fasn-1 183 
184 
Forward - GGATAATACTGGAGAAGGATCG 
Reverse - ATGTTGTCCGAAGACTGAG 
mdh-2 195 
196 
Forward - TTCCGAGCTTAAGGGACATGAC 
Reverse - GAGAATTTGGTGGATGGTTTGAC 
icl-1 197 
198 
Forward - GCTGTCAGTCGTGCGGTTAC 
Reverse - GCGGTGAGCGAAAGGATTT 
acdh-1 177 
178 
Forward - GCAAATGCAGATCCTAGCC 
Reverse - GTTTGTCTTTCCTCCTTATCTACAG 
acdh-9 179 
180 
Forward - GGCAGACTTCCAGTATAACC 
Reverse - GCGTTTCTAACGATTAGTCTG 
acdh-12 163 
164 
Forward - CCGATGTTTTCACTGTGTTTGC 
Reverse - CAAACGCTCTTTCGACAATGAAT 
ucp-4 165 
166 
Forward - CGAACTTAAAGATAATTGGCTAACTCA 
Reverse - CGACATCTGATGGAAGTGATACAA 
acs-17 161 
162 
Forward - GGAGACTATCACTGGAGAAGCTATG 
Reverse - GAACTGCTTCGTCTCCAAGAGTAG 
cdc-42 Askjaer Lab Forward -  CTTTGAGCAATGATGCGAAA  
Reverse -  TCATTCGAGAATGTCCGAGA 
pmp-3 Askjaer Lab Forward -  TGGCCGGATGATGGTGTCGC 
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